STOCK TITAN

Amass Brands flags going-concern doubt in Q3 2026

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Amass Brands reported third-quarter 2026 results, with net revenue of $5,368,515 versus $4,067,106 a year earlier. The quarter recorded a gross loss of $539,371, versus gross profit of $336,665, and net loss of $5,725,783, compared with $8,900,627. For the nine months ended September 30, 2026, revenue was $15,110,602 versus $13,912,481 and net loss was $16,316,603 versus $13,885,671.

Management said substantial doubt exists about Amass Brands’ ability to continue as a going concern within one year. At September 30, 2026, cash and cash equivalents were $818,937, the working capital deficit was $10,146,974, and operating activities used $7,612,731 during the first nine months. At that date, $550,000 of promissory notes and the Mezzanine Secured Notes were past due, while approximately $4.1 million owed under bulk-wine purchase commitments was past contractual payment dates. Nasdaq notified the company on July 22, 2026 that market-value requirements were unmet and in October 2026 of a minimum-bid-price deficiency. The company also recorded a $1,100,531 impairment of its Afterdream SAFE investment and a $1,282,510 loss on contracts in the quarter.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 4 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Moderate pointThird-quarter revenue was $5,368,515 versus $4,067,106 a year earlier.
  • Moderate pointThird-quarter net loss was $5,725,783 versus $8,900,627 in 2025.

Negative

  • Major point. Forward-looking: it has not happened yet and may not happen.Management cited substantial doubt about continued operations within one year.
  • Major pointNine-month net loss was $16,316,603 versus $13,885,671 in 2025.
  • Moderate pointOperating cash use was $7,612,731 versus $822,955 for the nine months ended September 30.
  • Moderate point$550,000 of promissory notes and approximately $4.1 million in bulk-wine commitments were past due at September 30, 2026.

Filing Explained

September thirtieth terms indicated about twelve point eight million potential common shares from Series C; an October amendment changed the conversion terms.

At September 30, 2026, 8,825 Series C preferred shares were outstanding and convertible into about 12.8 million common shares using the then-effective $0.75 minimum price; those common shares were potential issuance, not completed issuance. The filing reports that an October 22, 2026 amendment reduced the floor price to $1.00 and removed the separate $0.75 minimum for limited conversions, so the September 30 share estimate reflects earlier terms.

If those common shares are issued, they would increase the share count and reduce existing holders’ percentage ownership absent offsetting changes.

The filing also reports that a separate warrant to buy up to 3.5 million common shares was terminated on October 22, 2026, ending that warrant-based issuance path.

Third-quarter net revenue $5,368,515 Three months ended September 30, 2026; compared with $4,067,106 in 2025
Third-quarter gross loss $539,371 Three months ended September 30, 2026; compared with gross profit of $336,665 in 2025
Third-quarter net loss $5,725,783 Three months ended September 30, 2026; compared with $8,900,627 in 2025
Nine-month net revenue $15,110,602 Nine months ended September 30, 2026; compared with $13,912,481 in 2025
Nine-month net loss $16,316,603 Nine months ended September 30, 2026; compared with $13,885,671 in 2025
Cash used in operating activities $7,612,731 Nine months ended September 30, 2026; compared with $822,955 in 2025
Cash and cash equivalents $818,937 As of September 30, 2026
Working capital deficit $10,146,974 As of September 30, 2026
going concern financial
"ability to continue as a going concern within one year"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
working capital deficit financial
"a working capital deficit of $10,146,974"
A working capital deficit occurs when a company's short-term obligations—like bills, supplier payments and near-term debt—are larger than its readily available short-term resources such as cash, money expected from customers, and inventory that can be sold. Like a household whose monthly bills exceed its checking account, it signals potential difficulty paying immediate expenses, which matters to investors because it raises the chance the company will need outside financing or cut operations, affecting risk and value.
Level 3 inputs technical
"measured using Level 3 inputs"
Level 3 inputs are the assumptions and estimates a company uses to value assets or liabilities when there is no observable market price, so the valuation relies heavily on internal models and judgment. For investors this matters because these valuations are less verifiable and more subject to error or bias—like estimating the value of a unique vintage car versus checking a price list—and can materially affect reported earnings and balance-sheet strength.
variable interest entity financial
"HpO is a variable interest entity that the Company does not consolidate"
A variable interest entity (VIE) is a company structure where one party controls another company’s operations and economic outcomes through contracts or special arrangements instead of owning a majority of its voting shares. For investors, VIEs matter because the controlling party’s financial results, debts and risks can appear in the controller’s reports even though ownership looks separate, so understanding VIEs helps assess true exposure, governance limits and transparency—like spotting a puppet controlled by strings rather than direct ownership.
beneficial ownership limitation regulatory
"subject to a 9.99% beneficial ownership limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Simple Agreement for Future Equity financial
"Simple Agreement for Future Equity (“SAFE”)"
A simple agreement for future equity is an investment contract that gives an investor the right to receive company shares at a later financing event or sale instead of getting shares immediately. Think of it like a voucher that converts into ownership once the company’s value is formally set; it matters to investors because it fixes how and when ownership is awarded, affects how much of the company they ultimately own, and influences dilution and return potential.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue did AMSS report in Q3 2026?

AMSS reported third-quarter net revenue of $5,368,515 for the three months ended September 30, 2026, compared with $4,067,106 for the same period in 2025.

Why did AMSS report substantial doubt about continuing as a going concern?

Amass said continued operations depend on operating cash or additional working capital. The company said it had not generated enough operating cash to meet obligations to date and plans to raise capital through stock and loans, including additional purchases under the Streeterville facility, subject to the SPA’s conditions; it gave no assurance those efforts would succeed.

How many AMSS common shares were outstanding?

As of November 19, 2026, Amass Brands had 12,152,149 Common Stock shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
falseAMASS BRANDS0001851491--12-31Q3CA0Comparable Adjustments are items that management excludes from segment results because they are not reflective of current operations. For 2026 they comprise the August 2026 sale of bulk wine to Full Glass and its cost, the provision for losses on bulk wine purchase commitments and the write-down of the remaining bulk wine the Company has agreed to sell to Full Glass, all recorded in the third quarter of 2026, stock-based compensation and impairment losses; for 2025 they comprise bulk wine sales and related costs and storage, the loss on bulk wine purchase commitments recognized in the third quarter of 2025, stock-based compensation and the impairment loss recognized in the third quarter of 2025.Segment amounts are derived from the Company’s entity- and brand-level general ledger reporting: the Non-Alcoholic and Functional segment reflects the Good Twin brand activity and the Amass Electrolyte entity; the Wine & Spirits segment reflects the remaining operating entities.Unallocated amounts include costs held in the corporate infrastructure that are not allocated to any reporting segment and the shared-services fees charged to Afterdream, a related party (see Note 14), which are presented in net revenues.Segment gross profit is reconciled to gross profit on the consolidated statement of operations with the inclusion of unallocated amounts and Comparable Adjustments.Sales of excess bulk wine and the related costs and storage are not part of the Company’s regular operations and are excluded from the CODM’s review. For the third quarter of 2026, (a) also includes the bulk wine items listed above, and for the third quarter of 2025 it includes a $124,476 loss on bulk wine purchase commitments, which, as in the Company’s 2025 annual financial statements, is excluded because it resulted from the Company’s historical acquisitions and not from core wine operations.The CODM does not consider stock-based compensation or impairment losses in evaluating segment performance. 0001851491 2026-09-30 0001851491 2025-12-31 0001851491 2026-07-01 2026-09-30 0001851491 2025-07-01 2025-09-30 0001851491 2026-01-01 2026-09-30 0001851491 2025-01-01 2025-09-30 0001851491 2025-02-01 2025-02-01 0001851491 2025-04-01 2025-06-30 0001851491 2026-01-01 2026-03-31 0001851491 2026-04-01 2026-06-30 0001851491 2025-01-01 2025-12-31 0001851491 2026-11-19 0001851491 2026-05-20 0001851491 2025-01-01 2025-03-31 0001851491 2026-05-20 2026-05-20 0001851491 2026-08-19 2026-08-19 0001851491 2026-08-19 0001851491 2026-03-31 0001851491 2025-09-30 0001851491 2026-07-31 2026-07-31 0001851491 2026-09-23 0001851491 2026-09-30 2026-09-30 0001851491 2026-09-23 2026-09-23 0001851491 2026-03-17 0001851491 2026-08-31 2026-08-31 0001851491 2026-06-01 2026-06-30 0001851491 2026-06-30 0001851491 2026-07-31 0001851491 2026-10-22 0001851491 2026-04-08 0001851491 2024-12-31 0001851491 2025-03-31 0001851491 2025-06-30 0001851491 amss:SeriesSeedPreferredStockMember 2026-09-30 0001851491 us-gaap:SeriesAPreferredStockMember 2026-09-30 0001851491 us-gaap:SeriesBPreferredStockMember 2026-09-30 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-09-30 0001851491 srt:ChiefExecutiveOfficerMember 2026-09-30 0001851491 amss:PromissoryNotesMember 2026-09-30 0001851491 us-gaap:LineOfCreditMember srt:MinimumMember 2026-09-30 0001851491 us-gaap:LineOfCreditMember srt:MaximumMember 2026-09-30 0001851491 us-gaap:LineOfCreditMember 2026-09-30 0001851491 amss:MezzanineSecuredNotesMember 2026-09-30 0001851491 amss:SecuredPromissoryNoteMember 2026-09-30 0001851491 us-gaap:PurchaseCommitmentMember 2026-09-30 0001851491 us-gaap:LeaseholdImprovementsMember 2026-09-30 0001851491 us-gaap:FurnitureAndFixturesMember 2026-09-30 0001851491 us-gaap:OfficeEquipmentMember 2026-09-30 0001851491 us-gaap:PropertyPlantAndEquipmentMember 2026-09-30 0001851491 amss:BrandNamesMember 2026-09-30 0001851491 us-gaap:TradeNamesMember 2026-09-30 0001851491 amss:WebsiteDevelopmentMember 2026-09-30 0001851491 amss:NonCompetesMember 2026-09-30 0001851491 us-gaap:CustomerListsMember 2026-09-30 0001851491 amss:PromissoryNoteMember us-gaap:ConvertibleDebtMember 2026-09-30 0001851491 us-gaap:RelatedPartyMember 2026-09-30 0001851491 us-gaap:ConvertibleDebtMember 2026-09-30 0001851491 amss:TwoThousandTwentySixStockPlanMember 2026-09-30 0001851491 amss:SeriesB1PreferredStockWarrantMember 2026-09-30 0001851491 amss:WarrantsIssuedInFirstQuarterOfTwoThousandTwentySixMember 2026-09-30 0001851491 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2026-09-30 0001851491 amss:SeriesCConvertiblePreferredStockMember us-gaap:PreferredStockMember 2026-09-30 0001851491 amss:SeriesSeedPreferredStocksMember us-gaap:PreferredStockMember 2026-09-30 0001851491 amss:CommonNonVotingStockMember us-gaap:CommonStockMember 2026-09-30 0001851491 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2026-09-30 0001851491 amss:CommonVotingStockMember us-gaap:CommonStockMember 2026-09-30 0001851491 amss:SideLetterAgreementMember 2026-09-30 0001851491 amss:RawmaterialsMember 2026-09-30 0001851491 amss:HPOsMember 2026-09-30 0001851491 amss:PaycheckProtectionProgramLoanMember 2026-09-30 0001851491 amss:SbaEidlLoanMember 2026-09-30 0001851491 amss:AfterdreamMember 2026-09-30 0001851491 amss:AFTERDREAMIncMember amss:DeSoiMember 2026-09-30 0001851491 amss:SAFENotesMember amss:AFTERDREAMIncMember 2026-09-30 0001851491 amss:ConvertibleNotesMember 2026-09-30 0001851491 amss:PromissoryNotesMember amss:ShareholderMember 2026-09-30 0001851491 amss:HPOMember 2026-09-30 0001851491 amss:SimpleAgreementForFutureEquityMember amss:AfterdreamMember 2026-09-30 0001851491 amss:SimpleAgreementForFutureEquityMember 2026-09-30 0001851491 amss:StreetervilleWarrantsMember 2026-09-30 0001851491 amss:PromisoryNotesMember 2026-09-30 0001851491 us-gaap:LetterOfCreditMember 2026-09-30 0001851491 us-gaap:PreferredStockMember 2026-09-30 0001851491 srt:MinimumMember amss:SeriesCConvertiblePreferredStockMember 2026-09-30 0001851491 srt:MaximumMember amss:SeriesCConvertiblePreferredStockMember 2026-09-30 0001851491 amss:SeriesCConvertiblePreferredStockMember amss:ConversionFeatureDerivativeMember 2026-09-30 0001851491 amss:AFTERDREAMIncMember 2026-09-30 0001851491 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2026-09-30 0001851491 us-gaap:AccountsPayableMember 2026-09-30 0001851491 amss:FullGlassMember 2026-09-30 0001851491 amss:PastPaymentDateMember 2026-09-30 0001851491 amss:SeriesSeedPreferredStockMember 2025-12-31 0001851491 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001851491 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001851491 amss:SeriesCConvertiblePreferredStockMember 2025-12-31 0001851491 srt:ChiefExecutiveOfficerMember 2025-12-31 0001851491 amss:MezzanineSecuredNotesMember 2025-12-31 0001851491 amss:PromissoryNotesMember 2025-12-31 0001851491 us-gaap:LineOfCreditMember 2025-12-31 0001851491 amss:MezzanineSecuredNotesMember 2025-12-31 0001851491 amss:SecuredPromissoryNoteMember 2025-12-31 0001851491 us-gaap:PurchaseCommitmentMember 2025-12-31 0001851491 us-gaap:FurnitureAndFixturesMember 2025-12-31 0001851491 us-gaap:OfficeEquipmentMember 2025-12-31 0001851491 us-gaap:PropertyPlantAndEquipmentMember 2025-12-31 0001851491 us-gaap:LeaseholdImprovementsMember 2025-12-31 0001851491 amss:BrandNamesMember 2025-12-31 0001851491 us-gaap:TradeNamesMember 2025-12-31 0001851491 amss:WebsiteDevelopmentMember 2025-12-31 0001851491 amss:NonCompetesMember 2025-12-31 0001851491 us-gaap:CustomerListsMember 2025-12-31 0001851491 us-gaap:ConvertibleDebtMember 2025-12-31 0001851491 amss:SeriesB1PreferredStockWarrantMember 2025-12-31 0001851491 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001851491 amss:SeriesCConvertiblePreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001851491 amss:CommonNonVotingStockMember us-gaap:CommonStockMember 2025-12-31 0001851491 amss:SeriesSeedPreferredStocksMember us-gaap:PreferredStockMember 2025-12-31 0001851491 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001851491 amss:CommonVotingStockMember us-gaap:CommonStockMember 2025-12-31 0001851491 amss:RawmaterialsMember 2025-12-31 0001851491 amss:HPOsMember 2025-12-31 0001851491 amss:PaycheckProtectionProgramLoanMember 2025-12-31 0001851491 amss:SbaEidlLoanMember 2025-12-31 0001851491 amss:AFTERDREAMIncMember amss:DeSoiMember 2025-12-31 0001851491 amss:PromissoryNotesMember amss:ShareholderMember 2025-12-31 0001851491 amss:HPOMember 2025-12-31 0001851491 us-gaap:PropertyPlantAndEquipmentMember amss:GeneralAndAdministrativeExpensesMember 2025-01-01 2025-09-30 0001851491 us-gaap:OtherIntangibleAssetsMember 2025-01-01 2025-09-30 0001851491 srt:ConsolidationEliminationsMember amss:WineAndSpiritsMember 2025-01-01 2025-09-30 0001851491 srt:ConsolidationEliminationsMember amss:StockBasedCompensationMember 2025-01-01 2025-09-30 0001851491 srt:ConsolidationEliminationsMember 2025-01-01 2025-09-30 0001851491 us-gaap:NonUsMember 2025-01-01 2025-09-30 0001851491 srt:AmericasMember 2025-01-01 2025-09-30 0001851491 us-gaap:OperatingSegmentsMember 2025-01-01 2025-09-30 0001851491 us-gaap:IntersegmentEliminationMember 2025-01-01 2025-09-30 0001851491 us-gaap:OperatingSegmentsMember amss:WineAndSpiritsMember 2025-01-01 2025-09-30 0001851491 us-gaap:OperatingSegmentsMember amss:NonAlcoholicAndFunctionalMember 2025-01-01 2025-09-30 0001851491 us-gaap:ShippingAndHandlingMember 2025-01-01 2025-09-30 0001851491 us-gaap:ConvertibleDebtMember 2025-01-01 2025-09-30 0001851491 us-gaap:DerivativeMember 2025-01-01 2025-09-30 0001851491 amss:GeoffMcFarlaneMember 2025-01-01 2025-09-30 0001851491 amss:SeriesCConvertiblePreferredStockMember 2025-01-01 2025-09-30 0001851491 us-gaap:WarrantMember 2025-01-01 2025-09-30 0001851491 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-09-30 0001851491 amss:AFTERDREAMIncMember 2025-01-01 2025-09-30 0001851491 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001851491 us-gaap:PropertyPlantAndEquipmentMember amss:GeneralAndAdministrativeExpensesMember 2025-07-01 2025-09-30 0001851491 us-gaap:OtherIntangibleAssetsMember 2025-07-01 2025-09-30 0001851491 srt:ConsolidationEliminationsMember amss:WineAndSpiritsMember 2025-07-01 2025-09-30 0001851491 srt:ConsolidationEliminationsMember amss:StockBasedCompensationMember 2025-07-01 2025-09-30 0001851491 srt:ConsolidationEliminationsMember 2025-07-01 2025-09-30 0001851491 srt:AmericasMember 2025-07-01 2025-09-30 0001851491 us-gaap:NonUsMember 2025-07-01 2025-09-30 0001851491 us-gaap:OperatingSegmentsMember 2025-07-01 2025-09-30 0001851491 us-gaap:OperatingSegmentsMember amss:NonAlcoholicAndFunctionalMember 2025-07-01 2025-09-30 0001851491 us-gaap:OperatingSegmentsMember amss:WineAndSpiritsMember 2025-07-01 2025-09-30 0001851491 us-gaap:IntersegmentEliminationMember 2025-07-01 2025-09-30 0001851491 us-gaap:ShippingAndHandlingMember 2025-07-01 2025-09-30 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2025-07-01 2025-09-30 0001851491 us-gaap:ConvertibleDebtMember 2025-07-01 2025-09-30 0001851491 us-gaap:DerivativeMember 2025-07-01 2025-09-30 0001851491 amss:GeoffMcFarlaneMember 2025-07-01 2025-09-30 0001851491 amss:AFTERDREAMIncMember 2025-07-01 2025-09-30 0001851491 us-gaap:NoncontrollingInterestMember 2025-07-01 2025-09-30 0001851491 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001851491 us-gaap:LossOnLongTermPurchaseCommitmentMember 2025-07-01 2025-09-30 0001851491 us-gaap:PropertyPlantAndEquipmentMember amss:GeneralAndAdministrativeExpensesMember 2026-01-01 2026-09-30 0001851491 us-gaap:OtherIntangibleAssetsMember 2026-01-01 2026-09-30 0001851491 srt:ConsolidationEliminationsMember amss:WineAndSpiritsMember 2026-01-01 2026-09-30 0001851491 srt:ConsolidationEliminationsMember amss:StockBasedCompensationMember 2026-01-01 2026-09-30 0001851491 srt:ConsolidationEliminationsMember 2026-01-01 2026-09-30 0001851491 us-gaap:NonUsMember 2026-01-01 2026-09-30 0001851491 srt:AmericasMember 2026-01-01 2026-09-30 0001851491 us-gaap:ConvertibleDebtMember 2026-01-01 2026-09-30 0001851491 us-gaap:OperatingSegmentsMember 2026-01-01 2026-09-30 0001851491 us-gaap:IntersegmentEliminationMember 2026-01-01 2026-09-30 0001851491 us-gaap:OperatingSegmentsMember amss:WineAndSpiritsMember 2026-01-01 2026-09-30 0001851491 us-gaap:OperatingSegmentsMember amss:NonAlcoholicAndFunctionalMember 2026-01-01 2026-09-30 0001851491 us-gaap:ShippingAndHandlingMember 2026-01-01 2026-09-30 0001851491 amss:NetSalesMember us-gaap:CreditConcentrationRiskMember amss:CustomerAMember 2026-01-01 2026-09-30 0001851491 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember amss:CustomerAMember 2026-01-01 2026-09-30 0001851491 us-gaap:ConvertiblePreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-09-30 0001851491 amss:SecuredPromissoryNoteMember 2026-01-01 2026-09-30 0001851491 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001851491 us-gaap:DerivativeMember 2026-01-01 2026-09-30 0001851491 amss:GeoffMcFarlaneMember 2026-01-01 2026-09-30 0001851491 amss:SimpleAgreementForFutureEquityMember amss:AfterdreamMember 2026-01-01 2026-09-30 0001851491 amss:CommonStockWarrantsMember 2026-01-01 2026-09-30 0001851491 amss:WarrantsIssuedInFirstQuarterOfTwoThousandTwentySixMember 2026-01-01 2026-09-30 0001851491 us-gaap:PurchaseCommitmentMember 2026-01-01 2026-09-30 0001851491 us-gaap:WarrantMember 2026-01-01 2026-09-30 0001851491 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-09-30 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-01-01 2026-09-30 0001851491 amss:AFTERDREAMIncMember 2026-01-01 2026-09-30 0001851491 amss:SideLetterAgreementMember 2026-01-01 2026-09-30 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-01-01 2026-09-30 0001851491 us-gaap:PropertyPlantAndEquipmentMember amss:GeneralAndAdministrativeExpensesMember 2026-07-01 2026-09-30 0001851491 us-gaap:OtherIntangibleAssetsMember 2026-07-01 2026-09-30 0001851491 srt:ConsolidationEliminationsMember amss:WineAndSpiritsMember 2026-07-01 2026-09-30 0001851491 srt:ConsolidationEliminationsMember amss:StockBasedCompensationMember 2026-07-01 2026-09-30 0001851491 srt:ConsolidationEliminationsMember 2026-07-01 2026-09-30 0001851491 srt:AmericasMember 2026-07-01 2026-09-30 0001851491 us-gaap:NonUsMember 2026-07-01 2026-09-30 0001851491 us-gaap:OperatingSegmentsMember amss:WineAndSpiritsMember 2026-07-01 2026-09-30 0001851491 us-gaap:OperatingSegmentsMember amss:NonAlcoholicAndFunctionalMember 2026-07-01 2026-09-30 0001851491 us-gaap:OperatingSegmentsMember 2026-07-01 2026-09-30 0001851491 us-gaap:IntersegmentEliminationMember 2026-07-01 2026-09-30 0001851491 us-gaap:ShippingAndHandlingMember 2026-07-01 2026-09-30 0001851491 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember amss:CustomerAMember 2026-07-01 2026-09-30 0001851491 amss:NetSalesMember us-gaap:CreditConcentrationRiskMember amss:CustomerAMember 2026-07-01 2026-09-30 0001851491 us-gaap:ConvertibleDebtMember 2026-07-01 2026-09-30 0001851491 amss:PromissoryNotesMember 2026-07-01 2026-09-30 0001851491 us-gaap:DerivativeMember 2026-07-01 2026-09-30 0001851491 amss:AfterdreamMember 2026-07-01 2026-09-30 0001851491 us-gaap:AssetsMember 2026-07-01 2026-09-30 0001851491 amss:SAFENotesMember amss:AFTERDREAMIncMember 2026-07-01 2026-09-30 0001851491 amss:GeoffMcFarlaneMember 2026-07-01 2026-09-30 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2026-07-01 2026-09-30 0001851491 us-gaap:NoncontrollingInterestMember 2026-07-01 2026-09-30 0001851491 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001851491 us-gaap:ConvertiblePreferredStockMember us-gaap:PreferredStockMember 2026-07-01 2026-09-30 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-07-01 2026-09-30 0001851491 amss:FullGlassMember 2026-07-01 2026-09-30 0001851491 us-gaap:PreferredStockMember 2026-07-01 2026-09-30 0001851491 amss:AFTERDREAMIncMember 2026-07-01 2026-09-30 0001851491 amss:SideLetterAgreementMember 2026-07-01 2026-09-30 0001851491 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001851491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2026-07-01 2026-09-30 0001851491 amss:SettlementAgreementMember 2026-07-01 2026-09-30 0001851491 srt:ScenarioPreviouslyReportedMember 2026-07-01 2026-09-30 0001851491 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2025-01-01 2025-03-31 0001851491 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001851491 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001851491 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2026-01-01 2026-03-31 0001851491 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0001851491 us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001851491 amss:SeriesB1PreferredStockWarrantMember 2026-01-01 2026-03-31 0001851491 amss:TreasuryCommonStockMember 2026-01-01 2026-03-31 0001851491 amss:EquityTransactionsMember us-gaap:RelatedPartyMember 2026-01-01 2026-03-31 0001851491 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001851491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2026-01-01 2026-03-31 0001851491 amss:SeriesB1PreferredStockWarrantMember us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001851491 amss:SeriesB1PreferredStockWarrantMember amss:SeriesB1PreferredStockMember 2026-01-01 2026-03-31 0001851491 amss:AFTERDREAMIncMember amss:DeSoiMember 2025-01-01 2025-12-31 0001851491 amss:HPOsMember 2025-04-30 0001851491 amss:SimpleAgreementForFutureEquityMember amss:HPOsMember 2026-07-31 0001851491 us-gaap:AssetsMember 2026-07-31 0001851491 amss:SimpleAgreementForFutureEquityMember amss:AfterdreamMember 2026-06-16 2026-06-16 0001851491 amss:SimpleAgreementForFutureEquityMember amss:AfterdreamMember 2026-06-16 0001851491 amss:SimpleAgreementForFutureEquityMember srt:MinimumMember amss:AfterdreamMember 2026-06-17 2026-06-24 0001851491 amss:SimpleAgreementForFutureEquityMember srt:MaximumMember amss:AfterdreamMember 2026-06-17 2026-06-24 0001851491 us-gaap:ConvertibleDebtMember 2026-05-20 0001851491 us-gaap:ConvertiblePreferredStockMember 2026-05-20 2026-05-20 0001851491 amss:SeriesCConvertiblePreferredStockMember us-gaap:PreferredStockMember 2026-05-20 2026-05-20 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-05-20 2026-05-20 0001851491 us-gaap:LineOfCreditMember 2025-09-30 0001851491 us-gaap:LineOfCreditMember 2023-09-30 0001851491 us-gaap:LineOfCreditMember 2026-03-10 0001851491 amss:MezzanineSecuredNotesMember 2026-03-01 2026-03-31 0001851491 amss:MezzanineSecuredNotesMember us-gaap:RelatedPartyMember 2026-03-01 2026-03-31 0001851491 amss:SecuredPromissoryNoteMember 2024-04-30 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-03-17 2026-03-17 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-04-08 2026-04-08 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-04-08 0001851491 srt:ChiefExecutiveOfficerMember 2026-03-31 0001851491 amss:MezzanineSecuredNotesMember 2026-03-31 0001851491 amss:ConvertibleNotesMember 2026-03-31 0001851491 amss:ConvertibleNotesMember amss:MVLIncMember 2026-03-31 0001851491 srt:ChiefExecutiveOfficerMember 2022-01-31 0001851491 srt:ChiefExecutiveOfficerMember 2026-03-31 2026-03-31 0001851491 amss:PromissoryNotesMember amss:ShareholderMember 2025-01-31 0001851491 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001851491 us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2026-04-01 2026-06-30 0001851491 us-gaap:NoncontrollingInterestMember 2026-04-01 2026-06-30 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-04-01 2026-06-30 0001851491 amss:Amendment1Member amss:SeriesCConvertiblePreferredStockMember 2026-04-01 2026-06-30 0001851491 amss:Amendment2Member amss:SeriesCConvertiblePreferredStockMember 2026-04-01 2026-06-30 0001851491 amss:SeriesB1PreferredStockWarrantMember 2026-04-01 2026-06-30 0001851491 amss:StreetervilleWarrantsMember 2026-04-01 2026-06-30 0001851491 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001851491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2026-04-01 2026-06-30 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2025-04-01 2025-06-30 0001851491 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001851491 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001851491 us-gaap:NoncontrollingInterestMember 2025-04-01 2025-06-30 0001851491 amss:SecuredPromissoryNoteMember 2026-10-25 0001851491 amss:NasdaqMinimumBidPriceNoticeMember us-gaap:SubsequentEventMember 2026-10-09 0001851491 amss:StreetervilleWarrantsMember us-gaap:SubsequentEventMember 2026-10-22 0001851491 srt:MinimumMember amss:SeriesCTriggerEventMember us-gaap:SubsequentEventMember 2026-10-22 0001851491 srt:MaximumMember amss:SeriesCTriggerEventMember us-gaap:SubsequentEventMember 2026-10-22 0001851491 us-gaap:PreferredStockMember 2026-10-22 0001851491 amss:SeriesCTriggerEventMember us-gaap:SubsequentEventMember 2026-10-22 0001851491 amss:AFTERDREAMIncMember us-gaap:SubsequentEventMember 2026-10-01 2026-10-31 0001851491 us-gaap:SubsequentEventMember 2026-10-31 2026-10-31 0001851491 amss:AFTERDREAMIncMember 2026-07-01 2026-07-31 0001851491 amss:AFTERDREAMIncMember 2025-05-01 2025-05-31 0001851491 amss:TwoThousandTwentySixOmnibusIncentivePlanMember 2026-07-20 0001851491 amss:StreetervilleMember amss:SeriesCConvertiblePreferredStockMember 2026-08-19 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-08-19 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-08-19 2026-08-19 0001851491 amss:StreetervilleMember amss:SeriesCConvertiblePreferredStockMember 2026-08-19 2026-08-19 0001851491 us-gaap:CommonStockMember 2026-09-23 2026-09-23 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-09-23 2026-09-23 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-09-23 0001851491 amss:SeriesCConvertiblePreferredStockMember us-gaap:PreferredStockMember 2026-09-23 0001851491 amss:SeriesCConvertiblePreferredStockMember amss:ConversionFeatureDerivativeMember 2026-09-23 0001851491 us-gaap:CommonStockMember 2026-09-23 0001851491 us-gaap:ConvertiblePreferredStockMember 2026-03-17 0001851491 amss:SeriesCConvertiblePreferredStockMember 2026-04-07 0001851491 us-gaap:SeriesCPreferredStockMember us-gaap:SubsequentEventMember 2026-11-05 0001851491 us-gaap:SubsequentEventMember 2026-11-05 0001851491 amss:GeoffMcFarlaneMember 2025-08-01 2025-08-31 0001851491 us-gaap:SeriesCPreferredStockMember us-gaap:SubsequentEventMember 2026-11-05 2026-11-05 0001851491 us-gaap:SubsequentEventMember 2026-11-05 2026-11-05 0001851491 us-gaap:SubsequentEventMember 2026-10-26 0001851491 us-gaap:SeriesCPreferredStockMember us-gaap:SubsequentEventMember 2026-10-26 0001851491 amss:PromisoryNotesMember 2026-09-30 2026-09-30 0001851491 amss:PromisoryNotesMember us-gaap:SubsequentEventMember 2026-10-31 0001851491 us-gaap:PreferredStockMember 2025-08-19 0001851491 srt:MinimumMember 2026-07-31 2026-07-31 0001851491 amss:MezzanineSecuredNotesMember 2026-02-28 2026-02-28 0001851491 amss:ConvertibleNoteWarrantsMember us-gaap:SubsequentEventMember 2026-11-16 0001851491 us-gaap:RetainedEarningsMember 2025-09-30 0001851491 us-gaap:PreferredStockMember 2025-09-30 0001851491 us-gaap:CommonStockMember 2025-09-30 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2025-09-30 0001851491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2025-09-30 0001851491 us-gaap:NoncontrollingInterestMember 2025-09-30 0001851491 us-gaap:NoncontrollingInterestMember 2026-09-30 0001851491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2026-09-30 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2026-09-30 0001851491 us-gaap:CommonStockMember 2026-09-30 0001851491 us-gaap:ConvertiblePreferredStockMember us-gaap:PreferredStockMember 2026-09-30 0001851491 amss:TreasuryCommonStockMember 2026-09-30 0001851491 us-gaap:RetainedEarningsMember 2026-09-30 0001851491 us-gaap:RetainedEarningsMember 2024-12-31 0001851491 us-gaap:NoncontrollingInterestMember 2024-12-31 0001851491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2024-12-31 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2024-12-31 0001851491 us-gaap:CommonStockMember 2024-12-31 0001851491 us-gaap:PreferredStockMember 2024-12-31 0001851491 us-gaap:CommonStockMember 2025-03-31 0001851491 us-gaap:PreferredStockMember 2025-03-31 0001851491 us-gaap:NoncontrollingInterestMember 2025-03-31 0001851491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2025-03-31 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2025-03-31 0001851491 us-gaap:RetainedEarningsMember 2025-03-31 0001851491 us-gaap:RetainedEarningsMember 2025-12-31 0001851491 us-gaap:NoncontrollingInterestMember 2025-12-31 0001851491 us-gaap:PreferredStockMember 2025-12-31 0001851491 us-gaap:CommonStockMember 2025-12-31 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2025-12-31 0001851491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2025-12-31 0001851491 amss:TreasuryCommonStockMember 2025-12-31 0001851491 us-gaap:NoncontrollingInterestMember 2026-03-31 0001851491 us-gaap:CommonStockMember 2026-03-31 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2026-03-31 0001851491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2026-03-31 0001851491 us-gaap:PreferredStockMember 2026-03-31 0001851491 amss:TreasuryCommonStockMember 2026-03-31 0001851491 us-gaap:RetainedEarningsMember 2026-03-31 0001851491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2026-06-30 0001851491 us-gaap:NoncontrollingInterestMember 2026-06-30 0001851491 us-gaap:PreferredStockMember 2026-06-30 0001851491 us-gaap:CommonStockMember 2026-06-30 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2026-06-30 0001851491 amss:TreasuryCommonStockMember 2026-06-30 0001851491 us-gaap:RetainedEarningsMember 2026-06-30 0001851491 us-gaap:CommonStockMember 2025-06-30 0001851491 us-gaap:PreferredStockMember 2025-06-30 0001851491 us-gaap:NoncontrollingInterestMember 2025-06-30 0001851491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2025-06-30 0001851491 amss:AdditionalPaidInCapitalInclusionTreasuryStockMember 2025-06-30 0001851491 us-gaap:RetainedEarningsMember 2025-06-30 iso4217:USD xbrli:shares xbrli:pure utr:Month utr:Year iso4217:USD xbrli:shares amss:Segment utr:Day amss:FloorPrice
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 30, 2026
 
Or
 
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from __________ to __________
 
Commission File Number: 001-43286

Amass Brands Inc

(Exact name of registrant as specified in its charter)
 
Delaware
 
81-5227282
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
 
860 E Stowell Road,
Santa Maria,
CA
 
 
93454
(Address of principal executive offices)
 
(Zip Code)
 
(909) 293-8495
(Registrant’s telephone number, including area code)
 
N/A
(Former name, former address and former fiscal year, if changed since last report)
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.00001 per share
 
AMSS
 
Nasdaq Global Market
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes
x
  No
¨
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes
x
  No
¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer  
¨
Accelerated filer  
¨
Non-accelerated filer  
x
Smaller reporting company  
x
 
Emerging growth company  
x
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes
¨
  No
x
 
As of November 19, 2026, the registrant had a total of 12,152,149 shares of Common Stock, $0.00001 par value, outstanding.
 
 
 
AMASS BRANDS INC
INDEX TO FORM 10-Q
 
 
 
Page
PART I – FINANCIAL INFORMATION
1
 
 
 
Item 1.
Financial Statements (Unaudited)
1
 
 
 
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
21
 
 
 
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
35
 
 
 
Item 4.
Controls and Procedures
36
 
 
 
PART II – OTHER INFORMATION
38
 
 
 
Item 1.
Legal Proceedings
38
 
 
 
Item 1A.
Risk Factors
38
 
 
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
39
 
 
 
Item 3.
Defaults Upon Senior Securities
39
 
 
 
Item 4.
Mine Safety Disclosures
39
 
 
 
Item 5.
Other Information
39
 
 
 
Item 6.
Exhibits
40
 
 
 
SIGNATURES
41
 
i
 
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
 
Certain statements in this Quarterly Report on Form 10-Q are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations and financial position, business plan and strategy, future revenue, timing and likelihood of success, plans and objectives of management for future operations, future results of anticipated products and prospects, plans and objectives of management are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements contained in this Quarterly Report on Form 10-Q may include, but are not limited to, statements about:
 
·
the implementation of our business model and our strategic plans for our business, product, services and technology;
·
our commercialization and marketing capabilities and strategy;
·
our ability to establish or maintain collaborations or strategic relationships or obtain additional funding;
·
our competitive position;
·
the scope of protection that we are able to establish and maintain for intellectual property rights covering our products, services and technology;
·
developments and projections relating to our competitors and our industry;
·
our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;
·
the period over which we estimate our existing cash and cash equivalents will be sufficient to fund our future operating expenses and capital expenditure requirements; and
·
the impact of new or existing laws and regulations on our business and strategy.
 
These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in “Risk Factors” of our Prospectuses dated May 18, 2026 and July 6, 2026, in any subsequent filing we make with the SEC, as well as in any documents incorporated by reference that describe risks and factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
 
Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on the forward-looking statements included in this Form 10-Q as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements.
 
In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to unduly rely upon these statements.
 
ii
 
 
PART I – FINANCIAL INFORMATION
 
Item 1. Financial Statements (Unaudited).
 
AMASS BRANDS INC
 
INDEX TO THE FINANCIAL STATEMENTS (UNAUDITED)
 
 
Page
 
 
Condensed Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025
2
 
 
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 2025 (Unaudited)
3
 
 
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the three and nine months ended September 30, 2026 and 2025 (Unaudited)
4
 
 
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025 (Unaudited)
5
 
 
Notes to Condensed Consolidated Financial Statements (Unaudited)
6
 
1
 
Amass Brands Inc

Condensed Consolidated Balance Sheets
(Unaudited)
 
 
 
September 30, 2026
 
 
December 31, 2025
 
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
818,937
 
 
$
824,962
 
Restricted cash
 
 
105,000
 
 
 
-
 
Accounts receivable, net
 
 
4,118,867
 
 
 
2,317,514
 
Due from related parties
 
 
67,916
 
 
 
1,389,996
 
Inventory, net
 
 
9,356,390
 
 
 
10,873,408
 
Interest receivable
 
 
139,960
 
 
 
68,112
 
Prepaid expenses and other current assets
 
 
476,307
 
 
 
178,205
 
Total current assets
 
 
15,083,377
 
 
 
15,652,197
 
Property and equipment, net
 
 
3,626
 
 
 
12,369
 
Intangible assets, net
 
 
1,700,752
 
 
 
2,202,579
 
Goodwill
 
 
2,972,280
 
 
 
2,972,280
 
Securities pledged as collateral, at fair value
 
 
-
 
 
 
3,347,564
 
Investments at fair value
 
 
2,593,766
 
 
 
-
 
Investments at cost
 
 
406,000
 
 
 
823,746
 
Related-party investment
 
 
787,918
 
 
 
-
 
Deposits
 
 
29,640
 
 
 
14,015
 
Total assets
 
$
23,577,359
 
 
$
25,024,750
 
 
 
 
 
 
 
 
 
 
Liabilities and stockholders’ deficit
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
 
$
 
9,157,344
 
 
$
8,257,052
 
Accrued expenses
 
 
4,543,147
 
 
 
4,306,428
 
Secured credit facility, current
 
 
3,492,555
 
 
 
3,277,034
 
Loans payable, current
 
 
1,016,998
 
 
 
897,854
 
Contract liabilities
 
 
4,215,612
 
 
 
3,042,044
 
Promissory notes payable, current
 
 
1,400,000
 
 
 
2,498,714
 
Derivative liabilities
 
 
623,471
 
 
 
37,962
 
Customer deposits
 
 
331,568
 
 
 
417,000
 
Interest payable
 
 
449,656
 
 
 
694,649
 
Obligation under repurchase agreement
 
 
-
 
 
 
400,000
 
Total current liabilities
 
 
25,230,351
 
 
 
23,828,737
 
Loans payable
 
 
164,570
 
 
 
831,568
 
Promissory notes payable, net
 
 
-
 
 
 
100,000
 
Convertible notes payable
 
 
-
 
 
 
378,725
 
SAFE notes
 
 
552,152
 
 
 
520,242
 
Total liabilities
 
 
25,947,073
 
 
 
25,659,272
 
Commitments and contingencies (Note 15)
 
 
 
 
 
 
 
 
Stockholders’ deficit:
 
 
 
 
 
 
 
 
Series C Convertible Preferred Stock, $0.00001 par; 35,000 and 0 shares authorized; 8,825 and 0 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively, liquidation preference of $9,834,927
 
 
7,812,317
 
 
 
-
 
Series B Preferred Stock, $0.00001 par
; 0 and 27,789,708 shares authorized;
 0 and 8,304,185 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively
 
 
-
 
 
 
82
 
Series A Preferred Stock, $0.00001 par
; 0 and 873,734 shares authorized;
0 and 873,734 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively
 
 
-
 
 
 
9
 
Series Seed Preferred Stock, $0.00001 par
; 0 and 12,529,020 shares authorized;
0 and 12,529,020 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively
 
 
-
 
 
 
125
 
Common stock, $0.00001
par, 250,000,000 and 66,700,000 shares authorized (including 3,200,000 shares of Common Non-Voting Stock at December 31, 2025); 12,014,080 and 3,364,984 shares issued and 11,858,705 and 3,364,984 shares outstanding as of September 30, 2026 and December 31, 2025, respectively
 
 
120
 
 
 
34
 
Additional paid-in capital
 
 
45,824,291
 
 
 
37,661,354
 
Treasury stock, 155,375 and 0 shares at cost
 
 
(1,393,713
)
 
 
-
 
Accumulated other comprehensive income
 
 
55,172
 
 
 
55,172
 
Accumulated deficit
 
 
(56,929,177
)
 
 
(40,705,027
)
Total Amass stockholders’ deficit
 
 
(4,630,990
)
 
 
(2,988,251
)
Non-controlling interest
 
 
2,261,276
 
 
 
2,353,729
 
Total stockholders’ deficit
 
 
(2,369,714
)
 
 
(634,522
)
Total liabilities and stockholders’ deficit
 
$
23,577,359
 
 
$
25,024,750
 
 
See accompanying notes to these unaudited condensed consolidated financial statements.
 
2
 
A
mass
Brands
Inc
Condensed Consolidated Statements of Operations
(Unaudited)
 
 
 
Three months
ended September 30,
2026
 
 
 
 
 
 
Three months
ended September 30,
2025
 
 
 
 
 
 
Nine months
ended September 30,
2026
 
 
 
 
 
 
Nine months
ended September 30,
2025
 
 
 
Net revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Spirits & wine revenues
 
$
5,082,915
 
 
$
 
4,015,774
 
 
$
 
14,473,797
 
 
$
13,630,660
 
Other revenues
 
 
285,600
 
 
 
51,332
 
 
 
636,805
 
 
 
281,821
 
Total net revenues
 
 
5,368,515
 
 
 
4,067,106
 
 
 
15,110,602
 
 
 
13,912,481
 
Cost of net revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cost of spirits & wine revenues
 
 
3,830,485
 
 
 
2,777,334
 
 
 
10,198,365
 
 
 
8,908,271
 
Cost of other revenues
 
 
794,891
 
 
 
828,631
 
 
 
1,600,607
 
 
 
1,183,757
 
Loss on contracts
 
 
1,282,510
 
 
 
124,476
 
 
 
1,282,510
 
 
 
124,476
 
Total cost of net revenues
 
 
5,907,886
 
 
 
3,730,441
 
 
 
13,081,482
 
 
 
10,216,504
 
Gross profit
 
 
(539,371
)
 
 
336,665
 
 
 
2,029,120
 
 
 
3,695,977
 
Operating expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sales and marketing
 
 
1,102,055
 
 
 
799,075
 
 
 
3,129,409
 
 
 
2,768,855
 
General and administrative
 
 
1,920,217
 
 
 
1,918,149
 
 
 
10,491,210
 
 
 
5,953,441
 
Impairment loss
 
 
1,100,531
 
 
6,064,603
 
 
 
1,550,216
 
 
 
6,064,603
 
Total operating expenses
 
 
4,122,803
 
 
 
8,781,827
 
 
 
15,170,835
 
 
 
14,786,899
 
Loss from operations
 
 
(4,662,174
)
 
 
(8,445,162
)
 
 
(13,141,715
)
 
 
(11,090,922
)
Other income (expense)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest income
 
 
71,849
 
 
 
49,850
 
 
 
75,558
 
 
 
84,085
 
Interest expense
 
 
(374,170
)
 
 
(448,333
)
 
 
(2,166,072
)
 
 
(2,484,585
)
Change in fair value of derivative liabilities
 
 
1,011,183
 
 
 
-
 
 
 
1,198,936
 
 
 
-
 
Change in fair value of SAFEs
 
 
(10,848
)
 
 
-
 
 
 
(31,910
)
 
 
-
 
Unrealized loss on investment at fair value
 
 
(433,764
)
 
 
-
 
 
 
(433,764
)
 
 
-
 
Other income (expense), net
 
 
(1,327,859
)
 
 
(56,982
)
 
 
(1,817,636
)
 
 
(394,249
)
Total other income (expense)
 
 
(1,063,609
)
 
 
(455,465
)
 
 
(3,174,888
)
 
 
(2,794,749
)
Net loss
 

(5,725,783
)
 

(8,900,627
)
 

(16,316,603
)
 

(13,885,671
)
Net loss attributable to non-controlling interest
 
 
(11,614
)
 
 
(2,517,796
)
 
 
(92,453
)
 
 
(2,609,215
)
Net loss attributable to parent
 
$
(5,714,169
)
 
$
(6,382,831
)
 
$
(16,224,150
)
 
$
(11,276,456
)
Deemed dividend on Series C Convertible Preferred Stock
 
 
(5,742,129
)
 
 
-
 
 
 
(5,742,129
)
 
 
-
 
Preferred Return on Series C Convertible Preferred Stock
 
 
(90,623
)
 
 
-
 
 
 
(90,623
)
 
 
-
 
Net loss attributable to common stockholders
 
$
(11,546,921
)
 
$
(6,382,831
)
 
$
(22,056,902
)
 
$
(11,276,456
)
Weighted average common shares outstanding — basic and diluted
 
 
11,627,135
 
 
 
3,270,919
 
 
 
8,651,491
 
 
 
3,147,485
 
Net loss per common share — basic and diluted
 
$
(0.99
)
 
$
(1.95
)
 
$
(2.55
)
 
$
(3.58
)
 
See accompanying notes to these unaudited condensed consolidated financial statements.
 
3
 
A
mass
Brands Inc
Condensed  
Consolidated Statements of Stockholders’ Equity (Deficit)
(Unaudited)
 
 
 
Preferred
(Shares)
 
 
 
 
Preferred
(Amount)
 
 
 
 
Common
(Shares)
 
 
 
 
Common
(Amount)
 
 
 
 
Additional
Paid-in Capital
 
 
 
 
Accumulated
Other
Comprehensive
Income
 
 
 
 
 
 
 
 
Accumulated
Deficit
 
 
 
 
Non-controlling
Interest
 
 
 
 
Total
Stockholders’
Equity
(Deficit)
 
 
 
 
Balances at December 31, 2024
 
 
21,706,939
 
 
$
216
 
 
 
2,899,343
 
 
$
29
 
 
$
35,881,552
 
 
$
57,459
 
 
$
(26,127,313
)
 
$
4,987,142
 
 
$
14,799,085
 
Exercise of stock options
 
 
-
 
 
 
-
 
 
 
2,084
 
 
 
-
 
 
 
375
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
375
 
Exercise of stock warrants
 
 
-
 
 
 
-
 
 
 
214,229
 
 
 
2
 
 
 
51,406
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
51,408
 
Stock-based compensation - options
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
44,548
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
44,548
 
Warrants issued with promissory notes payable
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
615,427
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
615,427
 
Offering costs
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(106,970
)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(106,970
)
Net loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(3,657,042
)
 
 
(62,579
)
 
 
(3,719,621
)
Balances at March 31, 2025
 
 
21,706,939
 
 
 
216
 
 
 
3,115,656
 
 
 
31
 
 
 
36,486,338
 
 
 
57,459
 
 
 
(29,784,355
)
 
 
4,924,563
 
 
 
11,684,252
 
Stock-based compensation - options
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
176,916
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
176,916
 
Issuance of Common Stock
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
470,759
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
470,759
 
Offering costs
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(289,785
)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(289,785
)
Net loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(1,236,583
)
 
 
(28,840
)
 
 
(1,265,423
)
Balances at June 30, 2025
 
 
21,706,939
 
 
 
216
 
 
 
3,115,656
 
 
 
31
 
 
 
36,844,228
 
 
 
57,459
 
 
 
(31,020,938
)
 
 
4,895,723
 
 
 
10,776,719
 
Stock-based compensation - Common Stock
 
 
-
 
 
 
-
 
 
 
54,607
 
 
 
1
 
 
 
416,104
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
416,105
 
Issuance of Common Stock
 
 
-
 
 
 
-
 
 
 
61,749
 
 
 
1
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
1
 
Exercise of stock options
 
 
-
 
 
 
-
 
 
 
103,702
 
 
 
1
 
 
 
18,666
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
18,667
 
Stock-based compensation - options
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
159,708
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
159,708
 
Offering costs
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(4,656
)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(4,656
)
Net loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(6,382,831
)
 
 
(2,517,796
)
 
 
(8,900,627
)
Balances at September 30, 2025
 
 
21,706,939
 
 
$
216
 
 
 
3,335,714
 
 
$
34
 
 
$
37,434,050
 
 
$
57,459
 
 
$
(37,403,769
)
 
$
2,377,927
 
 
$
2,465,917
 
 
 
 
Preferred
(Shares)
 
 
 
 
Preferred
(Amount)
 
 
 
 
Common
(Shares)
 
 
 
 
Common
(Amount)
 
 
 
 
Additional
Paid-in Capital
 
 
 
 
Treasury Stock
(Shares)
 
 
 
 
Treasury Stock
(Amount)
 
 
 
 
Accumulated
Other
Comprehensive
Income
 
 
 
 
 
 
 
 
Accumulated
Deficit
 
 
 
 
Non-controlling
Interest
 
 
 
 
Total
Stockholders’
Equity
(Deficit)
 
 
 
 
Balances at December 31, 2025
 
 
21,706,939
 
 
$
216
 
 
 
3,364,984
 
 
$
34
 
 
$
37,661,354
 
 
 
-
 
 
$
-
 
 
$
55,172
 
 
$
(40,705,027
)
 
$
2,353,729
 
 
$
(634,522
)
Issuance of Common Stock for services
 
 
-
 
 
 
-
 
 
 
77,776
 
 
 
1
 
 
 
693,658
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
693,659
 
Exercise of stock options
 
 
-
 
 
 
-
 
 
 
4,667
 
 
 
-
 
 
 
1,260
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
1,260
 
Exercise of stock warrants
 
 
740,328
 
 
 
7
 
 
 
222,026
 
 
 
2
 
 
 
986,217
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
986,226
 
Shares issued for extinguishment of interest payable
 
 
-
 
 
 
-
 
 
 
86,342
 
 
 
1
 
 
 
276,474
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
276,475
 
Repurchase of Common Stock
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(155,375
)
 
 
(1,393,713
)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(1,393,713
)
Stock-based compensation - options
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
220,932
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
220,932
 
Offering costs
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(37,315
)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(37,315
)
Net loss 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(3,035,704
)
 
 
(5,901
)
 
 
(3,041,605
)
Balances at March 31, 2026
 
 
22,447,267
 
 
 
223
 
 
 
3,755,795
 
 
 
38
 
 
 
39,802,580
 
 
 
(155,375
)
 
 
(1,393,713
)
 
 
55,172
 
 
 
(43,740,731
)
 
 
2,347,828
 
 
 
(2,928,603
)
Conversion of Preferred Stock to Common Stock
 
 
(22,447,267
)
 
 
(223
)
 
 
7,483,093
 
 
 
75
 
 
 
148
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Corrective issuance of Common Stock, net of cost
 
 
-
 
 
 
-
 
 
 
1,805
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Conversion of
C
onvertible
N
otes upon Direct Listing
 
 
-
 
 
 
-
 
 
 
223,050
 
 
 
2
 
 
 
3,791,848
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
3,791,850
 
Exercise of stock warrants
 
 
-
 
 
 
-
 
 
 
84,907
 
 
 
1
 
 
 
14,210
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
14,211
 
Exercise of stock options
 
 
-
 
 
 
-
 
 
 
12,915
 
 
 
-
 
 
 
2,925
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
2,925
 
Warrants issued in connection with Series C Convertible Preferred Stock
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
4,824,382
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
4,824,382
 
Issuance of Common Stock for services
 
 
-
 
 
 
-
 
 
 
170,766
 
 
 
2
 
 
 
1,938,139
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
1,938,141
 
Stock-based compensation - options
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
226,613
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
226,613
 
Offering costs
 
 
-
 
 
 
-
 
 
 
28,125
 
 
 
-
 
 
 
(272,893
)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(272,893
)
Warrant modifications
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
945,993
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
945,993
 
Net loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(7,474,277
)
 
 
(74,938
)
 
 
(7,549,215
)
Balances at June 30, 2026
 
 
-
 
 
 
-
 
 
 
11,760,456
 
 
 
118
 
 
 
51,273,945
 
 
 
(155,375
)
 
 
(1,393,713
)
 
 
55,172
 
 
 
(51,215,008
)
 
 
2,272,890
 
 
 
993,404
 
Stock-based compensation - options
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
90,255
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
90,255
 
Offering costs
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(373,810
)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(373,810
)
Amendment of Series C Convertible Preferred Stock
 
 
7,000
 
 
 
6,316,076
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
6,316,076
 
Issuance of Series C
Convertible Preferred Stock, net
 
 
2,000
 
 
 
1,639,716
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
1,639,716
 
Conversion of Series C Convertible Preferred Stock into Common Stock
 
 
(175
)
 
 
(143,475
)
 
 
253,624
 
 
 
2
 
 
 
143,473
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Deemed dividend on Series C Convertible Preferred Stock
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(5,742,129
)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(5,742,129
)
Warrant modifications
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
752,591
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
752,591
 
Series B-3 Preferred Stock issuance inducement
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(320,034
)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(320,034
)
Net loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(5,714,169
)
 
 
(11,614
)
 
 
(5,725,783
)
Balances at September 30, 2026
 
 
8,825
 
 
$
7,812,317
 
 
 
12,014,080
 
 
$
120
 
 
$
45,824,291
 
 
 
(155,375
)
 
$
(1,393,713
)
 
$
55,172
 
 
$
(56,929,177
)
 
$
2,261,276
 
 
$
(2,369,714
)
 
See accompanying notes to these unaudited condensed consolidated financial statements.
 
4
 
A
mass
Brands Inc
Condensed Consolidated Statements of Cash Flows
(Unaudited)
 
 
 
Nine months ended
September 30, 2026
 
 
 
 
Nine months ended
September 30, 2025
 
 
Cash flows from operating activities
 
 
-
 
 
 
-
 
Net loss
 
$
(16,316,603
)
 
$
(13,885,671
)
Adjustments to reconcile net loss to net cash used in operating activities
 
 
-
 
 
 
-
 
Depreciation and amortization
 
 
400,169
 
 
 
504,078
 
Stock-based compensation
 
 
537,800
 
 
 
381,172
 
Common Stock issued for services
 
 
2,631,800
 
 
 
416,105
 
Amortization of debt discounts
 
 
1,207,730
 
 
 
489,052
 
Failed offering costs and write-off of deferred offering costs
 
 
1,698,584
 
 
 
-
 
Reserve for expected credit losses
 
 
56,758
 
 
 
(2,434
)
Impairment of intangible assets and investments
 
 
1,550,216
 
 
 
6,064,603
 
Change in fair value of derivative liabilities
 
 
(1,198,936
)
 
 
-
 
Change in fair value of SAFEs
 
 
31,910
 
 
 
-
 
Unrealized loss on investment at fair value
 
 
433,764
 
 
 
-
 
Inventory obsolescence
 
 
1,160,806

 
 
578,029
 
Loss on sale of securities at fair value
 
 
-
 
 
 
280,143
 
Loss on disposal of property and equipment
 
 
-
 
 
 
60,742
 
Loss on vendor settlement
 
 
176,980
 
 
 
-
 
Changes in operating assets and liabilities
 
 
-
 
 
 
-
 
Accounts receivable
 
 
(1,858,111
)
 
 
736,330
 
Due from related parties
 
 
(67,916
)
 
 
-
 
Inventory, net
 
 
(151,876
)
 
 
3,099,226
 
Prepaid expenses and other current assets
 
 
(321,378
)
 
 
(307,542
)
Deposits
 
 
(15,625
)
 
 
 
-
 
Accounts payable
 
 
1,107,980
 
 
 
(40,165
)
Accrued expenses
 
 
236,720

 
 
(470,993
)
Interest receivable
 
 
(71,849
)
 
 
(59,339
)
Interest payable
 
 
70,210
 
 
 
1,211,355
 
Customer deposits
 
 
(85,432
)
 
 
-
 
Contract liabilities
 
 
1,173,568
 
 
 
122,354

Net cash used in operating activities
 
 
(7,612,731
)
 
 
(822,955
)
Cash flows from investing activities
 
 
-
 
 
 
-
 
Advances to related parties
 
 
(3,717
)
 
 
(171,848
)
Proceeds from sale of investment
 
 
-
 
 
 
500,000
 
Proceeds from notes receivable
 
 
-
 
 
 
421,653
 
Purchase of related-party investment
s
 
 
(1,786,710
)
 
 
-
 
Proceeds from disposal of property and equipment
 
 
-
 
 
 
11,610
 
Purchases of intangible assets
 
 
-
 
 
 
(17,470
)
Net cash (used in) provided by investing activities
 
 
(1,790,427
)
 
 
743,945
 
Cash flows from financing activities
 
 
-
 
 
 
-
 
Proceeds from (repayments of) secured credit facility, n
et
 
 
215,521
 
 
 
(138,543
)
Repayments of loans payable
 
 
(347,854
)
 
 
(729,472
)
Proceeds from promissory notes
 
 
-
 
 
 
945,000
 
Repayments of promissory notes
 
 
(250,000
)
 
 
-
 
Proceeds from convertible notes
 
 
1,351,675
 
 
 
-
 
Proceeds from issuance of Series C Convertible Preferred Stock
and warrant
 
 
9,000,000
 
 
 
-
 
Proceeds from issuance of Common Stock
 
 
-
 
 
 
470,759
 
Offering costs
 
 
(921,831
)
 
 
(401,417
)
Proceeds from exercise of stock options
 
 
4,185
 
 
 
19,042
 
Proceeds from exercise of warrants
 
 
850,437
 
 
 
51,408
 
Repayment of obligation under repurchase agreement
 
 
(400,000
)
 
 
-
 
Net cash provided by financing activities
 
 
9,502,133
 
 
216,777
Net change in cash, cash equivalents and restricted cash
 
 
98,975
 
 
 
137,767
 
Cash, cash equivalents and restricted cash, beginning of the period
 
 
824,962
 
 
 
693,946
 
Cash, cash equivalents and restricted cash, end of the period
 
$
923,937
 
 
$
831,713
 
Reconciliation of cash, cash equivalents and restricted cash to the balance sheets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
 
818,937
 
 
 
831,713
 
Restricted cash
 
 
105,000
 
 
 
-
 
Total cash, cash equivalents and restricted cash
 
$
923,937
 
 
$
831,713
 
Supplemental Disclosure of Cash Flow Information
 
 
-
 
 
 
-
 
Cash paid for income taxes
 
 
8,841
 
 
 
13,895
 
Cash paid for interest
 
 
177,426
 
 
 
738,257
 
Noncash Investing and Financing Activities
 
 
-
 
 
 
-
 
Transfer of investment for relief of debt
 
 
-
 
 
 
1,000,000
 
Warrants issued with promissory notes
 
 
-
 
 
 
615,427
 
Exchange of shareholder promissory note for convertible note
 
 
1,000,000
 
 
 
-
 
Conversion of Convertible Notes, accrued interest and related derivative liability into Common Stock
 
 
3,791,850
 
 
 
-
 
Common Stock issued as Series C commitment fee shares
 
 
450,000
 
 
 
-
 
Investment units transferred as Series B-3 Preferred Stock issuance inducement
 
 
320,034
 
 
 
-
 
Derivative recognized with Series C financing
 
 
1,086,101
 
 
 
-
 
Warrants issued with Series C Convertible Preferred Stock
 
 
4,824,382
 
 
 
-
 
Shares issued in extinguishment of accrued interest
 
 
276,475
 
 
 
-
 
Conversion of Series C Convertible Preferred Stock into Common Stock
 
 
143,475
 
 
 
-
 
Repurchase of Common Stock into treasury in settlement of advances to related parties
 
 
1,393,713
 
 
 
-
 
Warrant exercise proceeds applied to Secured Promissory Note principal
 
 
150,000
 
 
 
-
 
Deemed dividend on Series C Convertible Preferred Stock
 
 
5,742,129
 
 
 
-
 
Series C Convertible Preferred Stock derecognized on extinguishment
 
 
1,088,569
 
 
 
-
 
Discount from derivative liability
 
 
1,120,527
 
 
 
-
 
Derivative recognized on amendment of Series C Convertible Preferred Stock, net of derivative removed
 
 
514,622
 
 
 
-
 
Series C placement fee included in accounts payable
  
123,419
   
-
 
Reclassification of securities pledged as collateral to investments at fair value upon De Soi collateral release
 
 
3,347,564
 
 
 
-
 
Issuance of SAFE for reduction of promissory note principal
 
 
-
 
 
 
500,000
 
 
See accompanying notes to these unaudited condensed consolidated financial statements.
 
5
 
A
mass
Brands Inc
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
Note 1 – Organization and Nature of Business
 
Amass Brands Inc (“Amass” or the “Company”), is a corporation formed on September 22, 2016, under the laws of the State of Delaware. Headquartered in Santa Maria, California, the Company sells primarily alcoholic and non-alcoholic beverages through wholesale and online platforms globally.

On May 20, 2026, the Company’s Common Stock commenced trading on the Nasdaq Global Market under the ticker symbol “AMSS” pursuant to a direct listing (the “Direct Listing”). See Note 12.
 
Note 2 – Going Concern
 
The Company has evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued.
 
The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses and used cash in operations since inception and has limited available capital. At September 30, 2026, the Company had cash and cash equivalents of $818,937, a working capital deficit of $10,146,974, and it used $7,612,731 of cash in operating activities during the nine months then ended. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. The Company’s ability to continue as a going concern for the next twelve months is dependent upon its ability to generate sufficient cash flows from operations to meet its obligations, which it has not been able to accomplish to date, and/or to obtain additional working capital.
 
During the nine months ended September 30, 2026, the Company completed its Direct Listing and received aggregate proceeds of $9,000,000 from the issuance of Series C Convertible Preferred Stock and the associated warrant under the Streeterville Securities Purchase Agreement (the “SPA”) (see Note 12). In July and October 2026 the Company received notices from Nasdaq that it was not in compliance with the market value and minimum bid price requirements for continued listing on The Nasdaq Global Market (see Notes 12 and 17). The Company has not paid the Preferred Return on the Series C Convertible Preferred Stock for the second and third quarters of 2026; the holders may declare a separate Event of Default for each missed payment, which would increase the Stated Value and the Preferred Return rate (see Note 12). In addition, the Mezzanine Secured Notes are past due, and promissory notes with principal of $550,000 at September 30, 2026 and $1,250,000 as of the date these financial statements were issued had passed their maturity dates and had not been repaid (see Notes 9 and 17). The Company also owed approximately $4.1 million under bulk wine purchase commitments at September 30, 2026, all of which was past its contractual payment dates (see Note 15). The Company plans to raise additional capital as necessary to support its operating losses through the issuances of stock and loans, including additional purchases under the Streeterville facility, subject to the conditions of the SPA (see Note 12). No assurances can be given that the Company will be successful in these efforts. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities as a result of this uncertainty.
 
Note 3 – Summary of Significant Accounting Policies
 
Basis of accounting – The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as found in the Accounting Standards Codification (“ASC”) of the Financial Accounting Standards Board (“FASB”). The unaudited condensed consolidated financial statements include the accounts of the Company, its subsidiaries and a consolidated variable interest entity. The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the SEC applicable to interim period financial statements and do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the financial position and the results of operations for the periods presented.
 
These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto for the year ended December 31, 2025. Interim results are not necessarily indicative of the results that may be expected for a full year.
 
Concentrations of credit risk – Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company generally maintains balances in various operating accounts at financial institutions that management believes to be of high credit quality, in amounts that may, at times, exceed federally insured limits. The Company has not experienced any losses related to its cash and cash equivalents and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. As of September 30, 2026 and December 31, 2025, the Company’s cash and cash equivalents were held at accredited financial institutions. Restricted cash of $105,000 at September 30, 2026 is held in a bank savings account as collateral for a letter of credit.
 
6
 
Amass Brands Inc

Notes to Condensed Consolidated Financial Statements (Unaudited)
 
Additionally, the Company had the following concentrations in net sales and accounts receivable during the three and nine months ended September 30, 2026. Customers under common control are treated as a single customer. The concentrations were as follows:

 
 
 
Three months ended
September 30, 2026
 
 
 
 
Nine months ended
September 30, 2026
 
 
Customer A
 
 
 
 
 
 
 
 
 
 
Net Sales
 
 
16.7
%
 
 
14.8
%
Accounts Receivable
 
 
13.6
%
 
 
13.6
%
 
Fair value measurements – Certain assets and liabilities of the Company are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:
 
·
Level 1 – Quoted prices in active markets for identical assets or liabilities.
 
·
Level 2 – Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.
 
·
Level 3 – Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies, and similar techniques.
 
Derivative liabilities, SAFEs, investments at fair value, and securities pledged as collateral are measured using Level 3 inputs. The following tables present changes in Level 3 assets and liabilities measured at fair value for the nine months ended September 30, 2026:
 
Investments at Fair Value / Securities Pledged as Collateral
 
Amount
 
Balance, December 31, 2025 (securities pledged as collateral)
 
 
3,347,564
 
Reclassification upon release of collateral 
 
 
(3,347,564
)
Transfer to investments at fair value upon release of collateral 
 
 
3,347,564
 
Units transferred as Series B-3 Preferred Stock issuance inducement
 
 
(320,034
) 
Change in fair value
 
 
(433,764
) 
Balance, September 30, 2026 (investments at fair value)
 
$
2,593,766
 
 
Derivative Liabilities at Fair Value
 
Amount
 
Balance, December 31, 2025
 
 
37,962
 
Issuance of Convertible Notes and Warrants
 
 
1,120,527
 
Issuance of Series C Convertible Preferred Stock — conversion feature
 
 
849,236
 
Change in fair value
 
 
(1,198,936
)
Settlement upon conversion of Convertible Notes at the Direct Listing
 
 
(936,805
)
Derecognized on extinguishment of Series C Convertible Preferred Stock
 
 
(240,553
)
Recognized on extinguishment of Series C Convertible Preferred Stock (amended conversion feature)
 
 
755,175
 
Issued with Series C Convertible Preferred Stock at the Third Closing
 
 
236,865
 
Balance, September 30, 2026
 
$
623,471
 
 
SAFEs at Fair Value
 
Amount
 
Balance, December 31, 2025
 
 
520,242
 
Change in fair value
 
 
31,910
 
Balance, September 30, 2026
 
$
552,152
 
 
There were no transfers between Levels 1, 2, or 3 during the nine months ended September 30, 2026 or September 30, 2025. The carrying amounts of the Company’s cash, accounts receivable, accounts payable and other short-term financial instruments approximate fair value because of their short maturities. In addition, the Company’s investment in the Afterdream SAFE was measured at fair value on a nonrecurring basis at September 30, 2026, using Level 3 inputs, when it was impaired to its estimated fair value of $634,469 (see Note 6).
 
Valuation techniques and inputs – The Company’s financial instruments measured at fair value on a recurring basis include investments at fair value, which are classified as Level 3 due to significant unobservable inputs used in their valuation.
 
The fair value of the Company’s investment at fair value/securities pledged as collateral is sensitive to changes in key unobservable inputs such as public company comparables for multiples, the weighting of various models, volatilities, discount rates, and financial projections. If these assumptions were to change materially, it could significantly impact the fair value conclusions.
 
To value the investment at fair value, the Company used a market based approach by identifying similar companies, applying multiples of revenues and liquidation waterfall to reach the Company’s equity value in the investment, considering discounts for lack of marketability and including weighting for transactions where we sold stock.
 
The Company sold a portion of its investments during the nine months ended September 30, 2025, which caused losses. These losses were incurred for strategic reasons and not necessarily the value the Company would get for its highest and best use. However, such was used as an input in determining fair value as described above.
 
The Company’s derivative liabilities relate to embedded conversion features in convertible debt instruments and Series C preferred stock. These instruments are measured at fair value using a with-or-without probability weighted model. Significant unobservable inputs used in valuing derivative liabilities include the probability of conversion, the timeline for which the events are expected to occur, and discount rates applied. The fair value of the derivative liabilities is sensitive to changes in these significant unobservable inputs.
 
Additionally, the convertible debt instruments include embedded warrants. The Company values the warrant liabilities at fair value using a Monte Carlo simulation, which captures the path-dependent cash settlement mechanic under the Exchange Cap and the probability-weighted outcomes associated with a qualified financing event. Because the valuation relies on significant unobservable inputs, the warrant derivative liability is classified within Level 3 of the fair value hierarchy.
 
The Company’s SAFE is measured at fair value using a probability-weighted expected return valuation method. Significant unobservable inputs used in valuing the SAFE include the probability of each scenario, timeline for which the events are expected to occur, and discount rates. Because these inputs are unobservable and involve management judgement, the SAFE is classified as Level 3.

Valuation techniques and inputs are consistent with those described in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 and the audited financial statements for the year ended December 31, 2025.
 
Net loss per share
–
Basic and diluted net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of Common Stock outstanding during the period. Net loss attributable to common stockholders is net loss attributable to parent less the deemed dividend on the August 19, 2026 amendment of the Series C Convertible Preferred Stock ($5,742,129) and the cumulative Preferred Return accrued after that date, whether or not declared or paid ($90,623), a total of $5,832,752 for both the three and nine months ended September 30, 2026 (see Note 12). 
Potentially
dilutive securities excluded from diluted net loss per share
because
their effect would be anti-dilutive
were, at September 30, 2026, 8,825 shares of Series C Convertible Preferred Stock, convertible into approximately 12.8 million shares of Common Stock at the $0.75 per share minimum price in effect at th
e balance sheet date
(see Note 12), warrants to purchase 4,133,320 shares of Common Stock and options to purchase 1,173,510 shares of Common Stock, and, at September 30, 2025, preferred stock convertible into 7,235,646 shares of Common Stock, warrants to purchase 1,159,544 shares of Common Stock and options to purchase 1,123,162 shares of Common St
ock
.

Out-of-period correction
–
In the third quarter of 2026, the Company corrected an error in its previously issued unaudited condensed consolidated financial statements for the three and six months ended June 30, 2026, in which the
$490,000
placement agent fee for the Second Closing of the Series C Convertible Preferred Stock (see Note 12) was expensed in full. The correction allocated
$95,508
of the fee to the Series C Convertible Preferred Stock and
$335,045
to the warrant as issuance costs, which reduced general and administrative expenses and net loss for the three months ended September 30, 2026 by
$430,553
 
and increased the deemed dividend by
$95,508
.
Amounts for the nine months ended September 30, 2026 are correctly stated. The Company concluded that the error and its correction were not material to its previously issued or current interim financial statements
.
 
Accounts receivable – As of September 30, 2026 and December 31, 2025, the Company had a reserve for expected credit losses of $64,790 and $83,389, respectively.
 
Shipping and handling costs – Shipping and handling costs amounted to $239,550 and $163,101 for the three months ended September 30, 2026 and 2025, respectively, and $652,909 and $419,334 for the nine months then ended.

Advertising costs – Advertising costs amounted to $226,878 and $29,082 for the three months ended September 30, 2026 and 2025, respectively, and $550,909 and $89,057 for the nine months then ended.
 
Accounting pronouncements not yet adopted –
In November 2024, the FASB issued Accounting Standards Update (“ASU”) 2024-03, which requires disaggregated information about certain income statement expense line items to be disclosed on an annual and interim basis. The Company is required to adopt these disclosures for its annual period ending December 31, 2027 and for interim periods beginning January 1, 2028, with early adoption permitted, and the standard may be applied prospectively or retrospectively. The Company expects this standard to impact its disclosures with no material impacts to its results of operations, cash flows, or financial condition.
 
In December 2023, the FASB issued ASU 2023-09, which requires enhanced income tax disclosures, including disaggregated rate reconciliation and income taxes paid information. The Company is required to adopt these disclosures for its annual period ending December 31, 2026. The Company expects this standard to affect its disclosures only.
 
Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying condensed consolidated financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable under the
circumstances.
 
7
 
Amass Brands Inc

Notes to Condensed Consolidated Financial Statements (Unaudited)
 
Note 4 – Inventory, net
 
Inventory, net consisted of the following as of September 30, 2026 and December 31, 2025:
 
 
 
September 30, 2026
 
 
December 31, 2025
 
Raw materials
 
 
2,062,462
 
 
 
2,490,030
 
Work in process
 
 
2,195,884
 
 
 
4,627,130
 
Finished goods
 
 
9,146,239
 
 
 
7,215,511
 
Inventory reserve
 
 
(4,048,195
)
 
 
(3,459,263
)
Total inventory
 
$
9,356,390
 
 
$
10,873,408
 
 
As of September 30, 2026 and December 31, 2025, the Company had deposits for inventory purchases and production runs of $216,560 and $77,192, respectively, presented within prepaid expenses and other current assets.

The inventory reserve includes $889,615 recorded in the third quarter of 2026 to write down bulk wine included in work in process that the Company has agreed to sell to Full Glass under the Side Letter Agreement (see Note 6) to its net realizable value, based on the price agreed with Full Glass. The remainder of the reserve relates to slow-moving, excess and obsolete inventory. During the nine months ended September 30, 2026, the Company recorded net provisions of $1,078,031 to the reserve, charged to cost of net revenues, and released $489,099 of the reserve on the sale of the related inventory.
 
In July 2026, the Company entered into a settlement agreement with a glass supplier. In the third quarter of 2026, upon completion of the settlement payments, the supplier released $331,107 of accounts payable, and the Company wrote off $508,087 of glass held at the supplier’s warehouse that it will no longer receive. The resulting net loss of $176,980 is presented within other income (expense), net. Under the settlement, the supplier retained that glass in partial satisfaction of the amounts owed, and the Company received the glass covered by its settlement payments.
 
In the third quarter of 2026, the Company recognized a receivable of $361,910 for refunds of tariffs it had paid under the International Emergency Economic Powers Act on imported products, presented within accounts receivable, net, and as a reduction of cost of spirits & wine revenues. U.S. Customs and Border Protection approved the Company’s refund claim before September 30, 2026, and the Company collected substantially all of the receivable in October 2026.
 
Note 5 – Long-Lived Assets
 
Property and equipment, net – Property and equipment, net consists of the following:
 
 
 
September 30, 2026
 
 
December 31, 2025
 
Plant and equipment
 
 
113,159
 
 
 
113,159
 
Office and storage equipment
 
 
288
 
 
 
288
 
Furniture and fixtures
 
 
468
 
 
 
468
 
Leasehold improvements
 
 
95,373
 
 
 
95,373
 
Property and equipment, gross
 
 
209,288
 
 
 
209,288
 
Less: Accumulated depreciation and amortization
 
 
(205,662
)
 
 
(196,919
)
Property and equipment, net
 
$
3,626
 
 
$
12,369
 
 
Depreciation expense of $1,419 and $26,610 was included in general and administrative expenses for the three months ended September 30, 2026 and 2025, respectively, and $8,744 and $78,400 for the nine months then ended.
 
Intangible assets, net – Intangible assets, net consist of the following:
 
 
 
September 30, 2026
 
 
December 31, 2025
 
Website development
 
 
148,039
 
 
 
148,039
 
Tradename/transferred IP
 
 
353,254
 
 
 
457,116
 
Customer base
 
 
38,251
 
 
 
44,267
 
Non-competes
 
 
3,333
 
 
 
3,857
 
Brand names
 
 
3,264,000
 
 
 
3,264,000
 
Intangible assets, gross
 
 
3,806,877
 
 
 
3,917,279
 
Less: Accumulated amortization
 
 
(2,106,125
)
 
 
(1,714,700
)
Intangible assets, net
 
$
1,700,752
 
 
$
2,202,579
 
Goodwill
 
$
2,972,280
 
 
$
2,972,280
 
 
Amortization expense was $129,143 and $142,330 for the three months ended September 30, 2026 and 2025, respectively, and $391,425 and $425,678 for the nine months then ended, and is included in general and administrative expenses.
 
During the three months ended March 31, 2026, the Company recognized an impairment loss of $110,402 on the Gem&Bolt tradename, customer base, and non-competes following the cessation of Gem&Bolt production. No impairment of intangible assets or goodwill was recognized during the three months ended June 30, 2026 or September 30, 2026. The impairment loss of $6,064,603 recognized in the three and nine months ended September 30, 2025 related to goodwill and intangible assets.

During the third quarter of 2026, the Company identified indicators of impairment for its 222 Spirits (Calirosa) reporting unit, including declines in the reporting unit’s gross profit and in the revenue multiples of comparable spirits companies. Upon a quantitative assessment, the fair values of the tradename asset group and of the reporting unit exceeded their carrying amounts, and no impairment of the tradename or of goodwill was recognized.
 
 
8
 
Amass
Brands Inc
Notes to Condensed Consolidated Financial Statements (
Unaudited
)
 
Note 6 – Investments
 
De Soi – In August 2020, the Company entered into a joint venture to create De Soi, a celebrity-founded, non-alcoholic wine product company. The Company holds its interest in De Soi through AMASS De Soi Holdings LLC (“De Soi Holdings”), for which each unit is an economic right to one share of De Soi common stock. During 2025, the Company transferred its units of De Soi Holdings to AFTERDREAM, Inc. (“Afterdream”), a related party, in exchange for $400,000 in cash, with Afterdream pledging the underlying investment as collateral under a third-party secured promissory note and the Company recording a $400,000 obligation under a repurchase agreement (accounted for as a secured borrowing). In June 2026, the Company settled the repurchase obligation for the $400,000 repurchase price plus accrued interest of $20,800, and the De Soi units were released from collateral and returned to the Company. Accordingly, the investment is presented within investments at fair value at September 30, 2026 and within securities pledged as collateral at December 31, 2025.
 
During 2025, the Company transferred De Soi units to a holder of Series B-3 Preferred Stock as an inducement for the Series B-3 Preferred Stock financing. In the third quarter of 2026, the Company recognized the transfer, at the units’ fair value of $320,034, as a cost of issuing the Series B-3 Preferred Stock within additional paid-in capital, with a corresponding reduction of the investment.
 
In the third quarter of 2026, the Company recognized an unrealized loss of $433,764 on the investment, presented as unrealized loss on investment at fair value within other income (expense). The fair value of the Company’s investment in De Soi, which includes common units and Series Seed holdings, was $2,593,766 and $3,347,564 at September 30, 2026 and December 31, 2025, respectively. The Company elected the fair value option for this investment. See Note 3 for fair value measurement disclosures.
 
Full Glass – As partial consideration for the sale of the Winc.com DTC business unit, the Company received Common Units and warrants of the buyer. The investment is carried at cost less impairment. In July 2026, the Company entered into a Side Letter Agreement with Full Glass that replaced Full Glass’s remaining $4.0 million purchase obligation under the February 2024 Multi-Year Wine Purchase Agreement with a $427,000 settlement and provided for sales of bulk wine to Full Glass. Of the settlement, $406,000 is a deposit that Full Glass may apply toward the redemption of the Company’s units, either all of the units or a portion of them together with a further wine purchase. The Company recognized an impairment loss of $339,283 in the three months ended June 30, 2026, reducing the carrying value of the investment to $406,000, its estimated fair value based on the redemption terms. The carrying value was $406,000 and $745,283 as of September 30, 2026 and December 31, 2025, respectively, and no units had been redeemed as of September 30, 2026. In the third quarter of 2026, the Company wrote down the remaining wine to be sold to Full Glass by $889,615 to its estimated net realizable value, presented within cost of other revenues, and recognized $71,849 of interest income on amounts due from Full Glass. As of September 30, 2026, amounts received from Full Glass that had not yet been earned or applied were presented within customer deposits for future wine purchases ($331,568) and, within accrued expenses, settlement payments not yet applied ($590,830).
 
HpO – The Company received a 15% equity interest in Zerra Nutrition, Inc. (“HpO”) upon HpO’s formation in April 2025 for no consideration. During 2025, the Company made certain advances to HpO to support operations. In June 2026, the Company formalized the investment in a Simple Agreement for Future Equity (“SAFE”) issued by HpO for a purchase amount of up to $300,000 funded through July 2026. The SAFE is a post-money (valuation cap) instrument with a $5,000,000 post-money valuation cap and no discount, and is non-interest-bearing with no fixed maturity or repayment obligation. HpO is a related party because it is controlled by Geoff McFarlane, who is the majority owner and President of Resonant Subholdings Inc. (“Resonant”), an entity consolidated by the Company as a variable interest entity. The balance of the investment was $153,449 and $78,463 as of September 30, 2026 and December 31, 2025, respectively, presented within related-party investment at September 30, 2026 and within investments at cost at December 31, 2025. HpO is a variable interest entity that the Company does not consolidate because it is not the primary beneficiary. The SAFE is carried at cost less impairment, and no impairment or observable price change has been recognized. The Company’s maximum exposure to loss from its involvement with HpO is limited to the carrying amount of its investment.
 
Afterdream SAFE – In the second quarter of 2026, the Company entered into a SAFE (the “Afterdream SAFE”) with Afterdream, pursuant to which the Company invested $1,435,000 in exchange for the right to receive shares of Afterdream’s capital stock upon the occurrence of certain future events, with a post-money valuation cap of $7,500,000. Through two amendments in the same quarter, the purchase amount was increased to $1,535,000 and then to $1,735,000, with the valuation cap unchanged. Afterdream is a related party, as its majority owner is the Company’s co-founder and Chief Executive Officer (the “CEO”). As of September 30, 2026, the carrying value of the Afterdream SAFE investment was $634,469, after the impairment described below, presented as a related-party investment on the consolidated balance sheets.
 
Afterdream is a variable interest entity. The Company is not its primary beneficiary because it does not have the power to direct the activities that most significantly affect Afterdream’s economic performance, so Afterdream is not consolidated. The Company carries the SAFE at cost less impairment, adjusted for any observable price changes. No observable price changes have been recognized on the investment. Impairment of $1,100,531 was recognized as of September 30, 2026.
 
The Company’s maximum exposure to loss in respect of Afterdream was $702,385 at September 30, 2026, consisting of the $634,469 carrying amount of the SAFE investment recorded on the consolidated balance sheet and the $67,916 due from Afterdream (see Note 14). The Company has no obligation to provide further financial support to Afterdream beyond the amounts already funded and has provided no guarantees on its behalf.
 
The Company assesses the investment for impairment each reporting period, considering Afterdream’s ability to raise capital, its regulatory environment and its operating results. At September 30, 2026, management identified indicators of impairment, including Afterdream’s operating results below its plan, the delay of certain of its product relaunch to 2027, the federal restrictions on hemp-derived THC products scheduled to take effect on December 11, 2026, and its near-term funding needs; out of the aforementioned identified indicators, the impending regulatory changes proved most impactful. Management estimated the fair value of the investment at $634,469 using a venture capital method, a Level 3 fair value measurement on a nonrecurring basis. The significant unobservable inputs were the probability of each regulatory scenario (an 80% probability that Afterdream’s hemp-derived THC sales end in December 2026), a revenue multiple of 3.56x based on comparable publicly traded beverage companies, a discount rate of 55%, and the dilution expected from Afterdream’s future financing. Because the fair value was below the $1,735,000 carrying amount, the Company recognized an impairment loss of $1,100,531, presented within impairment loss in the condensed consolidated statements of operations for the three and nine months ended September 30, 2026.
 
Note 7 – Contract Losses
 
The Company identified that evidence existed, including a declining bulk wine market and demand concerns for finished goods wine, indicating that some of its long-term, unhedged purchase commitment contracts of bulk wine would incur losses in future periods. The Company records a provision when evidence exists that net realizable value is lower than the contractual price. The total liability associated with firm purchase commitment contracts was $4,215,612 and $3,042,044 as of September 30, 2026 and December 31, 2025, respectively, and is presented within contract liabilities on the consolidated balance sheets. The liability was reduced by $108,942 during the nine months ended September 30, 2026 on remeasurement and on wine received under the contracts. During the three months ended September 30, 2026, the Company recorded a provision of $1,282,510, presented within loss on contracts. The price agreed for bulk wine under the Full Glass Side Letter Agreement (see Note 6) is below the Company’s contractual purchase price and is used as the floor liquidation price that may be recoverable. The liability covers the expected loss on all of the Company’s firm purchase commitments at September 30, 2026. The related purchase commitments are described in Note 15. In October 2026, the Company signed a term sheet with one of these suppliers, non-binding except for certain provisions, to settle the amounts the Company owes that supplier (see Note 17).
 
9
 
Amass
Brands Inc
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
Note 8 – Derivative Liabilities
 
The Company issued convertible notes with embedded conversion features and warrants. The embedded conversion features do not qualify for equity classification under ASC 815 and were bifurcated and carried at fair value, and the associated warrants were recognized as liabilities, in each case with changes in fair value recorded in earnings.
 
Upon the Direct Listing on May 20, 2026, the Company’s convertible promissory notes converted into Common Stock (see Note 10) and the related conversion features were remeasured to fair value and reclassified to stockholders’ equity (deficit).
 
Derivative liabilities were $623,471 and $37,962 as of September 30, 2026 and December 31, 2025, respectively. At September 30, 2026 the derivative consists solely of the Series C Convertible Preferred Stock conversion feature as the warrant liability had negligible value. Changes in the fair value of derivative liabilities of $1,011,183 (net gain) and $0 were recognized for the three months ended September 30, 2026 and 2025, respectively, and $1,198,936 (net gain) and $0 for the nine months then ended.
 
Series C Convertible Preferred Stock conversion feature – Because the conversion price of the Series C Convertible Preferred Stock can become variable (see Note 12), the Company bifurcated the conversion feature and accounts for it as a derivative liability at fair value, with changes in fair value recognized in earnings. The Company recorded the conversion feature of the 7,000 shares issued at the Second Closing on May 20, 2026 at its issuance-date fair value of $849,236 (see Note 12).
 
The Company accounted for the August 19, 2026 amendment of the Series C Convertible Preferred Stock as an extinguishment (see Note 12). Immediately before the amendment, the Company remeasured the conversion feature, together with the holders’ default put, at its fair value of $240,553, a gain of $634,154 from June 30, 2026, and derecognized it with the extinguished preferred stock. The Company then recorded the conversion feature of the amended instrument at its fair value of $755,175 and the conversion feature of the 2,000 shares issued at the Third Closing on August 21, 2026 at its fair value of $236,865. The Company values the conversion feature by estimating the discount the holders would receive on conversion and then estimate the likelihood that they receive it. The conversion feature relating to the 175 shares converted on September 23, 2026 was remeasured to a negligible amount at conversion, a gain of $20,726. The Company recognized a gain on the conversion feature derivative of $1,002,723 for the three months and $1,198,936 for the nine months ended September 30, 2026. Significant unobservable input at September 30, 2026 was a 5% probability that the holders declare an Event of Default.
 
Note 9 – Debt
 
Secured credit facility – In September 2023, the Company entered into a Loan and Security Agreement to open a credit facility with a maximum aggregate principal amount of $8,000,000 (the ABL), reduced to $5,000,000 in 2026. Interest is accrued at the greater of (i) 12% and (ii) Prime Rate plus 3.75% per annum. Pursuant to the March 10, 2026 Credit Facility Amendment, the lender waived prior covenant defaults, the Tangible Working Capital and Tangible Net Worth covenants were reset to $2,500,000 each (tested quarterly), and the facility term was extended to September 30, 2026 with automatic one-year renewals; the facility renewed automatically through September 30, 2027. The outstanding balance on the ABL was $3,492,555 and $3,277,034 as of September 30, 2026 and December 31, 2025, respectively. The Company was in compliance with these covenants as of September 30, 2026.
 
Loans payable – The Company’s SBA EIDL loan had outstanding principal of $150,000 as of September 30, 2026 and December 31, 2025; accrued interest of $10,575 and $10,296, respectively, is presented within interest payable. The loan matures thirty years from the effective date and bears interest at 3.75% per annum. The Company’s Paycheck Protection Program loan of $14,570 was also outstanding as of September 30, 2026 and December 31, 2025.
 
As of September 30, 2026 and December 31, 2025, the principal balance of Mezzanine Secured Notes was $200,000 and $297,854, respectively. The related-party principal balance of $97,854 was repaid in February and March 2026. In March 2026, the Company extinguished $276,475 of interest in exchange for the exercise of 65,509 shares of Common Stock warrants for $26,479 and 20,833 shares of Common Stock for $249,996. As of September 30, 2026 and December 31, 2025, the accrued interest balance of Mezzanine Secured Notes was $269,531 and $524,125, respectively; none of the accrued interest was due to a related party. The notes, which had been extended through July 2026, were past due at September 30, 2026 and as of the date these financial statements were issued, while the Company remains in discussions with the holders regarding a further extension or repayment.
 
10
 
Amass
Brands Inc
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
In April 2024, Resonant, a variable
interest entity consolidated by the Company (see Note 14),
issued a Secured Promissory Note with an original principal balance of $2,500,000. Following the January 2026 Amendment No. 3
(accounted for as a troubled debt restructuring, so future payments reduce the carrying amount and no interest expense is recognized)
and Amendment No. 4 (a $150,000 partial warrant exercise applied against principal), and after the monthly installments paid through September 2026, eight $50,000 monthly installments remain payable from October 2026 through May 2027, plus a $417,000 balloon payment at the June 30, 2027 maturity. The outstanding balance was $816,998 and $1,266,998 as of September 30, 2026 and December 31, 2025, respectively. The Secured Promissory Note is
personally
guaranteed by the
Company’s
CEO
.
 
Promissory notes payable –
As of September 30, 2026 and December 31, 2025, the Company had promissory notes with a total outstanding principal balance of $1,400,000 and $2,650,000, respectively; $250,000 of principal was repaid during the three months ended September 30, 2026. The notes outstanding at September 30, 2026 accrue interest at a rate of 12% per annum and matured or mature between August 2026 and March 2027. Notes with principal of $550,000 had passed their maturity dates at September 30, 2026 and had not been repaid (see Note 17). The December 31, 2025 balance also included the $1,000,000 note issued to a shareholder in January 2025, which was exchanged for a convertible note in February 2026 and converted into Common Stock upon the Direct Listing (see Note 10). Accrued interest payable on the notes was $169,550 and $149,758 at September 30, 2026 and December 31, 2025, respectively.
 
Note 10 – Convertible Debt
 
From November 2025 through March 2026, the Company issued unsecured convertible promissory notes (“Convertible Notes”) to investors in an aggregate principal amount of $2,766,316, bearing interest at 9% per annum. Of the Convertible Notes, $1,000,000 was issued to MVL Inc., a related party (see Note 14). In connection with the issuances, the Company also issued warrants to purchase shares of Common Stock with an exercise price equal to the greater of $10.00 or the volume-weighted average trading price, exercisable following the Company’s listing on Nasdaq and expiring 180 days thereafter.
 
Upon the consummation of the Direct Listing on May 20, 2026, which constituted a qualified financing under the terms of the Convertible Notes, the outstanding principal and accrued interest automatically converted into 223,050 shares of Common Stock at a price equal to 80% of the price paid by new investors, and the remaining unamortized debt discount was charged to interest expense. As of September 30, 2026, no Convertible Notes remained outstanding, compared with a net carrying value of $378,725 at December 31, 2025. Interest expense recognized on the Convertible Notes (including accretion of discounts and the write-off of the unamortized discount upon conversion) was $0 and $0 for the three months ended September 30, 2026 and 2025, respectively, and $1,239,942 and $0 for the nine months then ended.
 
Note 11 – Simple Agreement for Future Equity (“SAFE”)
 
In February 2025, WKND Drinks Inc. (formerly Good Twin Inc.), a wholly owned subsidiary of the Company that operates the Good Twin brand, issued a SAFE to an investor in exchange for $500,000, which was applied toward the repayment of amounts outstanding under a previously issued secured promissory note. The SAFE has a post-money valuation cap of $5.0 million, does not bear interest, and has no stated maturity date. The Company determined that the SAFE does not qualify for equity classification and records it as a liability at fair value, with changes in fair value recognized in earnings. As of September 30, 2026 and December 31, 2025, the carrying value of the SAFE was $552,152 and $520,242, respectively. Losses from the changes in fair value of $10,848 and $31,910 were recognized in earnings for the three and nine months ended September 30, 2026, respectively, and $0 for both periods in 2025. No conversion or settlement events have occurred to date.
 
11
 
Amass
Brands Inc
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
Note 12 – Stockholders’ Equity (Deficit)
 
Direct Listing – On May 20, 2026, the Company’s Common Stock commenced trading on the Nasdaq Global Market under the ticker symbol “AMSS” through a direct listing that was not underwritten.
 
Conversion of Preferred Stock – On April 8, 2026, all outstanding shares of the Company’s Series Seed, Series A and Series B Preferred Stock (including all sub-series) automatically converted into an aggregate of 7,483,093 shares of Common Stock under the Company’s Seventh Amended and Restated Certificate of Incorporation, a reclassification within stockholders’ equity (deficit) with no income statement impact.
 
Series C Convertible Preferred Stock – Streeterville Private Placement – In connection with the Direct Listing, the Company entered into a Securities Purchase Agreement with Streeterville Capital, LLC (“Streeterville”) dated March 17, 2026, as amended April 7, 2026, for the sale of up to $30.0 million of Series C Convertible Preferred Stock (35,000 shares authorized; Stated Value $1,086.96 per share) in multiple closings. At the First Closing on April 8, 2026, the Company issued to Streeterville 28,125 shares of Common Stock as commitment fee shares and, for $10,000, a warrant to purchase up to 3,500,000 shares of Common Stock at $16.00 per share. At the Second Closing on May 20, 2026, the Company issued 7,000 shares of Series C Convertible Preferred Stock for $6,990,000, less a $30,000 transaction expense amount; proceeds from the First and Second Closings were $7,000,000. The Company allocated the proceeds as follows: $4,824,382 to the warrant issued to Streeterville (recorded within additional paid-in capital) on a relative fair value basis, $849,236 to the conversion feature derivative at its issuance-date fair value (see Note 8), and the remainder to the Series C Convertible Preferred Stock, to which initial issuance costs of $237,813 were allocated.
 
The Series C Convertible Preferred Stock is convertible into Common Stock at an initial conversion price equal to the Nasdaq Valuation Price, as defined in the Certificate of Designation (the “Fixed Price”). After the earlier of six months from the listing date, a Trigger Event or an Event of Default, the conversion price becomes the lesser of the Fixed Price and 90% of the lowest daily volume-weighted average price during the ten trading days prior to conversion (the “Market Price”), subject to a floor price of $4.00 per share (the “Floor Price”). On a trading day on which the Common Stock trades at a price 10% or more above the Nasdaq Minimum Price, as defined in the Certificate of Designation (a “Limited Conversion Event”) and on the following trading day, the holders may also convert at the lower of the Fixed Price and the Market Price (“Limited Conversions”). Under the original Certificate of Designation, Limited Conversions were subject to the Floor Price. The Amended and Restated Certificate of Designation effective August 19, 2026 reduced the minimum price for Limited Conversions to $0.75 per share. On October 22, 2026, the Floor Price was reduced to $1.00 per share and the $0.75 minimum for Limited Conversions was removed (see Note 17). Conversions are subject to a 9.99% beneficial ownership limitation and the Exchange Cap under Nasdaq Rule 5635(d); holders of 74.72% of the Common Stock approved issuances above the Exchange Cap by written consent dated as of March 17, 2026. Beginning six months after the applicable issuance date, the Company may, at the Board’s discretion, redeem all or any portion of the outstanding Series C Convertible Preferred Stock for cash at 115% of its liquidation amount.
 
The Company entered into two amendments during the second quarter of 2026 related to the warrant described above. The amendments reduced the exercise price from $16.00 to $5.00, and then to $3.00 per share for 90-day periods. The Company accounted for each reduction as a modification of an equity-classified instrument and recognized the incremental fair value of $514,313 and $431,680, respectively, within additional paid-in capital. The incremental fair value of the first amendment was charged to operations in the second quarter of 2026 as failed offering costs. The incremental fair value of the second amendment was deferred as offering costs and charged to operations in the third quarter of 2026 as failed offering costs (see below).
 
In July 2026, a third amendment reduced the warrant exercise price to $1.50 per share for a 30-day period, which lapsed in August 2026 without exercise, and the exercise price reverted to $16.00 per share. The $752,591 incremental fair value of the third amendment, recognized in additional paid-in capital, and the $431,680 deferred for the second amendment were charged to operations as failed offering costs of $1,184,271, included in other income (expense), net for the three and nine months ended September 30, 2026. The warrant was terminated on October 22, 2026 (see Note 17).
 
12
 
Amass
Brands Inc
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
Receipt on July 22, 2026 of notices from Nasdaq that the market value of the Company’s listed securities and of its publicly held shares was below the minimums for continued listing on The Nasdaq Global Market (compliance period to January 19, 2027) constituted a Trigger Event under the Series C Certificate of Designation, after which the variable conversion price described above applies. See Note 17 for the minimum bid price notice received in October 2026
.
 
Amended and Restated Certificate of Designation and Third Closing
–
On August 19, 2026, with the consent of the holders of a majority of the Series C Convertible Preferred Stock, the Company filed an Amended and Restated Certificate of Designation of Preferences and Rights of Series C Convertible Preferred Stock, which, among other things, changed the cash redemption and Limited Conversion terms described under “Accounting for the amendment” below. On August 21, 2026, the Company issued
2,000 shares of Series C Convertible Preferred Stock to Streeterville for $2,000,000
(the “Third Closing”). On September 23, 2026, Streeterville converted 175 shares of Series C Convertible Preferred Stock, with an aggregate
Stated Value of $190,218, into 253,624 shares of Common Stock at a conversion price of $0.75 per share in a Limited Conversion; the fair value of the related conversion feature derivative was
negligible
(see Note 8), and the carrying value of the converted shares, $
143,475
,
was
reclassified to
Common Stock and additional paid-in capital, with no gain or loss on the conversion. As of September 30, 2026, 8,825 shares of Series C Convertible Preferred Stock were issued and outstanding, with an
aggregate Stated Value of
$9,592,422
, an aggregate liquidation preference of $9,834,927 including $242,505 of
accrued and unpaid Preferred Return and a carrying value of $
7,812,317
.
 
Accounting for the amendment
–
The Amended and Restated Certificate of Designation removed the holders’ right to cash redemption after an
Event of Default
and reduced the minimum price for Limited Conversions from the $4.00 floor price to $0.75 per share. The Company accounted for the amendment as an extinguishment of the Series C Convertible Preferred Stock. It removed the carrying value of $1,088,569 and the related conversion feature derivative of $240,553 and recorded the amended instrument at its fair value of $
7,071,251
, comprising $
6,316,076
for the preferred stock and $
755,175
for the conversion feature derivative (see Note 8). The $5,742,129 difference is a deemed dividend that was charged to additional paid-in capital, is deducted in computing net loss per share (see Note 3) and did not affect net loss. The fair value of the preferred stock was measured as the Preferred Return to May 20, 2028 and the Stated Value, discounted at a 22.42% yield calibrated to the price paid at the Third
Closing.
From August 19, 2026, the Series C Convertible Preferred Stock is presented in permanent equity, because the holders can receive cash only on an actual liquidation, dissolution or winding up of the Company or on a deemed liquidation event in which all holders of equally and more subordinated equity instruments of the Company would always be entitled to also receive the same form of consideration
.

 
Third Closing allocation
–
The Company allocated the $2,000,000
Third Closing proceeds first to the conversion feature derivative at its fair value of
$
236,865
(see Note 8) and the remaining $
1,763,135
to
the
Series C Convertible Preferred Stock. The $140,000 placement agent fee, 
 
unpaid at September 30, 2026,
was allocated $123,419
to the
 
Series C Convertible Preferred Stock and $16,581 to general and administrative expenses.
 
Reinvestment right
–
Under the SPA, Streeterville may purchase up to $5,000,000 of additional Series C Convertible Preferred Stock at $1,000 per share until at least November 20, 2027. From August 19, 2026, the right is classified in equity.
 
Preferred Return
–
Each share of Series C Convertible Preferred Stock accrues a cumulative Preferred Return on its Stated Value of 2% per quarter, compounding daily, payable within five trading days after the end of each calendar quarter in cash or in additional shares of Series C Convertible Preferred Stock at the Company’s election. The Preferred Return is payable without declaration by the Board of Directors. The Company has not paid the Preferred Return for the periods ended June 30, 2026 and September 30, 2026. Because the Preferred Return is a feature of the outstanding Series C Convertible Preferred Stock, the Company recognizes it when
paid or when declared by the Board; accrued and unpaid Preferred Return is included in the $9,834,927 liquidation preference of the outstanding Series C Convertible Preferred Stock (but is not recognized as a liability or in its carrying value) and
deducted in computing net loss per share. Accrued and unpaid Preferred Return at September 30, 2026 was $243,888, of which $70,074 was past due; $242,505 ($27.48 per share) related to the 8,825 shares outstanding. If the Company fails to pay the Preferred Return when due and the failure is not cured within five trading days, the holders may declare an Event of Default, upon which the Stated Value would increase by 15% (approximately $1.4 million for one declaration and approximately $2.9 million to $3.1 million for both, on the shares outstanding at September 30, 2026) and the Preferred Return would accrue at 18% per annum. Both payments are past their cure periods, and no Event of Default has been declared. The Preferred Return accrued after August 19, 2026 is deducted in computing net loss per share (see Note 3).

 
13

Amass
Brands Inc
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
Common stock –
As of September 30, 2026, the Company was authorized to issue 250,000,000 shares of Common Stock with $0.00001 par value. As of September 30, 2026, 12,014,080 shares were issued and 11,858,705 shares were outstanding (net of 155,375 treasury shares); as of December 31, 2025, 3,364,984 shares were issued and outstanding. Each holder of
Common Stock
is entitled to one vote for each share held.
 
Stock transactions for the nine months ended September 30, 2026 –
During the three months ended September 30, 2026,
the Company issued
253,624
shares of Common Stock on the conversion
of Series C Convertible Preferred Stock 
described
above
.
Common Stock issued during the six months ended June 30, 2026, for services, on the exercise of warrants and options, on the
conversion of
preferred stock 
and Convertible Notes, as
Series C 
commitment fee shares, in a corrective issuance and in extinguishment of accrued interest, is presented in
the 
condensed consolidated statements
of 
stockholders’ equity (deficit) and described in Notes 9, 10 and 13. Shares
issued for advisory services were
recognized in general and administrative expenses based on the fair value of the shares at the time of issuance.

The Company authorized and had outstanding the following shares as of September 30, 2026 and December 31, 2025:
 
 
 
September 30, 2026
Authorized
 
 
 
 
September 30, 2026
Outstanding
 
 
 
 
December 31, 2025
Authorized
 
 
 
 
December 31, 2025
Outstanding
 
 
Common Stock
 
 
250,000,000
 
 
 
11,858,705
 
 
 
63,500,000
 
 
 
3,273,965
 
Common Non-Voting Stock
 
 
-
 
 
 
-
 
 
 
3,200,000
 
 
 
91,019
 
Series Seed Preferred Stock (all sub-series)
 
 
-
 
 
 
-
 
 
 
12,529,020
 
 
 
12,529,020
 
Series A Preferred Stock
 
 
-
 
 
 
-
 
 
 
873,734
 
 
 
873,734
 
Series B Preferred Stock (all sub-series)
 
 
-
 
 
 
-
 
 
 
27,789,708
 
 
 
8,304,185
 
Series C Convertible Preferred Stock
 
 
35,000
 
 
 
8,825
 
 
 
-
 
 
 
-
 
 
14
 
Amass
Brands Inc
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
Note 13 – Stock Options and Warrants
 
In September 2016, the Company adopted the 2016 Stock Plan (the “2016 Plan”), as amended, which authorized 1,726,130 shares as of September 30, 2026. Stock options granted under the 2016 Plan typically vest over a four-year period with a one-year cliff. On April 7, 2026, the Company’s Board of Directors adopted, and its stockholders approved, the AMASS Brands Inc. 2026 Omnibus Incentive Plan, which reserves 1,220,000 shares of Common Stock for issuance, subject to an annual increase beginning in 2027. On July 20, 2026, the Company registered those shares on Form S-8.
 
 
 
Options
 
 
Weighted Average
Exercise Price
 
 
 
 
Intrinsic Value
 
Outstanding as of December 31, 2025
 
 
1,213,313
 
 
$
0.21
 
 

 
 
Granted
 
 
—
 
 
 
—
 
 
 
 
 
Exercised
 
 
(17,582
)
 
$
0.24
 
 
 
 
 
Forfeited
 
 
(22,221
)
 
$
0.18
 
 
 
 
 
Outstanding as of September 30, 2026
 
 
1,173,510
 
 
$
0.21
 
 
$
310,843
 
Exercisable as of September 30, 2026
 
 
840,523
 
 
$
0.21
 
 
$
226,831
 
 
Stock-based compensation expense for stock options of $90,255 and $159,708 was recognized for the three months ended September 30, 2026 and 2025, respectively, and $537,800 and $381,172 for the nine months then ended, and is included in general and administrative expenses in the accompanying consolidated statements of operations. Total unrecognized compensation cost related to non-vested stock option awards amounted to $1,516,187 as of September 30, 2026. The remaining expense is expected to be recognized over a weighted-average period of approximately 27 months. No stock options, restricted stock units or other equity awards were granted during the nine months ended September 30, 2026. The weighted average remaining contractual life of options outstanding at September 30, 2026 was 7.5 years.
 
Common Stock warrants – A summary of information related to Common Stock warrants for the nine months ended September 30, 2026 is as follows:
 
 
 
Shares
 
 
Weighted Average
Exercise Price
 
 
Outstanding as of December 31, 2025
 
 
716,816
 
 
$
2.19
 
Granted
 
 
3,905,695
 
 
 
15.19
 
Exercised
 
 
(382,744
)
 
 
0.94
 
Cancelled or expired
 
 
(106,447
)
 
 
1.96
 
Outstanding as of September 30, 2026
 
 
4,133,320
 
 
$
14.60
 
Exercisable as of September 30, 2026
 
 
4,133,320
 
 
$
14.60
 
 
Warrants granted during the nine months ended September 30, 2026 consist of the warrant to purchase up to 3,500,000 shares of Common Stock issued to Streeterville at the First Closing, 276,632 warrants with an exercise price of $10.00 issued with the Convertible Notes, whose number of shares was determined on the Direct Listing, and 129,063 Common Stock warrants issued upon the conversion of Series B-1 preferred stock warrants. During the nine months ended September 30, 2026, 382,744 Common Stock warrant shares were exercised at a weighted average exercise price of $0.94.
 
In the first quarter, the Company issued 222,026 shares of Common Stock and 740,328 shares of Series B-1 Preferred Stock upon the exercise of warrants, including the Series B-1 preferred stock warrant exercises described below, for aggregate consideration of $986,226 (of which $150,000 was applied against loans payable); for the second-quarter exercises, $14,211 was received in cash (settling into the issuance of 84,907 shares of Common Stock). 106,447 warrants were cancelled or expired at a weighted average exercise price of $1.96. Of the 1,328,185 Series B-1 preferred stock warrants outstanding at December 31, 2025, 940,996 were exercised during the first quarter of 2026 for 740,328 shares of Series B-1 Preferred Stock, including 409,722 exercised on a net basis, and the remaining 387,189 were converted into 129,063 Common Stock warrants at the 3-to-1 conversion ratio of the Series B-1 Preferred Stock; no preferred stock warrants were outstanding at September 30, 2026. The Streeterville warrant was terminated on October 22, 2026, and the warrants issued with the Convertible Notes expire on November 16, 2026. The weighted average remaining contractual life of warrants outstanding at September 30, 2026 was 4.0 years.
 
Note 14 – Related-Party Transactions
 
The Company has entered into the following transactions with related parties. Amounts are as of, and for the periods ended, September 30, 2026 and December 31, 2025 (balance sheet) or September 30, 2026 and 2025 (results of operations), as applicable.
 
Due from related parties - Chief Executive Officer advances
 
The CEO received various advances from the Company. In January 2022, the Company entered into a loan agreement with the CEO under which the outstanding balance accrued interest at 1.6% per annum. Interest earned on the advances was not material in any period presented. The net amount due from the CEO was $0 and $1,389,996 as of September 30, 2026 and December 31, 2025, respectively. The advances were settled in March 2026 through the repurchase of 155,375 shares of Common Stock from the CEO, at a price of $8.97 per share based on the Company’s most recent Regulation Crowdfunding sales price, resulting in treasury stock of $1,393,713. No amounts were outstanding at September 30, 2026.
 
AFTERDREAM, Inc. - services, De Soi secured borrowing and repurchase obligation
 
Afterdream is a related party because its majority owner is the Company’s CEO. The Company provided certain operational and administrative services to Afterdream under an earlier arrangement in 2025. Beginning in July 2026, the Company provides accounting and systems support and financial planning and analysis services to Afterdream for $15,000 per month; related-party services revenue of $45,000 was recognized in each of the three and nine months ended September 30, 2026. Under the earlier arrangement, the Company charged Afterdream $5,000 per month from May 2025 and recognized related-party services revenue of $15,000 and $25,000 for the three and nine months ended September 30, 2025, respectively. At September 30, 2026, amounts due from Afterdream were $67,916, consisting of $45,000 of unpaid services fees and $22,916 of expenses paid by the Company on Afterdream’s behalf, and are presented as due from related parties on the consolidated balance sheets. In October 2026, Afterdream paid $48,560 of these amounts to the Company.
 
15
 
Amass
Brands Inc
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
During 2025, the Company
transferred its units of AMASS De Soi Holdings LLC to Afterdream in exchange for $400,000 in cash and entered into a related repurchase obligation, accounted for as a secured borrowing. In June 2026, the collateral was released and the repurchase obligation was extinguished; the obligation was $0 and $400,000 as of September 30, 2026 and December 31, 2025, respectively. See Note 6 for a further description of these transactions.
 
AFTERDREAM, Inc. - Simple Agreement for Future Equity
 
In the second quarter of 2026, the Company entered into a SAFE with Afterdream, as subsequently amended. As of September 30, 2026, the funded purchase amount of the Afterdream SAFE investment was
$1,735,000 
and its carrying value was $634,469, after a $1,100,531 impairment recognized in the third quarter of 2026. See Note 6 for a further description.
 
Zerra Nutrition, Inc. (“HpO”)
 
HpO is a related party because it is controlled by Geoff McFarlane, who is the majority owner and President of Resonant, an entity the Company consolidates as a variable interest entity.
The carrying value of the Company’s investment in HpO, formalized in June 2026
as a SAFE,
was $153,449 and $78,463 as of September 30, 2026 and December 31, 2025, respectively. See Note 6 for a further description.

Geoff McFarlane - consulting services

Geoff McFarlane served as a consultant to the Company at $20,000 per month following the end of his term as Interim Chief Financial Officer in August 2025, and the Board of Directors has appointed him Interim Chief Financial Officer effective November 17, 2026. Fees for his services, paid through Nouvelle Noir, Inc., were $60,000 for each of the three months ended September 30, 2026 and 2025 and $180,000 for each of the nine months ended September 30, 2026 and 2025.

 
Mezzanine Secured Notes - related-party holder
 
One of the three Mezzanine Secured Notes
was held by Nitehous LLC, a related party because the CEO serves as its executor and Geoff McFarlane (see above) is affiliated with it;
the related-party principal balance ($97,854 at December 31, 2025) was repaid in February and March 2026, together with $3,953 of accrued interest paid in February 2026, and no principal or accrued interest was due to a related party at September 30, 2026. See Note 9 for a further description of the Mezzanine Secured Notes.
 
Promissory note -
principal owner
 
In January 2025, the Company issued a promissory note with a principal balance of $1,000,000
to MVL Inc., a principal owner that beneficially owns more than
10%
of the Company’s Common Stock.
The note was exchanged for a convertible promissory note in February 2026 and, upon the consummation of the Direct Listing on May 20, 2026, converted into shares of Common Stock. The outstanding balance was $0 and $1,000,000 as of September 30, 2026 and December 31, 2025, respectively. See Notes 9 and 10 for a further description of these transactions.
 
Convertible notes issued to related parties
 
Of the $2,766,316 aggregate principal amount of Convertible Notes issued from November 2025 through March 2026, $1,000,000 was issued to MVL Inc. (f/k/a Alchemi Project Inc.), a principal owner that beneficially owns more than 10% of the Company’s Common Stock. Upon the consummation of the Direct Listing on May 20, 2026, all Convertible Notes, including the note held by MVL Inc., automatically converted into shares of Common Stock. No Convertible Notes were outstanding at September 30, 2026. See Notes 10 and 12.
 
16
 
Amass
Brands Inc
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
Equity transactions with related parties
 
During the three months ended March 31, 2026, 258,126 shares of Series B-1 Preferred Stock were issued upon the exercise of warrants by MVL Inc. for proceeds of $378,000. Those shares converted into Common Stock on April 8, 2026 together with all other outstanding preferred stock. See Note 12.
 
Resonant Subholdings Inc.
 
Resonant is consolidated by the Company as a variable interest entity. In April 2024, the Company sold trademarks to Resonant, which financed the purchase with the Secured Promissory Note described in Note 9, and the Company licenses the trademarks back. The Company is the primary beneficiary of Resonant because it has the power to direct the use of the trademarks, which are Resonant’s only significant assets, and its license payments fund Resonant’s payments on the Secured Promissory Note. Because Resonant is consolidated, the sale and the license are eliminated: the trademarks, which the Company developed internally, have no carrying amount in the consolidated balance sheets, and the Secured Promissory Note, $816,998 and $1,266,998 as of September 30, 2026 and December 31, 2025, respectively, is presented in loans payable. Resonant’s majority owner and President, Geoff McFarlane, also controls HpO, and Resonant is a party to the Secured Promissory Note amendments described in Note 9.
 
Note 15 – Commitments and Contingencies
 
Lease commitments – The Company leases its Santa Maria, CA warehouse under a one-year lease renewed in January 2026, with an obligation of $42,248 per month through December 2026. The Company’s office space is a coworking arrangement with a term of twelve months or less, which the Company accounts for as a short-term lease; the related rent expense was not material in any period presented. For the three months ended September 30, 2026 and 2025, the Company incurred warehouse rent and utilities expense of $150,482 and $130,452, respectively, and for the nine months then ended, $448,353 and $474,947, respectively. No material obligations exist on the Company’s current operating leases beyond the Santa Maria lease as of September 30, 2026.
 
Purchase commitments – Amounts owed under these commitments are based on commitments to purchase certain varietals of bulk wine for various quantities through 2028. As of September 30, 2026, amounts due under scheduled payments were approximately $4.1 million for which the Company has not yet received the bulk wine. The Company has assessed the bulk wine under these contracts for potential losses. The Company has recognized a $4,215,612 liability for losses on these commitments (see Note 7), and storage fees accrue under certain of the contracts on wine not picked up. Annual obligations through 2028 are approximately $2.0 million per annum. During the three months ended September 30, 2026, the Company accrued $157,847 of interest payable to one of these suppliers, presented in interest expense and accrued expenses. The Company has signed a term sheet with one of these suppliers, non-binding except for certain provisions, to settle amounts due and cancel future obligations (see Note 17).
 
Contingencies – The Company may be subject to pending legal proceedings and regulatory actions in the ordinary course of business. The results of such proceedings cannot be predicted with certainty, but the Company does not anticipate that the final outcome, if any, arising out of any such matters will have a material adverse effect on its business, financial condition, or results of operations.
 
17
 
Amass
Brands Inc
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
Note 16 – Business Segment Information
 
During the second quarter of 2026, in connection with the Company becoming a public company and the continued growth of its functional non-alcoholic beverage business, the CEO, who is the Company’s Chief Operating Decision Maker (“CODM”), realigned the Company’s internal management financial reporting. The Company now reports its operating results in two reportable segments: (i) Wine & Spirits and (ii) Non-Alcoholic and Functional. The Wine & Spirits segment comprises the Company’s alcoholic wine portfolio (including Summer Water, Pizzolato MUSE, and the Natural Merchants and AMASS wine brands) and its spirits portfolio (AMASS spirits, Gem&Bolt mezcal, and Calirosa tequila). The Non-Alcoholic and Functional segment comprises the Company’s functional non-alcoholic beverage brands: Good Twin non-alcoholic wine and AMASS Electrolytes. Prior-period segment information has been recast to conform to the new segment presentation. Before the second quarter of 2026, the Company reported two segments, Wine and Spirits, with the non-alcoholic businesses included within those segments.
 
The business segments reflect how the Company’s operations are managed, how resources are allocated, how operating performance is evaluated by senior management, and the structure of its internal financial reporting. Management excludes certain Comparable Adjustments from its evaluation of the results of each operating segment as these Comparable Adjustments are not reflective of core operations of the segments. Certain items such as costs related to corporate communications, development, finance, strategy and growth, executive management, human resources, investor relations, IT, and legal are general costs applicable to the consolidated group and are not allocated to the reportable segments. The accounting policies of the segments are the same as those described in Note 3. The CODM evaluates the performance of each segment, and allocates resources among them, using segment loss from operations, which excludes Comparable Adjustments and unallocated amounts; segment loss from operations is also used in determining the incentive compensation of segment management. The CODM does not review segment assets.

Segment information is as follows:
 
For the three months ended September 30, 2026
 
Wine &
Spirits
 
 
 
 
Non-
Alcoholic
and
Functional
 
 
 
 
 
 
 
 
Total
segment (a)
 
 
 
 
Unallocated
amounts (b)
 
 
 
 
Comparable
Adjustments (c)
 
 
 
 
Consolidated
 
Net revenues
 
 
4,644,092
 
 
 
641,153
 
 
 
5,285,245
 
 
 
45,000
 
 
 
38,270
 
 
 
5,368,515
 
Cost of net revenues
 
 
2,951,499
 
 
 
478,205
 
 
 
3,429,704
 
 
 
-
 
 
 
2,478,182
 
 
 
5,907,886
 
Gross profit (d)
 
 
1,692,593
 
 
 
162,948
 
 
 
1,855,541
 
 
 
45,000
 
 
 
(2,439,912
)
 
 
(539,371
)
Sales and marketing
 
 
692,571
 
 
 
348,367
 
 
 
1,040,938
 
 
 
61,117
 
 
 
-
 
 
 
1,102,055
 
General and administrative
 
 
780,362
 
 
 
378,715
 
 
 
1,159,077
 
 
 
670,885
 
 
 
90,255
 
 
 
1,920,217
 
Impairment loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
1,100,531
 
 
1,100,531
Income (loss) from operations
 
 
219,660
 
 
(564,134
)
 
 
(344,474
)
 
 
(687,002
)
 
 
(3,630,698
)
 
 
(4,662,174
)
Other income (expense) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1,063,609
)
Loss before income taxes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(5,725,783
)
 
For the three months ended September 30, 2025
 
Wine &
Spirits
 
 
 
 
Non-
Alcoholic
and
Functional
 
 
 
 
 
 
 
 
Total
segment (a)
 
 
 
 
Unallocated
amounts (b)
 
 
 
 
Comparable
Adjustments (c)
 
 
 
 
Consolidated
 
Net revenues
 
 
3,930,060
 
 
 
122,046
 
 
 
4,052,106
 
 
 
15,000
 
 
 
-
 
 
 
4,067,106
 
Cost of net revenues
 
 
3,514,992
 
 
 
90,973
 
 
 
3,605,965
 
 
 
-
 
 
 
124,476
 
 
 
3,730,441
 
Gross profit (d)
 
 
415,068
 
 
 
31,073
 
 
 
446,141
 
 
 
15,000
 
 
 
(124,476
)
 
 
336,665
 
Sales and marketing
 
 
766,677
 
 
 
32,188
 
 
 
798,865
 
 
 
210
 
 
 
-
 
 
 
799,075
 
General and administrative
 
 
1,042,957
 
 
 
37,379
 
 
 
1,080,336
 
 
 
721,943
 
 
 
115,870
 
 
 
1,918,149
 
Impairment loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
6,064,603
 
 
 
6,064,603
 
Income (loss) from operations
 
 
(1,394,566
)
 
 
(38,494
)
 
 
(1,433,060
)
 
 
(707,153
)
 
 
(6,304,949
)
 
 
(8,445,162
)
Other income (expense) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (455,465
) 
Loss before income taxes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (8,900,627
)
 
18
 
Amass
Brands Inc
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
For the nine months ended September 30, 2026
 
Wine &
Spirits
 
 
 
 
Non-
Alcoholic
and
Functional
 
 
 
 
 
 
 
 
Total
segment (a)
 
 
 
 
Unallocated
amounts (b)
 
 
 
 
Comparable
Adjustments (c)
 
 
 
 
Consolidated
 
Net revenues
 
 
13,453,231
 
 
 
1,574,101
 
 
 
15,027,332
 
 
 
45,000
 
 
 
38,270
 
 
 
15,110,602
 
Cost of net revenues
 
 
9,397,767
 
 
 
1,205,533
 
 
 
10,603,300
 
 
 
-
 
 
 
2,478,182
 
 
 
13,081,482
 
Gross profit (d)
 
 
4,055,464
 
 
 
368,568
 
 
 
4,424,032
 
 
 
45,000
 
 
 
(2,439,912
)
 
 
2,029,120
 
Sales and marketing
 
 
2,194,085
 
 
 
794,545
 
 
 
2,988,630
 
 
 
140,779
 
 
 
-
 
 
 
3,129,409
 
General and administrative
 
 
2,547,146
 
 
 
708,105
 
 
 
3,255,251
 
 
 
6,698,159
 
 
 
537,800
 
 
 
10,491,210
 
Impairment loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
1,550,216
 
 
 
1,550,216
 
Loss from operations
 
 
(685,767
)
 
 
(1,134,082
)
 
 
(1,819,849
)
 
 
(6,793,938
)
 
 
(4,527,928
)
 
 
(13,141,715
)
Other income (expense)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(3,174,888
)
Loss before income taxes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(16,316,603
)
 
For the nine months ended September 30, 2025
 
Wine &
Spirits
 
 
 
 
Non-
Alcoholic
and
Functional
 
 
 
 
 
 
 
 
Total
segment (a)
 
 
 
 
Unallocated
amounts (b)
 
 
 
 
Comparable
Adjustments (c)
 
 
 
 
Consolidated
 
Net revenues
 
 
13,236,677
 
 
 
522,068
 
 
 
13,758,745
 
 
 
25,000
 
 
 
128,736
 
 
 
13,912,481
 
Cost of net revenues
 
 
9,421,320
 
 
 
355,262
 
 
 
9,776,582
 
 
 
(49
)
 
 
439,971
 
 
 
10,216,504
 
Gross profit (d)
 
 
3,815,357
 
 
 
166,806
 
 
 
3,982,163
 
 
 
25,049
 
 
 
(311,235
)
 
 
3,695,977
 
Sales and marketing
 
 
2,607,066
 
 
 
149,874
 
 
 
2,756,940
 
 
 
11,915
 
 
 
-
 
 
 
2,768,855
 
General and administrative
 
 
3,429,177
 
 
 
137,360
 
 
 
3,566,537
 
 
 
1,903,226
 
 
 
483,678
 
 
 
5,953,441
 
Impairment loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
6,064,603
 
 
 
6,064,603
 
Loss from operations
 
 
(2,220,886
)
 
 
(120,428
)
 
 
(2,341,314
)
 
 
(1,890,092
)
 
 
(6,859,516
)
 
 
(11,090,922
)
Other income (expense)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(2,794,749
)
 
Loss before income taxes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(13,885,671

)
 
(a)
Segment amounts are derived from the Company’s entity- and brand-level general ledger reporting: the Non-Alcoholic and Functional segment reflects the Good Twin brand activity and the Amass Electrolyte entity; the Wine & Spirits segment reflects the remaining operating entities.
 
(b)
Unallocated amounts include costs held in the corporate infrastructure that are not allocated to any reporting segment and the shared-services fees charged to Afterdream, a related party (see Note 14), which are presented in net revenues.
 
(c)
Comparable Adjustments are items that management excludes from segment results because they are not reflective of current operations. For 2026 they comprise the August 2026 sale of bulk wine to Full Glass and its cost, the provision for losses on bulk wine purchase commitments and the write-down of the remaining bulk wine the Company has agreed to sell to Full Glass, all recorded in the third quarter of 2026, stock-based compensation and impairment losses; for 2025 they comprise bulk wine sales and
related costs and storage, the loss on bulk wine purchase commitments recognized in the third quarter of 2025, stock-based compensation and the impairment loss
recognized in the third quarter of 2025.
 
(d)
Segment gross profit is reconciled to gross profit on the consolidated statement of operations with the inclusion of unallocated amounts and Comparable Adjustments.

Comparable adjustments were as follows:
 
 
 
Three months
ended September 30,
2026
 
 
 
 
 
 
Three months
ended September 30,
2025
 
 
 
 
 
 
Nine months
ended September 30,
2026
 
 
 
 
 
 
Nine months
ended September 30,
2025
 
 
 
Net revenues — sales of bulk wine (a)
 
 
38,270
 
 
 
-
 
 
 
38,270
 
 
 
128,736
 
Cost of net revenues — bulk wine and write-downs (a)
 
 
2,478,182
 
 
 
124,476
 
 
 
2,478,182
 
 
 
439,971
 
General and administrative — stock-based compensation (b)
 
 
90,255
 
 
 
159,708
 
 
 
537,800
 
 
 
381,172
 
General and administrative — storage on bulk wine (a)
 
 
-
 
 
 
(43,838
)
 
 
-
 
 
 
102,506
 
Impairment loss (b)
 
 
1,100,531
 
 
6,064,603
 
 
 
1,550,216
 
 
 
6,064,603
 
Comparable adjustments, Operating loss
 
 
(3,630,698
)
 
 
(6,304,949
)
 
 
(4,527,928
)
 
 
(6,859,516
)
 
(a)
Sales of excess bulk wine and the related costs and storage are not part of the Company’s regular operations and are excluded from the CODM’s review. For the third quarter of 2026, (a) also includes the bulk wine items listed above, and for the third quarter of 2025 it includes a $124,476 loss on bulk wine purchase commitments, which, as in the Company’s 2025 annual financial statements, is excluded because it resulted from the Company’s historical acquisitions and not from core wine operations.
 
(b)
The CODM does not consider stock-based compensation or impairment losses in evaluating segment performance.
 
19
 
Amass
Brands Inc
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
Our principal area of operation is in the U.S. Current operations for one of the spirits brands are in Mexico. Revenues are attributed to countries based on the location of the customer. Geographic data is as follows:
 
 
 
Three months
ended September 30,
2026
 
 
 
 
 
 
Three months
ended September 30,
2025
 
 
 
 
 
 
Nine months
ended September 30,
2026
 
 
 
 
 
 
Nine months
ended September 30,
2025
 
 
 
Net revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.
 
 
5,364,595
 
 
 
4,056,406
 
 
 
15,061,700
 
 
 
13,883,688
 
Non-U.S.
 
 
3,920
 
 
 
10,700
 
 
 
48,902
 
 
 
28,793
 
Total net revenues
 
$
5,368,515
 
 
$
4,067,106
 
 
$
15,110,602
 
 
$
13,912,481
 
 
Note 17 – Subsequent Events
 
Nasdaq minimum bid price notice – On October 9, 2026, the Company received a notice from Nasdaq that it did not meet the $1.00 minimum bid price requirement for continued listing. The Company has until April 7, 2027 to regain compliance.
 
Second Amended and Restated Series C Certificate of Designation – On October 22, 2026, with the consent of Streeterville as sole holder, the Company filed a Second Amended and Restated Certificate of Designation of the Series C Convertible Preferred Stock. It reduces the Floor Price from $4.00 per share to $1.00 per share and removes the $0.75 per share minimum from the definition of Market Price, so that Limited Conversions, which are made at the lower of the Fixed Price and the Market Price, are no longer subject to a minimum conversion price. The Company has not completed its evaluation of the accounting for the amendment, which will be reflected in the fourth quarter of 2026, and cannot yet estimate its financial effect.
 
Termination of Streeterville Warrant – On October 22, 2026, the Company and Streeterville terminated the warrant to purchase up to 3,500,000 shares of Common Stock issued under the SPA, with no payment. See Notes 12 and 13.
 
Expiration of Convertible Note Warrants – The warrants to purchase 276,632 shares of Common Stock issued with the Convertible Notes, exercisable at the greater of $10.00 per share and the volume-weighted average trading price, expired unexercised on November 16, 2026, 180 days after the May 20, 2026 Direct Listing. The warrants had a negligible fair value at September 30, 2026. See Notes 8, 10 and 13.

Series C Convertible Preferred Stock Purchase and Conversion – On October 26, 2026, the Company issued 500 shares of Series C Convertible Preferred Stock to Streeterville under the SPA for proceeds of $500,000. The Company has not completed its evaluation of the accounting for the purchase, including the measurement of the conversion feature, and cannot yet estimate its financial effect. On November 5, 2026, Streeterville converted 70 shares of Series C Convertible Preferred Stock, with an aggregate Stated Value of $76,087, into 293,444 shares of Common Stock at a conversion price of $0.26 per share.

Preferred Return – The Preferred Return on the Series C Convertible Preferred Stock for the third quarter of 2026, payable within five trading days after September 30, 2026, was not paid (see Note 12).

Reverse stock split proposal – On October 30, 2026, the Board approved, and the Company filed a proxy statement for, a proposal to authorize reverse stock splits of the Common Stock. Under the amended proxy statement filed on November 9, 2026, the proposal authorizes one or more reverse stock splits at a ratio of not less than 1-for-2, with the cumulative effect of all such reverse stock splits not to exceed 1-for-250, to be determined by the Board, and the Board called a special meeting of stockholders for December 17, 2026 to vote on the proposal. Share and per-share amounts in these financial statements do not reflect any reverse stock split.

Promissory notes payable – Subsequent to September 30, 2026, the Company repaid $50,000 of promissory note principal, and promissory notes with principal of $750,000 matured. As of the date these financial statements were issued, promissory notes with principal of $1,250,000 had passed their maturity dates and had not been repaid. See Note 9.

Bulk wine supplier term sheet – In October 2026, the Company signed a term sheet with one of its bulk wine suppliers, non-binding except for certain provisions, under which certain of the Company’s wine brands and the related inventory would be transferred to the supplier in exchange for the cancellation of all amounts the Company owes the supplier and of the Company’s remaining purchase commitments with the supplier, and the Company’s issuance to the supplier of an $850,000 promissory note. Separately, and whether or not the transaction closes, the Company would issue 600,000 shares of Common Stock to the supplier, subject to required consents and approvals, for a $300,000 credit against the amounts owed. Closing is subject to definitive agreements and required consents, with an outside date of December 31, 2026. Under the binding provisions of the term sheet, if the transaction has not closed by December 31, 2026, other than because of the supplier, all amounts the Company owes the supplier, net of payments made and of the $300,000 credit if the shares have been issued, become due on January 1, 2027. The Company cannot yet estimate the gain or loss on the transaction, which depends on closing. See Notes 5 and 7.
 
Officer transition – On October 21, 2026, the Company’s Chief Financial Officer notified the Company of his resignation effective November 16, 2026, and the Board of Directors appointed Geoff McFarlane as Interim Chief Financial Officer effective November 17, 2026 (see Note 14).
 
20
 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
 
You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. Some of the information contained in this discussion and analysis, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the “Risk Factors” section of our Prospectuses dated May 18, 2026 and July 6, 2026, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.
 
This MD&A, which should be read in conjunction with our financial statements, is organized as follows: Overview: a general description of our business, which we believe is important in understanding the results of our operations, financial condition, and potential future trends. Strategy: a description of our strategy and a discussion of recent developments, and significant divestitures, acquisitions, and investments. Recent developments: a summary of the material transactions and events that occurred during, or shortly after, the three months ended September 30, 2026. Results of operations: an analysis of our results of operations presented on a business segment basis, including Adjusted EBITDA, a non-GAAP measure. Liquidity and capital resources: an analysis of our cash flows, outstanding debt, liquidity position, and commitments. Critical accounting policies and estimates: accounting policies that are considered important to our results of operations and financial condition, require significant judgment, and involve significant management estimates. Emerging Growth Company and Smaller Reporting Company Status: a discussion of our reporting status.
 
Overview
 
We are a consumer packaged goods company focused on developing, marketing, and distributing a portfolio of premium beverage brands across the wine, spirits, and functional non-alcoholic categories with the ethos of meeting the needs of the modern day consumer. Our products are primarily sold through a three-tier system to wholesale distributors, who then sell to retailers, bars, and restaurants, as well as directly to consumers through our e-commerce platforms. Our direct-to-consumer and e-commerce channel is growing, led by our non-alcoholic brands (Good Twin, which sells through its own e-commerce store and digital marketplaces, and AMASS Electrolytes, which launched direct-to-consumer during the second quarter of 2026), and we expect to continue developing direct sales alongside our three-tier wholesale distribution. Beginning in the second quarter of 2026, we report our operating results in two segments: (i) Wine & Spirits, comprising our alcoholic wine and spirits portfolios, and (ii) Non-Alcoholic and Functional, comprising our functional non-alcoholic beverage brands Good Twin and AMASS Electrolytes. Prior-period segment information has been recast to the new basis. See Note 16 to our unaudited condensed consolidated financial statements.
 
Geographic Markets
 
Substantially all of our net revenues are currently generated in the United States, which represents our primary market across our spirits, wine, and non-alcoholic beverage portfolios. Certain of our agave-based spirits products are produced in Mexico by our
wholly
owned Mexican subsidiary and third-party production arrangements, but we do not currently operate material direct sales or distribution operations outside the United States.
 
Strategy
 
Our long-term strategy, customer and market environment, marketing, sales, and distribution are unchanged from the strategy described in our Prospectus dated May 18, 2026, except as described below regarding the brand transfer term sheet. Within the Wine & Spirits segment, our wine strategy is centered on generating consistent cash flow while preserving market positioning and selectively growing key brands that drive long-term enterprise value, and our spirits strategy reflects a disciplined approach, with a near-term deprioritization in 2026 as we position the business for renewed growth in subsequent periods. In the Non-Alcoholic and Functional segment, we are investing behind Good Twin and the launch of AMASS Electrolytes to build our position in the functional non-alcoholic category. In the second quarter of 2026, we completed the Direct Listing of our common stock on the Nasdaq Global Market.
 
21
 
Recent Developments
 
·
Streeterville Series C Convertible Preferred Stock (August–October 2026). On August 19, 2026, we amended the terms of the Series C Convertible Preferred Stock. We accounted for the amendment as an extinguishment, recorded a deemed dividend of approximately $5.7 million that did not affect net loss, and moved the stock from mezzanine equity to permanent equity. On August 21, 2026, we issued 2,000 shares of Series C Convertible Preferred Stock to Streeterville for $2,000,000 (the “Third Closing”). On September 23, 2026, Streeterville converted 175 shares into 253,624 shares of common stock at $0.75 per share. On October 22, 2026, we filed a Second Amended and Restated Certificate of Designation that reduces the Floor Price from $4.00 to $1.00 per share and removes the $0.75 minimum price on Limited Conversions, which could result in greater dilution to existing stockholders, and we and Streeterville terminated the warrant to purchase up to 3,500,000 shares of common stock with no payment. See Notes 12 and 17.
 
·
Nasdaq continued-listing notices; Series C Trigger Event (July and October 2026). On July 22, 2026, we received notices from Nasdaq stating that we are not in compliance with the minimum Market Value of Listed Securities and minimum Market Value of Publicly Held Shares requirements for continued listing on the Nasdaq Global Market, with a 180-calendar-day period, through January 19, 2027, to regain compliance. On October 9, 2026, we received a further notice that the closing bid price of our common stock had been below $1.00 per share for 30 consecutive business days and that we are not in compliance with the minimum bid price requirement, with a 180-calendar-day grace period through April 7, 2027 to regain compliance. Receipt of the notices constituted a Trigger Event under the Series C Certificate of Designation, permitting conversions of the Series C Convertible Preferred Stock at the alternate conversion price described under “Liquidity and capital resources” below. In addition, the Preferred Return on the Series C Convertible Preferred Stock for the second and third quarters of 2026 was not paid, the $200,000 Mezzanine Secured Notes are past due, and $0.55 million of our promissory notes had passed their maturity dates and had not been repaid at September 30, 2026 ($1.25 million as of the date of this Report). See Notes 9, 12 and 17 to our unaudited condensed consolidated financial statements.
 
·
Full Glass Side Letter Agreement (July 2026). In July 2026, we entered into a Side Letter Agreement with Full Glass that replaced Full Glass’s remaining $4.0 million purchase obligation with a $427,000 settlement, of which $406,000 is a deposit that Full Glass may apply toward the redemption of our units in Full Glass. See Note 6.

·
Brand transfer term sheet (October 2026). In October 2026, we signed a term sheet, non-binding except for certain provisions, to transfer certain of our wine brands, and the related inventory, to one of our bulk wine suppliers. In exchange, the supplier would cancel all amounts we owe it, and we would issue an $850,000 promissory note. Separately, and whether or not the transaction closes, we would issue 600,000 shares of common stock to the supplier for a $300,000 credit against the amounts we owe. The transaction is subject to definitive agreements and to required consents. If it has not closed by December 31, 2026, other than because of the supplier, the amounts we owe the supplier become due on January 1, 2027. See Notes 5, 7 and 17.

·
Chief Financial Officer transition (October 2026). On October 23, 2026, we reported that Zachary Ament will resign as Chief Financial Officer effective November 16, 2026. His resignation did not result from any disagreement with the Company. Geoff McFarlane, a related party (see Note 14 to our unaudited condensed consolidated financial statements), will serve as Interim Chief Financial Officer and principal financial and accounting officer beginning November 17, 2026.


22
 
Results of Operations
 
The following table summarizes components of our unaudited consolidated statements of operations for the three months ended September 30, 2026 and 2025:
 

 
 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Dollar
Change
 
 
Percent
Change
 
Net revenue
 
 
5,368,515
 
 
 
4,067,106
 
 
 
1,301,409
 
 
 
32
%
Cost of net revenue
 
 
5,907,886
 
 
 
3,730,441
 
 
 
2,177,445
 
 
 
58
%
Gross profit
 
 
(539,371
)
 
 
336,665
 
 
 
(876,036
)
 
 
-260
%
Sales and marketing
 
 
1,102,055
 
 
 
799,075
 
 
 
302,980
 
 
 
38
%
General and administrative
 
 
1,920,217
 
 
 
1,918,149
 
 
 
2,068
 
 
 
0
%
Impairment loss
 
 
1,100,531
 
 
 
6,064,603
 
 
 
(4,964,072
)
 
 
-82
%
Total operating expenses
 
 
4,
122,803
 
 
 
8,781,827
 
 
 
(4,
659,024
)
 
 
-
53
%
Loss from operations
 
 
(
4,662,174
)
 
 
(8,445,162
)
 
 
3,782,988
 
 
 
45
%
Other income (expense)
 
 
(1,063,609
)
 
 
(455,465
)
 
 
(608,144
)
 
 
-134
%
Net loss
 
 
(
5,725,783
)
 
 
(8,900,627
)
 
 
3,174,844
 
 
 
36
%

The following table summarizes components of our unaudited consolidated statements of operations for the nine months ended September 30, 2026 and 2025:

 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
 
Dollar
Change
 
 
Percent
Change
 
Net revenue
 
 
15,110,602
 
 
 
13,912,481
 
 
 
1,198,121
 
 
 
9
%
Cost of net revenue
 
 
13,081,482
 
 
 
10,216,504
 
 
 
2,864,978
 
 
 
28
%
Gross profit
 
 
2,029,120
 
 
 
3,695,977
 
 
 
(1,666,857
)
 
 
-45
%
Sales and marketing
 
 
3,129,409
 
 
 
2,768,855
 
 
 
360,554
 
 
 
13
%
General and administrative
 
 
10,
491,210
 
 
 
5,953,441
 
 
 
4,
537,769
 
 
 
76
%
Impairment loss
 
 
1,550,216
 
 
 
6,064,603
 
 
 
(4,514,387
)
 
 
-74
%
Total operating expenses
 
 
15,
170,835
 
 
 
14,786,899
 
 
 
383,936

 
 
 
3
%
 
Loss from operations
 
 
(13,
141,715
)
 
 
(11,090,922
)
 
 
(2,050,793
)
 
 
-18
%
Other income (expense)
 
 
(3,174,888
)
 
 
(2,794,749
)
 
 
(380,139
)
 
 
-14
%
Net loss
 
 
(16,
316,603
)
 
 
(13,885,671
)
 
 
(2,430,932
)
 
 
-18
%
 
Comparable Adjustments
 
Management excludes from its evaluation of segment results the Comparable Adjustments, which affect comparability and are not reflective of the core operations of the segments. Segment operating performance and the incentive compensation of segment management are evaluated on core segment operating loss, which excludes Comparable Adjustments.
 
The Comparable Adjustments for each period are as follows:
 
 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
Net revenues
 
 
 
 
 
 
 
 
 
 
 
 
Sales of bulk wine (a)
 
 
38,270
 
 
 
-
 
 
 
38,270
 
 
 
128,736
 
Comparable adjustments, Net revenues
 
 
38,270
 
 
 
-
 
 
 
38,270
 
 
 
128,736
 
Cost of net revenues
 
 
 
 
 
 
 
 
 
 
 
 
Cost of sales of bulk wine (a)
 
 
306,057
 
 
 
-
 
 
 
306,057
 
 
 
146,565
 
Provision for losses on bulk wine purchase commitments and write-down of bulk wine (a)
 
 
2,172,125
 
 
 
124,476

 
 
 
2,172,125
 
 
 
124,476
 
Cost of write-down of unutilized wine pre-acquisition (b)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
168,930
 
Comparable adjustments, Cost of net revenues
 
 
2,478,182
 
 
 
124,476
 
 
 
2,478,182
 
 
 
439,971
 
General and administrative
 
 
 
 
 
 
 
 
 
 
 
 
Stock-based compensation (c)
 
 
90,255
 
 
 
159,708
 
 
 
537,800
 
 
 
381,172
 
Storage on bulk wine (a)
 
 
-
 
 
 
(43,838
)
 
 
-
 
 
 
102,506
 
Comparable adjustments, general and administrative
 
 
90,255
 
 
 
115,870
 
 
 
537,800
 
 
 
483,678
 
Impairment loss (d)
 
 
1,100,531
 
 
 
6,064,603
 
 
 
1,550,216
 
 
 
6,064,603
 
Comparable adjustments, Operating loss
 
 
(3,
630,698
)
 
 
(6,304,949
)
 
 
(4,527,928
)
 
 
(6,859,516
)
 
(a) Sales from divested business unit relate to the sale of Winc.com in June 2023. Those revenues, the associated costs and the storage costs incurred on the excess bulk wine are not part of our recurring business and are excluded from what our chief operating decision maker (“CODM”) views as regular operations, as are the related operating expenses. For 2026, (a) comprises the third-quarter 2026 bulk wine items described in Note 16 to our unaudited condensed consolidated financial statements and under “Gross profit” below. For 2025, (a) also includes a $124,476 loss on bulk wine purchase commitments recorded in the third quarter of 2025, which, as in our 2025 annual financial statements, is excluded because it resulted from our historical acquisitions and not from core wine operations.
 
(b) Write-down of excess bulk wine acquired with Winc, which we no longer sell through our own channels and do not consider part of ongoing operations.
 
(c) The Company does not include stock-based compensation in its evaluation of performance.
 
(d) The Company does not include impairment loss in its evaluation of performance.
 
23
 
Business Segments

Net revenue

 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Dollar
Change
 
 
Percent
Change
 
Wine & Spirits
 
 
4,644,092
 
 
 
3,930,060
 
 
 
714,032
 
 
 
18
%
Non-Alcoholic and Functional
 
 
641,153
 
 
 
122,046
 
 
 
519,107
 
 
 
425
%
Unallocated amounts
 
 
45,000
 
 
 
15,000
 
 
 
30,000
 
 
 
200
%
Comparable adjustments
 
 
38,270
 
 
 
-
 
 
 
38,270
 
 
 
n/m
Consolidated net revenues
 
 
5,368,515
 
 
 
4,067,106
 
 
 
1,301,409
 
 
 
32
%

 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
 
Dollar
Change
 
 
Percent
Change
 
Wine & Spirits
 
 
13,453,231
 
 
 
13,236,677
 
 
 
216,554
 
 
 
2
%
Non-Alcoholic and Functional
 
 
1,574,101
 
 
 
522,068
 
 
 
1,052,033
 
 
 
202
%
Unallocated amounts
 
 
45,000
 
 
 
25,000
 
 
 
20,000
 
 
 
80
%
Comparable adjustments
 
 
38,270
 
 
 
128,736
 
 
 
(90,466
)
 
 
-70
%
Consolidated net revenues
 
 
15,110,602
 
 
 
13,912,481
 
 
 
1,198,121
 
 
 
9
%
 
Consolidated net revenues increased 32% for the third quarter of 2026 and 9% for the nine months ended September 30, 2026. Non-Alcoholic and Functional net revenues increased to $0.6 million for the quarter and $1.6 million for the nine-month period, driven by growth of Good Twin, including direct-to-consumer and marketplace volume, and by AMASS Electrolytes, which launched in the second quarter of 2026 and contributed its first full quarter of wholesale and direct-to-consumer revenue.
 
Wine & Spirits net revenues increased 18% to $4.6 million for the third quarter of 2026 and 2% to $13.5 million for the nine-month period. Third-quarter 2026 shipments increased across the continuing wine portfolio and Calirosa compared with a third quarter of 2025 that was affected by the portfolio optimization, partially offset by the wind-down of discontinued brands. Unallocated net revenues are shared-services fees charged to Afterdream, a related party (see Note 14 to our unaudited condensed consolidated financial statements), and comparable adjustments to net revenues are the bulk wine sales described in footnote (a) under “Comparable Adjustments” above.
 
Core brands
 
We manage our portfolio around four priority core brands (Summer Water, Pizzolato MUSE, Good Twin and AMASS Electrolytes), where we concentrate marketing investment and distribution focus, and a broader set of other brands that we manage for cash flow and selective growth. If the brand transfer contemplated by the term sheet described in Note 17 to our unaudited condensed consolidated financial statements is completed, certain of our core brands would be removed from future results. Net revenues by brand grouping were as follows:
 

 
 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Dollar Change
 
 
Percent Change
 
Core brands
 
 
3,815,543
 
 
 
2,283,484
 
 
 
1,532,059
 
 
 
67
%
Other brands
 
 
1,624,924
 
 
 
1,684,526
 
 
 
(59,602
)
 
 
-4
%
Discontinued brands
 
 
95,973
 
 
 
276,294
 
 
 
(180,321
)
 
 
-65
%
Revenue attributable to brands
 
 
5,536,440
 
 
 
4,244,304
 
 
 
1,292,136
 
 
 
30
%
Trade spend and other amounts not attributed to a brand
 
 
(167,925
)
 
 
(177,198
)
 
 
9,273
 
 
 
5
%
Consolidated net revenues
 
 
5,
368,515
 
 
 
4,067,106
 
 
 
1,
301,409
 
 
 
32
%
 
24
 
 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
 
Dollar Change
 
 
Percent Change
 
Core brands
 
 
10,259,416
 
 
 
8,065,924
 
 
 
2,193,492
 
 
 
27
%
Other brands
 
 
4,977,
525
 
 
 
5,261,489
 
 
 
(283,964
)
 
 
-5
%
Discontinued brands
 
 
433,619
 
 
 
1,023,298
 
 
 
(589,679
)
 
 
-58
%
Revenue attributable to brands
 
 
15,670,
560
 
 
 
14,350,711
 
 
 
1,319,
849
 
 
 
9
%
Trade spend and other amounts not attributed to a brand
 
 
(559,958
)
 
 
(438,230
)
 
 
(121,728
)
 
 
-28
%
Consolidated net revenues
 
 
15,
110,602
 
 
 
13,912,481
 
 
 
1,
198,121
 
 
 
9
%

Core brand net revenues grew 67% for the three months and 27% for the nine months ended September 30, 2026 and represented 69% of revenue attributable to brands for the third quarter of 2026, compared with 54% in the prior-year quarter. All four core brands contributed: Good Twin and AMASS Electrolytes in the Non-Alcoholic and Functional segment, and higher third-quarter wholesale shipments of Summer Water and Pizzolato MUSE against a soft prior-year quarter. Other brands declined 4% for the quarter and 5% for the nine-month period on lower volume across the imported portfolio and the legacy AMASS wine and spirits labels, including the Biokult inventory quality issue described in our Q2 2026 Form 10-Q, partially offset by growth in Calirosa and the Pizzolato non-alcoholic spritz line. Discontinued brands (Gem&Bolt, Pizzolato Fields, Win and the other wine labels we have exited or are winding down, including the remaining Winc-legacy labels) declined 65% and 58%, consistent with the portfolio optimization described under “Strategy” above.
 
Trade spend and other amounts not attributed to a brand comprise promotional allowances, distributor billbacks and chargebacks, and similar payments and credits to distributors and retailers recorded as reductions of revenue, together with other revenue adjustments recorded after the initial sale that our general ledger does not attribute to an individual brand. These amounts decreased 5% for the third quarter of 2026, which includes $0.2 million of quarter-end accruals for distributor billbacks and promotional programs, and increased 28% for the nine-month period, reflecting expanded promotional programming behind wholesale placements for our core brands, deductions on the discounted sell-through of slower-moving inventory and the second-quarter distributor chargebacks and reconciliation items described in our Q2 2026 Form 10-Q.
 
Channel mix — direct-to-consumer and e-commerce

 
 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
Direct-to-consumer and e-commerce
 
 
216,558
 
 
 
28,833
 
 
 
544,096
 
 
 
106,830
 
Wholesale and other
 
 
5,
151,957
 
 
 
4,038,273
 
 
 
14,
566,506
 
 
 
13,805,651
 
Consolidated net revenues
 
 
5,
368,515
 
 
 
4,067,106
 
 
 
15,
110,602
 
 
 
13,912,481
 
 
All of our direct-to-consumer and e-commerce net revenues for the three and nine months ended September 30, 2026 related to non-alcoholic products: Good Twin, which sells through its own e-commerce store and digital marketplaces, and AMASS Electrolytes, which launched direct-to-consumer in the second quarter of 2026; AMASS Electrolytes wholesale sales are presented within wholesale and other. The prior-year periods included a negligible amount of alcoholic direct-to-consumer revenue; we no longer sell alcoholic products through this channel.
 
25
 
Gross profit
 
 
 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Dollar Change
 
 
Percent Change
 
Wine & Spirits
 
 
1,692,593
 
 
 
415,068
 
 
 
1,277,525
 
 
 
308
%
Non-Alcoholic and Functional
 
 
162,948
 
 
 
31,073
 
 
 
131,875
 
 
 
424
%
Unallocated amounts
 
 
45,000
 
 
 
15,000
 
 
 
30,000
 
 
 
200
%
Comparable adjustments
 
 
(2,439,912
)
 
 
(124,476
)
 
 
(2,315,436
)
 
 
-1,860
%
Consolidated gross profit
 
 
(539,371
)
 
 
336,665
 
 
 
(876,036
)
 
 
-260
%

 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
 
Dollar Change
 
 
Percent Change
 
Wine & Spirits
 
 
4,055,464
 
 
 
3,815,357
 
 
 
240,107
 
 
 
6
%
Non-Alcoholic and Functional
 
 
368,568
 
 
 
166,806
 
 
 
201,762
 
 
 
121
%
Unallocated amounts
 
 
45,000
 
 
 
25,049
 
 
 
19,951
 
 
 
80
%
Comparable adjustments
 
 
(2,439,912
)
 
 
(311,235
)
 
 
(2,128,677
)
 
 
-684
%
Consolidated gross profit
 
 
2,029,120
 
 
 
3,695,977
 
 
 
(1,666,857
)
 
 
-45
%
 
Segment gross profit is a component of segment loss from operations, the measure of segment profitability used by our CODM (see Note 16 to our unaudited condensed consolidated financial statements), and is reconciled to consolidated gross profit by adding unallocated amounts and Comparable Adjustments.
 
Consolidated gross margin was -10.0% of net revenues for the third quarter of 2026 compared with 8.3% for the third quarter of 2025, and 13.4% for the nine months ended September 30, 2026 compared with 26.6%, as cost of net revenues increased 58% and 28%, respectively. The third-quarter 2026 decline principally reflects Comparable Adjustments on bulk wine: the $1.3 million provision for losses on bulk wine purchase commitments (see Note 7 to our unaudited condensed consolidated financial statements), the $0.9 million write-down of the remaining bulk wine we have agreed to sell to Full Glass to net realizable value and the $0.3 million net loss on the August 2026 sale of bulk wine to Full Glass. These charges were partially offset by a $0.4 million accrual of tariff refunds. Wine & Spirits segment gross margin increased to 36.4% of segment net revenues for the third quarter of 2026 from 10.6%, and to 30.1% for the nine-month period from 28.8%. The third quarter of 2025 carried $0.8 million of inventory obsolescence and variance charges recorded in connection with the portfolio rationalization and the impairment review completed in that quarter; the third quarter of 2026 included a net credit of approximately $0.3 million to inventory obsolescence and variance, principally the tariff refund accrual. Excluding inventory obsolescence and variance, segment margin for the quarter was approximately level with the prior-year quarter. For the nine-month period, the third-quarter improvement was partially offset by second-quarter clearance sales of slower-moving inventory at little or no margin (including the sale of Calirosa Añejo to a discount grocery retailer), $0.3 million of first-half obsolescence and write-down charges, and tariffs on imported wine and elevated freight rates.
 
Non-Alcoholic and Functional segment gross margin was 25.4% of segment net revenues for the third quarter of 2026 compared with 25.5%, and 23.4% for the nine-month period compared with 32.0%. The nine-month margin compression is concentrated in Good Twin, where tariffs on imported product increased landed cost and we used expedited freight to keep the brand in stock through a period of rapid growth, and in the launch-period cost structure of AMASS Electrolytes, including outbound parcel freight on direct-to-consumer orders. We expect these pressures to moderate as freight and inventory positions normalize.
 
Gross margin, non-GAAP, by channel
 
Management uses gross margin by channel to evaluate the profitability of our direct-to-consumer and wholesale channels and to direct marketing and distribution investment. Gross margin by channel, on the same basis as the channel revenue table above, reflects costs directly attributable to each channel; inventory write-down and variance charges, which are not attributable to a specific channel, are presented separately:
 
 
 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
Direct-to-consumer and e-commerce gross profit
 
 
21,625
 
 
6,455
 
 
60,715
 
 
46,306
Gross margin
 
 
10.0
%
 
 
22.4
%
 
 
11.2
%
 
 
43.3
%
Wholesale and other gross profit
 
 
1,346,140
 
 
1,265,260
 
 
4,374,231
 
 
4,761,292
Gross margin
 
 
26.1
%
 
 
31.3
%
 
 
30.0
%
 
 
34.5
%
Inventory write-downs and other costs not attributed to a channel
 
 
(1,907,136
)
 
 
(935,050
)
 
 
(2,405,826
)
 
 
(1,111,621
)
Total gross profit
 
 
(539,371
)
 
 
336,665
 
 
2,029,120
 
 
3,695,977
 
Direct-to-consumer and e-commerce gross margin declined in both periods, principally reflecting outbound parcel freight (the recurring weekly e-commerce shipping cost for Good Twin and AMASS Electrolytes) and tariffs on imported product, against a very small prior-year revenue base. Wholesale and other gross margin declined on the tariff, freight and clearance-sale factors described under “Gross profit” above. The tariff refund accrual is included in inventory write-downs and other costs not attributed to a channel and is not reflected in either channel margin.
 
26

Product margin, non-GAAP, by brand grouping
 
Product margin by brand grouping was as follows. Trade spend and cost of net revenues not recorded by item, such as outbound freight, fulfillment, warehouse labor, excise taxes and inventory charges, are shown as a single reconciling line.
 
 
 
 
 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
Core brands product margin
 
 
1,556,093
 
 
950,869
 
 
4,238,329
 
 
3,428,084
Product margin percentage
 
 
40.8
%
 
 
41.6
%
 
 
41.3
%
 
 
42.5
%
Other brands product margin
 
 
406,741
 
 
617,011
 
 
1,112,351
 
 
1,992,133
Product margin percentage
 
 
25.0
%
 
 
36.6
%
 
 
22.3
%
 
 
37.9
%
Discontinued brands product margin
 
 
30,822
 
 
11,435
 
 
121,025
 
 
180,947
Product margin percentage
 
 
32.1
%
 
 
4.1
%
 
 
27.9
%
 
 
17.7
%
Trade spend and costs not attributed to individual items
 
 
(2,533,027
)
 
 
(1,242,650
)
 
 
(3,442,585
)
 
 
(1,905,187
)
Total gross profit
 
 
(539,371
)
 
 
336,665
 
 
2,029,120
 
 
3,695,977
 
The core brands we are investing behind had product margin of 40.8% for the third quarter and 41.3% for the nine months, compared with 41.6% and 42.5% in the prior-year periods, while margin pressure was concentrated in continuing other brands, reflecting the clearance activity, tariffs and Biokult disruption described above. Discontinued brands’ margins were higher than in the prior-year periods, which absorbed the clearance of the remaining Pizzolato Fields inventory below cost in the third quarter of 2025. The reconciling line contains costs our general ledger does not record by item, including the outbound parcel freight and third-party fulfillment costs of our direct-to-consumer channel, which support Good Twin and AMASS Electrolytes, the third-quarter 2025 inventory charges and the third-quarter 2026 bulk wine items and tariff refund accrual described under “Gross profit” above. We expect margins to expand as our brands scale, particularly AMASS Electrolytes, as fixed production and fulfillment costs are spread over higher volumes. We are also evaluating initiatives to improve margins, including price increases.
 
Management uses product margin to compare profitability across brand groupings. Product margin excludes the costs in the reconciling line, so it does not measure overall profitability and is not a substitute for gross profit or gross margin under GAAP.
 
Management uses adjusted gross profit and adjusted gross margin, which are non-GAAP measures, to assess product profitability excluding inventory write-down and variance charges and bulk wine items that it does not consider indicative of ongoing operations. The table below excludes the inventory write-down and variance charges and the bulk wine items that are also adjusted in Adjusted EBITDA. Adjusted gross margin is computed on consolidated net revenues without adjustment.
 
 
 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
Consolidated gross profit
 
 
(539,371
)
 
 
336,665
 
 
2,029,120
 
 
3,695,977
Gross margin
 
 
-10.0
%
 
 
8.3
%
 
 
13.4
%
 
 
26.6
%
Inventory write-downs and variance, net
 
 
1,907,136
 
 
935,050
 
 
2,175,288
 
 
1,103,980
Bulk wine, net
 
 
267,946
 
 
-
 
 
267,946
 
 
17,829
Adjusted gross profit, non-GAAP
 
 
1,635,711
 
 
1,271,715
 
 
4,472,354
 
 
4,817,786
Adjusted gross margin
 
 
30.5
%
 
 
31.3
%
 
 
29.6
%
 
 
34.6
%
 
Adjusted gross margin declined in both periods, reflecting the tariff, freight and clearance-sale factors described under “Gross profit” above, higher trade spend, including the second-quarter Biokult billbacks, and brand and channel mix, including the growing share of lower-margin direct-to-consumer non-alcoholic volume. The inventory and bulk wine adjustments are described under “Gross profit” above.

Gross margin: ongoing factors and sources of improvement


We expect losses on our remaining bulk wine purchase commitments (see Note 7 to our unaudited condensed consolidated financial statements), tariffs, freight rates, trade spend and the growing share of lower-margin direct-to-consumer volume to continue to weigh on gross margin.

We believe gross margin can improve from the following sources, although there can be no assurance that it will: (i) lower levels of Comparable Adjustments; (ii) the end of clearance activity as slower-moving inventory is sold through; (iii) a return to standard freight modes for Good Twin as its inventory position normalizes; (iv) a larger share of net revenues from wholesale sales of our core brands, since wholesale and other gross margin exceeds direct-to-consumer and e-commerce gross margin and our core brands carry higher margins than our other brands; (v) lower outbound freight and fulfillment cost per direct-to-consumer order as that channel grows; and (vi) reduced exposure to bulk wine purchase commitments, including through the brand transfer transaction described in Note 17 to our unaudited condensed consolidated financial statements, which is not binding and may not be completed. These statements are forward-looking statements; see “Cautionary Statement Regarding Forward-Looking Statements.”
 
27
 
Sales and marketing
 
 
 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Dollar
Change
 
 
Percent
Change
 
Wine & Spirits
 
 
692,571
 
 
 
766,677
 
 
 
(74,106
)
 
 
-10
%
Non-Alcoholic and Functional
 
 
348,367
 
 
 
32,188
 
 
 
316,179
 
 
 
982
%
Unallocated amounts
 
 
61,117
 
 
 
210
 
 
 
60,907
 
 
 
n/m
 
Comparable adjustments
 
 
-
 
 
 
-
 
 
 
-
 
 
 
n/m
Consolidated sales and marketing
 
 
1,102,055
 
 
 
799,075
 
 
 
302,980
 
 
 
38
%
 
 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
 
Dollar
Change
 
 
Percent
Change
 
Wine & Spirits
 
 
2,194,085
 
 
 
2,607,066
 
 
 
(412,981
)
 
 
-16
%
Non-Alcoholic and Functional
 
 
794,545
 
 
 
149,874
 
 
 
644,671
 
 
 
430
%
Unallocated amounts
 
 
140,779
 
 
 
11,915
 
 
 
128,864
 
 
 
1,082
%
Comparable adjustments
 
 
-
 
 
 
-
 
 
 
-
 
 
 
n/m
Consolidated sales and marketing
 
 
3,129,409
 
 
 
2,768,855
 
 
 
360,554
 
 
 
13
%
 
Sales and marketing expense, which includes the payroll costs of our sales, marketing and digital teams, increased 38% to $1.1 million for the third quarter of 2026 and 13% to $3.1 million for the nine-month period. Non-Alcoholic and Functional sales and marketing expense increased to $0.3 million for the quarter and $0.8 million for the nine-month period, reflecting investment behind Good Twin and the AMASS Electrolytes launch, including paid digital media (principally Meta) and other media fees of $0.6 million for the nine-month period compared with $0.1 million in the prior year. Wine & Spirits sales and marketing expense decreased 10% for the quarter and 16% for the nine-month period on tighter discipline around trade, sampling and promotional spend. Unallocated sales and marketing of $0.1 million for the nine-month period is corporate brand and public-relations spend.
 
General and administrative
 

 
 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Dollar
Change
 
 
Percent
Change
 
Wine & Spirits
 
 
780,362
 
 
 
1,042,957
 
 
 
(262,595
)
 
 
-25
%
Non-Alcoholic and Functional
 
 
378,715
 
 
 
37,379
 
 
 
341,336
 
 
 
913
%
Unallocated amounts
 
 
670,885
 
 
 
721,943
 
 
 
(51,058
)
 
 
-7
%
Comparable adjustments
 
 
90,255
 
 
 
115,870
 
 
 
(25,615
)
 
 
-22
%
Consolidated general and administrative
 
 
1,920,217
 
 
 
1,918,149
 
 
 
2,068
 
 
 
0
%
 

 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
 
Dollar
Change
 
 
Percent
Change
 
Wine & Spirits
 
 
2,547,146
 
 
 
3,429,177
 
 
 
(882,031
)
 
 
-26
%
Non-Alcoholic and Functional
 
 
708,105
 
 
 
137,360
 
 
 
570,745
 
 
 
416
%
Unallocated amounts
 
 
6,698,159
 
 
 
1,903,226
 
 
 
4,794,933
 
 
 
252
%
Comparable adjustments
 
 
537,800
 
 
 
483,678
 
 
 
54,122
 
 
 
11
%
Consolidated general and administrative
 
 
10,
491,210
 
 
 
5,953,441
 
 
 
4,
537,769
 
 
 
76
%
 
General and administrative expense was essentially unchanged for the third quarter of 2026 and increased $4.5 million, or 76%, for the nine-month period, principally from unallocated corporate costs of operating as a public company. Third-quarter 2026 G&A is net of a $0.4 million out-of-period reduction for the Maxim placement agent fee that was expensed in the second quarter (see Note 3 to our unaudited condensed consolidated financial statements). Unallocated G&A was $0.7 million for the third quarter of 2026 compared with $0.7 million; excluding that reduction, it increased mainly from higher legal and directors’ and officers’ insurance costs, partially offset by lower financial advisory fees. For the nine-month period, unallocated G&A was $6.7 million compared with $1.9 million, mainly from $3.0 million of professional fees related to the Direct Listing and the Series C financing, of which $2.6 million was settled in shares of Common Stock, and higher legal, investor relations and insurance costs. Wine & Spirits G&A declined 26% for the nine-month period, while Non-Alcoholic and Functional G&A grew with the build-out of AMASS Electrolytes. Stock-based compensation, presented within Comparable Adjustments, was $0.1 million for the third quarter of 2026 and $0.5 million for the nine-month period.
 
Impairment
 
We recognized a $1.1 million impairment loss in the third quarter of 2026 on our investment in the Afterdream SAFE (see Note 6 to our unaudited condensed consolidated financial statements). Impairment loss of $1.6 million for the nine months ended September 30, 2026 also included the $0.3 million second-quarter impairment of our investment in Full Glass in connection with the Side Letter Agreement described in Note 6 and the $0.1 million first-quarter impairment of intangible assets associated with our Gem&Bolt acquisition. In the third quarter of 2025, we recognized a $6.1 million impairment of goodwill and intangible assets, principally related to the 222 Spirits (Calirosa) reporting unit. Impairment amounts are treated as Comparable Adjustments.

The Afterdream impairment is a non-cash charge. It reflects the measurement of our SAFE at its estimated fair value at September 30, 2026, which takes into account Afterdream’s results to date, the timing of its product relaunch, the federal restrictions on hemp-derived THC products scheduled to take effect on December 11, 2026, and its near-term funding needs. We continue to believe in Afterdream and its prospects for continued growth, including its non-THC product line and the relaunch planned for 2027.

Management continues to believe, consistent with views expressed by other industry leaders, that a workable regulatory framework for hemp-derived THC products will be agreed by early
2027 although
the timing and outcome remain uncertain. In parallel, Afterdream is preparing to launch non-THC products in the first quarter of 2027, expanding the brand into categories that do not depend on the resolution of THC regulation. These developments are reflected in our assessment of the investment’s fair value, which assigns a 20% probability to a scenario in which Afterdream’s hemp-derived THC sales continue.

 
28
 
Operating loss

 
 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Dollar Change
 
 
Percent Change
 
Wine & Spirits
 
 
219,660
 
 
 
(1,394,566
)
 
 
1,614,226
 
 
 
116
%
Non-Alcoholic and Functional
 
 
(564,134
)
 
 
(38,494
)
 
 
(525,640
)
 
 
-1,366
%
Unallocated amounts
 
 
(
687,002
)
 
 
(707,153
)
 
 
20,151
 
 
 
3
%
Comparable adjustments
 
 
(3,
630,698
)
 
 
(6,304,949
)
 
 
2,674,251
 
 
 
42
%
Consolidated operating loss
 
 
(4,662,174
)
 
 
(8,445,162
)
 
 
3,782,988
 
 
 
45
%
 
 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
 
Dollar Change
 
 
Percent Change
 
Wine & Spirits
 
 
(685,767
)
 
 
(2,220,886
)
 
 
1,535,119
 
 
 
69
%
Non-Alcoholic and Functional
 
 
(1,134,082
)
 
 
(120,428
)
 
 
(1,013,654
)
 
 
-842
%
Unallocated amounts
 
 
(6,793,938
)
 
 
(1,890,092
)
 
 
(4,903,846
)
 
 
-259
%
Comparable adjustments
 
 
(4,
527,928
)
 
 
(6,859,516
)
 
 
2,331,588
 
 
 
34
%
Consolidated operating loss
 
 
(13,
141,715
)
 
 
(11,090,922
)
 
 
(2,050,793
)
 
 
-18
%
 
Consolidated loss from operations narrowed by $3.8 million for the third quarter of 2026 and widened by $2.1 million for the nine-month period. The third-quarter improvement reflects the lower impairment loss described under “Impairment” above
,
the $1.3 million increase in Wine & Spirits gross profit
and the $0.4 million out-of-period reduction in general and administrative expenses described under “General and administrative” above
, partially offset by the $2.4 million of Comparable Adjustments to gross profit on bulk wine described under “Gross profit” above and the Non-Alcoholic and Functional investment. Wine & Spirits moved to segment operating income for the third quarter of 2026, and its nine-month segment operating loss narrowed, on the gross profit improvement described above. Non-Alcoholic and Functional segment operating loss widened in both periods, reflecting the sales and marketing investment described above and $0.2 million of payroll costs charged to the segment in the third quarter of 2026.
For the nine-month period, higher
unallocated amounts principally reflect the costs described under “General and administrative” above
, and
the $2.3 million decrease in Comparable Adjustments partially offset that increase.
 
Adjusted EBITDA, non-GAAP
 
In addition to our results determined in accordance with U.S. GAAP, we use Adjusted EBITDA, a non-GAAP financial measure, to evaluate our operating performance. We define Adjusted EBITDA as net loss before interest, income taxes, depreciation and amortization, further adjusted for a fixed set of add-backs: one-off deal and direct-listing costs; stock-based compensation; stock-settled banker fees; impairment and bad debt, net; write-off of deferred offering costs; changes in the fair value of derivative liabilities and SAFEs; inventory write-downs and variance, net, which includes losses on bulk wine purchase commitments; juice storage; merchant and factoring fees; the net results of bulk wine and of the divested business unit; and one-time items, net, under which one-time gains are deducted and one-time losses are added back. Recurring public-company operating costs (including annual exchange listing fees,
directors’
and
officers’
insurance, incremental headcount and ongoing investor-relations costs) are not added back and remain in Adjusted EBITDA.
 
We present Adjusted EBITDA because management uses it to evaluate operating performance and allocate resources, and because we believe it assists investors in comparing our operating performance across periods by removing items that are non-cash or
that we do
not
consider
indicative of our ongoing operations. Adjusted EBITDA has limitations as an analytical tool: it excludes interest expense on indebtedness we are obligated to service, it excludes depreciation and amortization of assets that will need to be replaced, and other companies may calculate similarly titled measures differently, limiting comparability. Adjusted EBITDA should be considered in addition to, and not as a substitute for or superior to, net loss or any other measure determined in accordance with U.S. GAAP. The following table reconciles net loss, the most directly comparable GAAP measure, to Adjusted EBITDA:

 
 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
Net loss
 
 
(
5,725,783
)
 
 
(8,900,627
)
 
 
(16,316,603
)
 
 
(13,885,671
)
Interest expense
 
 
374,170
 
 
 
448,333
 
 
 
2,166,072
 
 
 
2,484,585
 
Interest income
 
 
(71,849
)
 
 
(49,850
)
 
 
(75,558
)
 
 
(84,085
)
Provision for income taxes
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Depreciation and amortization
 
 
130,562
 
 
 
168,940
 
 
 
400,169
 
 
 
504,078
 
EBITDA
 
 
(5,
292,900
)
 
 
(8,333,204
)
 
 
(13,825,920
)
 
 
(10,981,093
)
One-off deal and direct-listing costs
 
 
(384,516
)
 
 
-
 
 
 
1,013,849
 
 
 
-
 
Write-off of deferred offering costs
 
 
1,184,271
 
 
 
-
 
 
 
1,698,584
 
 
 
-
 
Stock-based compensation
 
 
90,255
 
 
 
159,708
 
 
 
537,800
 
 
 
381,172
 
Impairment loss and bad debt, net
 
 
1,139,426
 
 
 
6,072,467
 
 
 
1,606,974
 
 
 
6,062,169
 
Change in fair value of derivative liabilities
 
 
(1,011,183
)
 
 
-
 
 
 
(1,198,936
)
 
 
-
 
Change in fair value of SAFEs
 
 
10,848
 
 
 
-
 
 
 
31,910
 
 
 
-
 
Stock-settled banker and advisory fees
 
 
-
 
 
 
416,105
 
 
 
2,631,800
 
 
 
416,105
 
Bulk wine, net
 
 
267,946
 
 
 
-
 
 
 
267,946
 
 
 
17,829
 
Inventory write-downs and variance, net
 
 
1,907,136
 
 
 
935,050
 
 
 
2,175,288
 
 
 
1,103,980
 
Juice storage
 
 
13,952
 
 
 
95,398
 
 
 
10,440
 
 
 
644,137
 
Merchant and factoring fees
 
 
4,008
 
 
 
27,937
 
 
 
28,943
 
 
 
49,958
 
One-time items, net
 
 
162,652
 
 
 
(15,000
)
 
 
50,789
 
 
 
(15,000
)
Total adjustments
 
 
3,384,795
 
 
 
7,691,665
 
 
 
8,855,387
 
 
 
8,660,350
 
Adjusted EBITDA
 
 
(1,908,105
)
 
 
(641,539
)
 
 
(4,970,533
)
 
 
(2,320,743
)
 
29
 
Adjusted EBITDA declined for both the third quarter and the nine months ended September 30, 2026, principally reflecting the higher ongoing public-company operating costs described under “General and administrative” above, which are not added back, the $0.4 million unrealized loss on our investment in De Soi in the third quarter of 2026, and the sales and marketing investment behind the Non-Alcoholic and Functional segment. Adjusted gross profit rose $0.4 million for the third quarter and fell $0.3 million for the nine-month period.
One-off deal and direct-listing costs for the third quarter of 2026 are net of the $0.4 million out-of-period reduction for the Maxim placement agent fee, which was added back when it was expensed in the second quarter.
Inventory write-downs and variance, net and bulk wine, net are described under “Gross profit” above; one-off deal and direct-listing costs and stock-settled banker and advisory fees under “General and administrative” above; impairment under “Impairment” above; and the write-off of deferred offering costs under “Other income (expense)” below. For the nine-month period, one-off deal and direct-listing costs also include direct-listing legal fees of $0.6 million and the initial Nasdaq listing payment. One-time items, net for the third quarter of 2026 principally comprise the glass supplier settlement loss (see Note 4 to our unaudited condensed consolidated financial statements).
 
Other income (expense)
 

 
Three months
ended September 30,
2026
 
 
Three months
ended September 30,
2025
 
 
Dollar
Change
 
 
Percent
Change
 
Interest income
 
 
71,849
 
 
 
49,850
 
 
 
21,999
 
 
 
44
%
Interest expense
 
 
(374,170
)
 
 
(448,333
)
 
 
74,163
 
 
 
17
%
Change in fair value of derivative liabilities
 
 
1,011,183
 
 
 
-
 
 
 
1,011,183
 
 
 
n/m
Change in fair value of SAFEs
 
 
(10,848
)
 
 
-
 
 
 
(10,848
)
 
 
n/m
Unrealized loss on investment at fair value
 
 
(433,764
)
 
 
-
 
 
 
(433,764
)
 
 
n/m
Other income (expense), net
 
 
(1,
327,859
)
 
 
(56,982
)
 
 
(1,
270,877
)
 
 
-2,
230
%
Consolidated other income (expense)
 
 
(1,063,609
)
 
 
(455,465
)
 
 
(608,144
)
 
 
-134
%

 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
 
Dollar
Change
 
 
Percent
Change
 
Interest income
 
 
75,558
 
 
 
84,085
 
 
 
(8,527
)
 
 
-10
%
Interest expense
 
 
(2,166,072
)
 
 
(2,484,585
)
 
 
318,513
 
 
 
13
%
Change in fair value of derivative liabilities
 
 
1,198,936
 
 
 
-
 
 
 
1,198,936
 
 
 
n/m
Change in fair value of SAFEs
 
 
(31,910
)
 
 
-
 
 
 
(31,910
)
 
 
n/m
Unrealized loss on investment at fair value
 
 
(433,764
)
 
 
-
 
 
 
(433,764
)
 
 
n/m
Other income (expense), net
 
 
(
1,817,636
)
 
 
(394,249
)
 
 
(1,
423,387
)
 
 
-
361
%
Consolidated other income (expense)
 
 
(3,174,888
)
 
 
(2,794,749
)
 
 
(380,139
)
 
 
-14
%
 
Interest expense for the third quarter of 2026 includes $0.2 million of interest on amounts payable to a bulk wine supplier (see Note 15 to our unaudited condensed consolidated financial statements). Nine-month interest expense also includes a noncash write-off of approximately $1.0 million of unamortized discount on the Convertible Notes upon their conversion in May 2026. Other income (expense), net for the third quarter of 2026 principally reflects $1.2 million of failed offering costs on the Streeterville warrant amendments (see Note 12); for the nine-month period it also includes the $0.5 million charge for the first warrant amendment in the second quarter.
The $0.4 million unrealized loss on investment at fair value is the remeasurement of our investment in De Soi (see Note 6).
The gain on the change in fair value of derivative liabilities principally reflects the remeasurement of the Series C Convertible Preferred Stock conversion feature (see Note 8).
 
30
 
Liquidity and Capital Resources
 
Sources of Liquidity
 
We have historically funded our operations through issuances of stock, credit facilities, term loans, revenue producing activities, convertible debt, and SAFE agreements. During the nine months ended September 30, 2026, we received approximately $9.0 million in aggregate from the issuance of Series C Convertible Preferred Stock and the associated warrant under the Streeterville SPA, and our Convertible Notes (aggregate principal of approximately $2.8 million plus accrued interest) converted into common stock, eliminating that indebtedness. As of September 30, 2026, we had cash and cash equivalents of approximately $0.8 million and restricted cash of approximately $0.1 million, and the outstanding balance under our ABL was approximately $3.5 million against a maximum credit of $5.0 million (subject to borrowing-base availability); the lender’s borrowing-base calculation at that date showed approximately $0.3 million of additional availability; the ABL renewed automatically through September 30, 2027, and we were in compliance with its financial covenants at September 30, 2026. Our remaining debt service consists principally of the Secured Promissory Note ($50,000 monthly through May 2027 plus a $417,000 balloon payment), $1.4 million of promissory notes bearing interest at 12%, of which $0.55 million had passed its maturity date at September 30, 2026 ($1.25 million as of the date of this Report) and the remainder matures between October 2026 and March 2027, and the $200,000 Mezzanine Secured Notes, which are past due. See Note 9. We also have long-term bulk wine purchase contracts, under which approximately $4.1 million owed at September 30, 2026 was past its contractual payment dates (see Note 15 to our unaudited condensed consolidated financial statements).
 
Based on our recurring losses from operations incurred since inception, expectation of continuing operating losses for the foreseeable future, and the need to raise additional capital to finance our future operations, we have concluded that there is substantial doubt regarding our ability to continue as a going concern within one year after the date these financial statements are issued. The conditions we considered include the unpaid Preferred Return on our Series C Convertible Preferred Stock (see “Streeterville facility” below), the Nasdaq continued-listing notices, the past-due Mezzanine Secured Notes and promissory notes described above, and our bulk wine purchase commitments, including approximately $4.1 million owed at September 30, 2026 that was past its contractual payment dates, our remaining purchase obligations and the recoverability of the related wine inventory.
 
Cash Flows
 
 
 
Nine months
ended September 30,
2026
 
 
Nine months
ended September 30,
2025
 
 
Dollar Change
 
Net cash used in operating activities
 
 
(7,612,731
)
 
 
(822,955
)
 
 
(6,789,776
)
Net cash (used in) provided by investing activities
 
 
(1,790,427
)
 
 
743,945
 
 
 
(2,534,372
)
Net cash provided by (used in) financing activities
 
 
9,502,133
 
 
 
216,777

 
 
9,285,356
 
Net change in cash, cash equivalents and restricted cash
 
 
98,975
 
 
 
137,767
 
 
 
(38,792
)
 
Operating activities.
Net cash used in operating activities was $7.6 million for the nine months ended September 30, 2026, compared with $0.8 million for the prior-year period. The increase reflects the higher cash operating loss (the net loss includes $8.
7 million and $8.
8 million of net noncash items in
the current and prior-year periods, respectively
, including the $6.1 million impairment in the prior-year period) and a $1.9 million increase in accounts receivable, partially offset by a $1.2 million increase in contract liabilities and a $1.1 million increase in accounts payable. The prior-year period benefited from a $3.1 million reduction in inventory and a $1.2 million increase in interest payable. See the condensed consolidated statements of cash flows for the other changes in operating assets and liabilities.
 
Investing activities.
Net cash used in investing activities was $1.8 million for the nine months ended September 30, 2026, reflecting $1.8 million of purchases of related-party investments (the Afterdream and HpO SAFEs), compared with $0.7 million provided in the prior-year period (which included $0.5 million of proceeds from the partial sale of our De Soi investment and $0.4 million of collections on the Full Glass note receivable, partially offset by $0.2 million of advances to related parties).
 
Financing activities.
Net cash provided by financing activities for the nine months ended September 30, 2026 was $9.5 million, driven by approximately $9.0 million of Series C proceeds (First, Second and Third Closings), $1.4 million of convertible note proceeds received in the first quarter, $0.9 million of warrant and option exercises and $0.2 million of net ABL draws, partially offset by $0.9 million of offering costs paid in cash, $0.3 million of repayments of loans payable (the Secured Promissory Note installments and the related-party Mezzanine Secured Note), $0.25 million of repayments of promissory notes and the $0.4 million settlement of the repurchase obligation. The prior-year period provided $0.2 million: $0.9 million of promissory note proceeds and $0.5 million of common stock issuances exceeded $0.7 million of loan repayments, $0.4 million of offering costs and $0.1 million of net repayments under the ABL.
 
Streeterville facility
 
Under the SPA, subsequent purchases of Series C Convertible Preferred Stock (up to the $30.0 million commitment) are at our election during the two-year commitment period, subject to
the
conditions described under “
Future funding requirements” below. Since the July 2026 Trigger Event, conversions are at
the lower of the fixed price and 90% of the lowest daily VWAP in the ten trading days
before
conversion, subject to a floor price that was reduced to $1.00 per share on October 22, 2026
;
Limited
Conversions are
not subject to the floor price
and, since
October 22, 2026
, have no minimum price (see Note 12).
The 8,825 shares of Series C Convertible Preferred Stock outstanding at September 30, 2026 had an aggregate stated value of $9.6 million; for illustration only, based on stated value and excluding accrued and unpaid Preferred Return, if all of those shares were converted at 90% of the September 30, 2026 closing price of $0.4737 per share with no minimum price, as would apply to Limited Conversions after October 22, 2026, they would convert into approximately 22.5 million shares of common stock; at the $0.75 per share minimum that applied from August 19 to October 22, 2026, approximately 12.8 million shares; and at the $1.00 per share minimum floor price that applies from October 22, 2026, approximately 9.6 million shares. We had 11.9 million shares of common stock outstanding at September 30, 2026. These amounts are before the 9.99% beneficial ownership limitation and the Exchange Cap. We believe this facility will enhance near-term liquidity but will also result in dilution to existing stockholders and could constrain other financing alternatives. We have not paid the Preferred Return on the Series C Convertible Preferred Stock that was payable after June 30, 2026 and September 30, 2026; accrued and unpaid Preferred Return was $0.2 million at September 30, 2026. Failure to pay the Preferred Return when due permits the holders to declare an Event of Default, upon which the Stated Value of the Series C Convertible Preferred Stock would increase by 15%
for each declaration
(approximately $1.4 million
for one declaration and $2.9 million to $3.1 million for both
) and the Preferred Return would accrue at 18% per annum. See Note 12 to our unaudited condensed consolidated financial statements.
 
31
 
Future funding requirements
 
We anticipate that we will continue to incur net losses for the foreseeable future.
On October 26,
2026, we
issued
additional Series C Convertible Preferred Stock to Streeterville
for $500,000, which we received in November 2026
(see Note 17 to our unaudited condensed consolidated financial statements). The Board has called a special meeting of stockholders for December 17, 2026 to vote on authorizing one or more reverse stock splits, which may help us regain compliance with the Nasdaq minimum bid price requirement (see Note 17 to our unaudited condensed consolidated financial statements). We do not believe that our existing cash and cash equivalents, together with availability under the Streeterville facility and our ABL, will be sufficient to fund our operating plan for the twelve months following the issuance of this Report, and we will require additional capital; see the going-concern discussion above and in Note 2 to our unaudited condensed consolidated financial statements. Our ability to make further purchases under the Streeterville facility is subject to conditions, including minimum trading-price, market-capitalization and stockholders’ equity conditions that, in light of the Nasdaq notices described above, we may not be able to satisfy. We had a total stockholders’ deficit of $2.37 million at September 30, 2026, below the $2.5 million stockholders’ equity requirement of The Nasdaq Capital Market, to which we may apply to transfer our securities.
 
Our ability to continue as a going concern for the next twelve months is dependent upon our ability to generate sufficient cash flows from operations to meet our obligations, which we have not been able to accomplish to date, and/or to obtain additional working capital through equity or debt financings, refinancings or extensions of existing obligations, or reductions in operating costs.
 
Material cash requirements
 
Our material cash requirements consist primarily of debt obligations, amounts due under SAFEs upon triggering events, leases and licensing fees, payables to inventory suppliers, payables for professional services, and bulk wine purchase commitments. The table below summarizes our material cash requirements as of September 30, 2026, separated between short-term (within the next twelve months) and long-term (thereafter):

Category
 
Next 12
Months
 
 
Thereafter
 
 
Total
 
Secured credit facility principal and interest (1)
 
$
3,912
 
 
$
—
 
 
$
3,912
 
Other debt principal and interest (2)
 
 
3,035
 
 
 
165
 
 
 
3,200
 
SAFEs and convertible instruments (3)
 
 
—
 
 
 
552
 
 
 
552
 
Leases and licensing fees (4)
 
 
127
 
 
 
—
 
 
 
127
 
Supplier
and other operating
payables (5)
 
 
5,
233
 
 
 
—
 
 
 
5,
233
 
Professional service payables (6)
 
 
6,
039
 
 
 
—
 
 
 
6,
039
 
Bulk wine purchase commitments (7)
 
 
6,083
 
 
 
3,544
 
 
 
9,627
 
Total material cash requirements
 
$
24,429
 
 
$
4,261
 
 
$
28,690
 
 
(amounts in thousands)
 
Note: Amounts reflect contractual obligations and known commitments as of September 30, 2026 and do not include discretionary operating expenditures.
 
(1) Represents scheduled principal and interest payments under our credit facility, assuming renewal of the credit facility in the ordinary course consistent with historical practice. Amounts are based on contractual repayment terms in effect as of the reporting date and do not reflect potential acceleration resulting from covenant breaches or events of default. Includes twelve months of interest at the contractual minimum rate of 12% per annum on the approximately $3.5 million outstanding at September 30, 2026 ($0.4 million).
 
(2) Represents scheduled principal and interest payments under our other indebtedness based on contractual terms in effect as of the reporting date, including the Secured Promissory Note installments under Amendment No. 3, as modified by Amendment No. 4. The amounts presented do not reflect potential acceleration, extensions, refinancings, or other modifications that management may pursue.
 
(3) Our SAFEs and convertible instruments do not require scheduled cash repayment and are generally convertible into equity upon the occurrence of a qualifying financing, liquidity event, or other specified triggering events. As a result, no cash payments are reflected in the short-term column; amounts presented in the long-term column reflect potential settlement amounts only in the event that conversion does not occur.
 
(4) Represents the $42,248 monthly obligation under the Santa Maria warehouse lease through December 2026. We do not have any other material leases or licensing fees.
 
(5) Represents
amounts owed at September 30, 2026
to suppliers
in
our supply chain
(producers of wine and other products, packaging, freight, warehousing and storage) and to other operating vendors ($3.
1 million
, presented in accounts
payable
) and
to two bulk wine suppliers
under payment arrangements, including accrued interest ($2.1 million,
presented in accrued expenses on the condensed consolidated balance sheets
).
It does not include professional service payables (see footnote (6)), amounts owed under bulk wine purchase commitments (see footnote (7)), $1.3 million for goods received but not yet invoiced, or accrued payroll, taxes and other accrued expenses.
Management continues to negotiate settlements and extended payment plans with certain vendors, including the conversion of a portion of outstanding payables into term debt.
 
(6) Represents payables to professional service providers, primarily for legal and transaction services, including $2.0 million payable to an investment bank.
 
(7) Represents amounts owed at September 30, 2026 under bulk wine purchase commitments with two suppliers, all of which were past their contractual payment dates, and scheduled payments under these contracts through 2028 (approximately $2.0 million within the next twelve months and approximately $3.5 million thereafter). The $4.2 million liability for losses on these commitments (see Note 7 to our unaudited condensed consolidated financial statements) is not added to these amounts. Storage fees on wine not picked up are not included. The amounts do not reflect the brand transfer term sheet described in Note 17 to our unaudited condensed consolidated financial statements.

 
32

 
Critical estimates
 
Inventory valuation
 
Inventories are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out (FIFO) method and includes all costs to bring inventory to its current condition, including inbound freight and duties. We regularly evaluate inventory for potential obsolescence, slow-moving or excess quantities, spoilage, shrinkage, and changes in net realizable value. These estimates require management judgment and are influenced by factors such as changes in consumer demand, supply chain disruptions, inflation, and raw material price volatility, any of which could materially impact our results. Estimation in the periods presented included expected losses on long-term supply contracts where the net realizable value of certain inventoriable goods is believed to be below the contractual purchase price. As it pertains to the Company’s bulk wine purchase, this includes consideration of the varietal, vintage, and volume of product versus the market price.
 
Long-term contracts
 
We evaluate long-term supply and purchase contracts to determine whether the expected costs to fulfill our obligations exceed the anticipated economic benefits. When estimated costs under a supply contract exceed its realizable value, we recognize a loss for the difference in accordance with U.S. GAAP. These estimates require management judgment regarding future market prices, utilization, and recoverability, and actual results may differ from those estimates. At September 30, 2026, the liability for losses on bulk wine purchase commitments was $4.2 million. The price agreed for bulk wine under the Full Glass Side Letter Agreement is below our contractual purchase price and used as a floor price for liquidation value. The liability covers the expected loss on all of our firm purchase commitments at September 30, 2026; a decline in the expected market price for the contracted wine would increase the liability.
 
Impairment on goodwill
 
We allocate the purchase price in business combinations to net assets, including identifiable intangible assets and goodwill. Goodwill and indefinite-lived intangible assets are not amortized, but are tested for impairment at least annually or whenever indicators of impairment arise. Definite-lived intangible assets are amortized over their useful lives and tested for impairment when events or changes in circumstances indicate that the carrying value may not be recoverable. Inputs to impairment tests include market multiples, forecasted cash flows, growth rates, margins, allocations between reporting units, and long-term projections.

At September 30, 2026, the fair value of our Calirosa reporting unit exceeded its carrying amount by approximately 10%. A decline in the revenue multiple or in Calirosa’s results could result in an impairment of goodwill in a future period.
 
Intangible asset valuation
 
The determination of the fair value of identifiable intangible assets acquired in business combinations requires significant management judgment. The Company values trademarks and other brand-related intangible assets using the relief-from-royalty method, which estimates the present value of future after-tax cash flows saved by owning the asset rather than licensing it. Key inputs include projected revenues attributable to the acquired brands, an assumed royalty rate, and a discount rate that reflects the time value of money and the risk characteristics of the underlying cash flows.
 
Fair value of equity awards
 
We grant equity-based awards for compensation purposes. The measurement of compensation expense for these awards requires management to estimate the fair value of the underlying common stock (for awards granted prior to our Direct Listing), as well as the awards on the grant date, which require assumptions regarding expected term, volatility, dividend yield, and forfeiture rates. Changes in these assumptions could materially affect the amount of expense recognized in our financial statements.
 
Fair value measurements of investments
 
The Company measures certain investments at fair value on a recurring basis under ASC 820, using Level 3 inputs due to significant unobservable assumptions. Fair value is determined using a market-based approach that considers comparable company multiples, liquidity discounts, and recent transactions. Changes in these assumptions could materially affect the valuation.
 
Impairment of investments measured under the measurement alternative. The Company accounts for its investment in the Afterdream SAFE at cost less impairment under ASC 321. When indicators of impairment exist, the Company estimates the fair value of the investment and recognizes an impairment loss for the amount by which the carrying amount exceeds fair value. At September 30, 2026, the Company estimated the fair value of the investment at $634,469 using a venture capital method that weights two regulatory scenarios (an 80% probability that Afterdream’s hemp-derived THC sales end in December 2026), applies a revenue multiple of 3.56x based on comparable publicly traded beverage companies and a discount rate of 55%, and reflects the dilution expected from Afterdream’s future financing, and recognized an impairment loss of $1,100,531 (see Note 6 to our unaudited condensed consolidated financial statements). These inputs require significant judgment.
 
33
 
Accounts receivable
 
Accounts receivable are derived from products and services delivered to customers and are stated at their net realizable value. The Company establishes an allowance for expected credit losses on financial assets, including trade and other receivables, at each reporting date. The allowance reflects management’s estimate of lifetime expected credit losses based on historical collection experience, the type and credit quality of the customer, the age of outstanding receivables, and current and expected future economic conditions.
 
Derivative liabilities
 
The accounting for the Company’s derivative liabilities requires the use of significant estimates and management judgment. These derivative liabilities arise from the conversion feature of our Series C Convertible Preferred Stock and, before the May 20, 2026 Direct Listing, from embedded conversion features within our convertible notes that do not qualify for equity classification under applicable accounting guidance. The fair value of the conversion feature is estimated with a valuation model whose significant inputs are not observable (Level 3). At September 30, 2026, the derivative liabilities consist solely of the conversion feature of the Series C Convertible Preferred Stock, whose fair value depends on assumptions about our stock price and its volatility, the timing and amount of future conversions, and the probability of a Trigger Event or an Event of Default; its carrying value was $623,471 at September 30, 2026 (see Note 8).
 
The accounting for the August 19, 2026 amendment of the Series C Convertible Preferred Stock also required significant judgment. We concluded that the amendment was an extinguishment and that the stock is permanent equity from that date. We valued the amended stock using a 22.42% yield calibrated to the price paid at the Third Closing. The value of the conversion feature depends on our stock price and on how likely the holders are to convert at a discount. Different assumptions would change the $5.7 million deemed dividend, the $0.6 million derivative liability at September 30, 2026 and the related gain (see Notes 8 and 12 to our unaudited condensed consolidated financial statements).
 
Convertible debt
 
The accounting for the Company’s convertible promissory notes and associated warrants requires the application of complex accounting guidance and the use of significant estimates and assumptions. The Company evaluated the embedded conversion features and related warrants under applicable accounting standards to determine whether these instruments qualify for equity classification or must be accounted for as derivative liabilities. For those features that do not qualify for equity classification, the Company records them at fair value as derivative liabilities, with changes in fair value recognized in earnings until settlement or expiration. The Convertible Notes converted into Common Stock upon the Direct Listing in May 2026 (see Note 10).
 
SAFE notes
 
The accounting for the Simple Agreement for Future Equity (“SAFE”) issued in connection with the Good Twin business requires the application of significant judgment and the use of estimates. Because the SAFE contains contingent settlement provisions that could require cash settlement upon certain events outside the Company’s control, the Company concluded that the instrument should be classified as a liability and measured at fair value, with changes in fair value recognized in earnings until conversion or settlement. Estimating the fair value of the SAFE requires the use of valuation models and significant assumptions, including the estimated equity value of Good Twin, expected volatility, the probability and timing of potential equity financings or liquidity events, and other market-based inputs.
 
Emerging Growth Company and Smaller Reporting Company Status
 
The Jumpstart Our Business Startups Act of 2012 permits an “emerging growth company” such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected not to “opt out” of such extended transition period. As a result of this election, our consolidated financial statements may not be comparable to other public companies that comply with new or revised accounting pronouncements as of public company effective dates. We are also a “smaller reporting company” as defined in Rule 12b-2 under the Exchange Act and may take advantage of the scaled disclosure requirements available to smaller reporting companies.
 
34
 
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
 
Global Trade Environment
 
We continue to monitor developments in global trade policy, including the potential for new or increased tariffs and retaliatory actions by trading partners. These factors may impact our sourcing, cost structure, and international growth strategy, and we actively evaluate mitigation strategies to limit potential adverse effects. We expect certain market conditions and their related impacts to persist through fiscal 2026, which could materially affect our results of operations and financial condition. We regularly evaluate margin profiles on all of our imported products and action on mitigation strategies to reduce the impact of tariffs or other global market factors, including pricing actions, productivity improvements, inventory management, and optimized marketing, which may not be sufficient in all cases. Additionally, severe weather events could adversely impact both our supply chain and consumer purchasing behavior.
 
Inflation Risk
 
Inflationary pressures have the potential to adversely affect our business operations, financial condition, and results of operations. Rising costs associated with cost of labor, research and development costs, and raw materials can lead to increased production and operational expenses. If we are unable to pass these increased costs onto our customers through pricing adjustments, our profit margins may be negatively impacted. Furthermore, inflation can influence consumer behavior, particularly in discretionary spending categories such as premium beverages.
 
35
 
Item 4. Controls and Procedures.
 
Evaluation of Disclosure Controls and Procedures
 
We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
 
In connection with the preparation of this Quarterly Report on Form 10-Q, our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2026. Based on that evaluation, and as a result of the material weaknesses in our internal control over financial reporting described below, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2026, our disclosure controls and procedures were not effective at the reasonable assurance level.
 
Material Weaknesses
 
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.
 
In connection with the audit of our financial statements
for the year ended December 31, 2025
, our independent registered public accounting firm identified, and management concurred with, the first two of the following material weaknesses in our internal control over financial reporting, and in connection with the preparation of this Quarterly Report on Form 10-Q, management identified the third:
 
·
Absence of a comprehensive and formalized accounting and financial reporting policies and procedures manual. We did not have a comprehensive and formalized accounting and financial reporting policies and procedures manual sufficient to ensure accurate and timely financial reporting, including with respect to periodic and year-end closing procedures, accrual and cutoff of accounts receivable and accounts payable, reconciliation of significant accounts, the establishment and review of accounting estimates, the preparation and review of closing and recurring journal entries, the documentation of the responsibilities of accounting personnel and management review procedures, and the design and maintenance of effective controls over information technology systems relevant to the preparation of financial statements.
·
Insufficient segregation of duties. Certain controls were concentrated in a small number of employees and members of management, primarily as a result of our size, which prevented appropriate segregation of duties and could amplify the risk arising from related party transactions. We also had not adopted a formal approval matrix establishing authorization limits for transactions and journal entries.
·
Ineffective controls over complex and non-routine transactions. We did not design and maintain effective controls over the identification, technical accounting evaluation and review of complex and non-routine transactions, including equity and financing transactions, on a timely basis.

Notwithstanding the material weaknesses described above, our management has concluded that the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q present fairly, in all material respects, our financial position, results of operations and cash flows as of and for the periods presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
 
In preparing this Quarterly Report on Form 10-Q, we identified certain corrections required stemming from prior period transactions, which we concluded were not material to either the prior period or the current period. Management considers this a further indication of the material weaknesses described above.
 
Remediation Plan

 
Our management, with the oversight of the Audit Committee of our Board of Directors, has adopted a formal remediation plan (the “Remediation Plan”) designed to remediate the material weaknesses described above and to enhance our internal control over financial reporting. The Remediation Plan is organized into three workstreams, each directly addressing one of the identified material weaknesses. The Remediation Plan is being implemented under the oversight of the Audit Committee, which receives quarterly progress reports, and is monitored by a Remediation Steering Committee comprised of our Chief Financial Officer and Controller. Principal remediation activities include the following.
 
With respect to accounting and financial reporting policies and procedures, we are:
 
·
developing, adopting and maintaining a comprehensive accounting policies and procedures manual documenting our significant accounting policies in accordance with U.S. GAAP;
·
establishing formalized month-end, quarter-end and year-end closing procedures and checklists, including standardized close calendars, account reconciliation requirements, materiality thresholds and reviewer sign-offs;
 
36
 
·
designing and implementing formal management review controls, including variance analysis and independent review and approval of manual, non-routine and related party journal entries;
·
assessing and enhancing information technology general controls over our financial reporting systems, including user access provisioning and deprovisioning and change management controls; and
·
performing a financial reporting risk assessment, including a fraud risk assessment, and mapping identified risks to specific controls.
 
With respect to segregation of duties, we are:
 
·
assessing our accounting organization and developing a formal segregation of duties matrix to identify and resolve conflicting responsibilities;
·
preparing formal role descriptions and authorization limits, and adding or reallocating personnel as necessary so that a secondary party reviews and/or approves transactions across all significant processes;
·
establishing a formal policy and process for the identification, approval, review and monitoring of related party transactions, including Audit Committee or independent director pre-approval;
·
reviewing and configuring user roles and permissions within our enterprise resource planning system to enforce segregation of duties; and
·
implementing compensating controls, including independent Chief Financial Officer review and approval of journal entries and dual-authorization requirements for disbursements above defined thresholds, together with ongoing monitoring and periodic reporting to the Audit Committee.

With respect to complex and non-routine transactions, we are:

·
preparing technical accounting memoranda for complex and non-routine transactions, including equity and financing transactions, reviewed and approved by the Chief Financial Officer before the transactions are recorded; and
·
engaging third-party technical accounting advisors to assist with the evaluation of such transactions.

We expect to substantially complete the remediation activities within twelve months of the adoption of the Remediation Plan, but in no event later than the filing of our first Annual Report on Form 10-K that requires a management assessment of internal control over financial reporting under Section 404(a) of the Sarbanes-Oxley Act of 2002. We will not consider the material weaknesses to be remediated until the applicable controls have been designed appropriately and have operated effectively for a sufficient period of time (at a minimum, two consecutive quarterly close cycles) to permit management to conclude, through testing, that the controls are operating effectively, and until the Audit Committee has reviewed and concurred with management’s conclusion. As an “emerging growth company” within the meaning of the Jumpstart Our Business Startups Act of 2012, our independent registered public accounting firm is not required to attest to the effectiveness of our internal control over financial reporting for so long as we qualify as an emerging growth company. We can give no assurance that our remediation efforts will be successful or that additional material weaknesses will not be identified in the future.
 
Changes in Internal Control Over Financial Reporting
 
Except for the ongoing implementation of the remediation activities described above, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

On October 21, 2026, our Chief Financial Officer notified us of his resignation, and our Board of Directors has appointed Geoff McFarlane Interim Chief Financial Officer effective November 17, 2026. Mr. McFarlane controls entities with which we have related party transactions, including Resonant, which we consolidate as a variable interest entity, and HpO (see Note 14 to our unaudited condensed consolidated financial statements). Because the compensating controls described above include independent Chief Financial Officer review and approval of journal entries, related party transactions and journal entries involving these entities, and payments to Nouvelle Noir, Inc., through which his fees are paid, will be reviewed and approved by the Audit Committee, without Mr. McFarlane’s participation.
 
Inherent Limitations on Effectiveness of Controls
 
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.
 
37
 
PART II - OTHER INFORMATION
 
Item 1. Legal Proceedings.
 
None.
 
Item 1A. Risk Factors.
 
As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. For additional risks relating to our operations carefully consider the factors discussed in “Risk Factors” of our Prospectuses dated May 18, 2026
(File No.: 333-294941) and July 6, 2026 (File No.: 333-297139) (collectively “Prospectuses”), which could materially affect our business, financial condition or future results.

Except as described below, there have been no other material changes from the Risk Factors as previously disclosed in such Prospectuses.
The risks described in our Prospectuses and herein are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially adversely affect our business, financial condition, cash flows and/or future results.


We have received notices from Nasdaq that we do not meet certain continued listing requirements of The Nasdaq Global Market, and if we do not regain compliance, our common stock could be delisted.


On July 22, 2026, we received two notification letters from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that, for the 30 consecutive business days from June 8, 2026 through July 21, 2026, (i) the market value of our listed securities was below the minimum of $50,000,000 required under Nasdaq Listing Rule 5450(b)(2)(A) and (ii) the market value of our publicly held shares was below the minimum of $15,000,000 required under Nasdaq Listing Rules 5450(b)(2)(C) and 5450(b)(3)(C). Nasdaq also noted that we do not meet the requirements of Nasdaq Listing Rule 5450(b)(3)(A). The notices had no immediate effect on the listing or trading of our common stock.


We have until January 19, 2027 to regain compliance. To regain compliance, the market value of our listed securities must close at $50,000,000 or more and the market value of our publicly held shares must close at $15,000,000 or more, in each case for a minimum of ten consecutive business days during the compliance period. Nasdaq may, in its discretion, require us to meet these requirements for a longer period, generally not more than 20 consecutive business days. If we do not regain compliance by January 19, 2027, Nasdaq will provide written notification that our common stock is subject to delisting, and we may appeal that determination to a hearings panel. We may also consider applying to transfer our common stock to The Nasdaq Capital Market, provided that we satisfy the continued listing requirements for that market. Those requirements include a stockholders’ equity requirement of $2.5 million, and we had a total stockholders’ deficit of $2.37 million at September 30, 2026. There can be no assurance that we will regain compliance, that any appeal would be successful or that any transfer would be approved.


On October 9, 2026, we received a letter from the Listing Qualifications Staff of Nasdaq stating that the bid price of our common stock had closed below $1.00 per share for the 30 consecutive business days from August 26, 2026 to October 8, 2026 and that, as a result, we do not comply with Nasdaq Listing Rule 5450(a)(1), which sets forth the minimum bid price requirement for continued listing on The Nasdaq Global Market (the “Minimum Bid Price Requirement”). The notice had no immediate effect on the listing of our common stock. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), we have a 180-calendar day grace period, through April 7, 2027, to regain compliance by evidencing a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days. If we do not regain compliance by April 7, 2027, we may be provided a second 180-calendar day period if we apply to transfer our common stock from The Nasdaq Global Market to The Nasdaq Capital Market. To qualify, we must meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, other than the Minimum Bid Price Requirement, and notify Nasdaq of our intent to cure the deficiency, including by effecting a reverse stock split if necessary. The October 9, 2026 notice does not affect the separate compliance period, through January 19, 2027, for the market value requirements described above. If we do not regain compliance within the applicable compliance periods, including any extensions that may be granted by Nasdaq, our common stock will be subject to delisting.


Receipt of the July 22, 2026 notices constituted a Trigger Event under the Certificate of Designation of our Series C Convertible Preferred Stock, which permits conversions at reduced prices. In addition, further purchases of Series C Convertible Preferred Stock by one of our investors are subject to minimum trading-price, market-capitalization and stockholders’ equity conditions that, in light of the Nasdaq notices, we may not be able to satisfy.


We intend to monitor the market value of our listed securities, the market value of our publicly held shares and the closing bid price of our common stock during the applicable compliance periods and will consider the various options available to us if our common stock does not trade at a level that is likely to regain compliance. These options include the reverse stock split for which we are seeking stockholder approval at our special meeting currently scheduled on December 17, 2026. If we effect a reverse stock split to regain compliance with the Minimum Bid Price Requirement, we must complete it no later than ten business days before the end of the applicable compliance period.


If we fail to continue to meet all applicable Nasdaq Global Market requirements in the future and Nasdaq determines to delist our common stock, the delisting could substantially decrease trading in our common stock; adversely affect the market liquidity of our common stock as a result of the loss of market efficiencies associated with Nasdaq and the loss of federal preemption of state securities laws; adversely affect our ability to obtain financing on acceptable terms, if at all; and may result in the potential loss of confidence by investors, suppliers, customers, and employees and fewer business development opportunities. Additionally, the market price of our common stock may decline further and stockholders may lose some or all of their investment.


There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq.


If Nasdaq delists our shares of common stock from trading on its exchange for failure to meet Nasdaq’s listing standards, we and our stockholders could face significant material adverse consequences including:


·
a limited availability of market quotations for our securities;
·
reduced liquidity for our securities;
·
a determination that our common stock is a “penny stock” which will require brokers trading in our Common Stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;
·
a limited amount of news and analyst coverage; and
·
a decreased ability to issue additional securities or obtain additional financing in the future.


38

The “Trigger Event” under the Certificate of Designation of our Series C Convertible Preferred Stock, conversions at prices below the original floor price and our past-due Mezzanine Secured Notes increase the risks relating to our liquidity, dilution of our existing stockholders and our ability to continue our operations.


Receipt of the July 22, 2026 Nasdaq compliance deficiency notices constituted a “Trigger Event” under the Certificate of Designation of our Series C Convertible Preferred Stock, as amended. The Trigger Event permits conversions at a price based on the recent trading price of our common stock, subject to a floor price. In addition, the August 19, 2026 amendment to the Certificate of Designation reduced the minimum price for conversions made on certain trading days (“Limited Conversions”) from $4.00 to $0.75 per share, and the October 22, 2026 amendment reduced the floor price to $1.00 per share and eliminated the minimum price for Limited Conversions. As such, investors holding our Series C Convertible Preferred Stock can convert such preferred stocks at prices below the original floor price. As a result, future conversions may be made at prices that decline with the market price of our common stock. Those conversions could result in the issuance of a substantially greater number of shares and significant dilution to our existing stockholders. The issuance and resale of these shares could depress the market price of our common stock. A lower stock price could in turn increase the number of shares issuable on conversion and make it more difficult for us to regain compliance with Nasdaq’s continued listing requirements.


In addition, the Mezzanine Secured Notes are past due. The holders may seek to exercise their remedies, and we cannot assure you that we will be able to extend or repay the notes on acceptable terms, if at all. Any such action, together with our limited cash and our need for additional capital, could adversely affect our liquidity and our ability to fund our operations. It could also require us to curtail our operations. Promissory notes with principal of $1.25 million had also passed their maturity dates and had not been repaid as of the date of this Report, we have not paid the Preferred Return on the Series C Convertible Preferred Stock when due, and the minimum conversion price for Limited Conversions has been eliminated, which increases the potential dilution described above (see Notes 9, 12 and 17 to our unaudited condensed consolidated financial statements).

 
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
 
During the three months ended September 30, 2026, we issued the following securities that were not registered under the Securities Act. On August 21, 2026, at the third closing under the Securities Purchase Agreement dated March 17, 2026 (as amended, the “SPA”) with Streeterville Capital, LLC, we issued and sold 2,000 shares of Series C Convertible Preferred Stock for an aggregate purchase price of $2,000,000, in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D. We agreed to pay Maxim Group LLC, as placement agent, a cash fee of $140,000 in connection with the third closing, which had not been paid as of September 30, 2026. On September 23, 2026, we issued 253,624 shares of common stock to Streeterville upon the conversion of 175 shares of Series C Convertible Preferred Stock, in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act; no commission or other remuneration was paid for soliciting the conversion.
 
Item 3. Defaults Upon Senior Securities.
 
(a) At September 30, 2026, principal of $200,000 of our Mezzanine Secured Notes and $550,000 of our promissory notes was past due. Accrued and unpaid interest at September 30, 2026 was $269,531 on the Mezzanine Secured Notes and $47,442 on the past-due promissory notes. As of the date of this Report, the past-due principal was $200,000 of Mezzanine Secured Notes and $1,250,000 of promissory notes, a total of $1,450,000. See Notes 9 and 17 to our unaudited condensed consolidated financial statements. (b) We have not paid the Preferred Return on our Series C Convertible Preferred Stock that was payable within five trading days after June 30, 2026 and after September 30, 2026. At September 30, 2026, accrued and unpaid Preferred Return was $242,505 ($27.48 per share) on the 8,825 shares outstanding, and a further $1,383 accrued on the 175 shares converted on September 23, 2026, a total of $243,888, of which $70,074 was past due. See Note 12 to our unaudited condensed consolidated financial statements.
 
Item 4. Mine Safety Disclosures.
 
Not applicable.
 
Item 5. Other Information.
 
Rule 10b5-1 trading arrangements –
During the three months ended September 30, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

39

Item 6. Exhibits
 
Exhibit
No.
 
 
Description
3.1

Eighth Amended and Restated Certificate of Incorporation (Incorporated by Reference to Exhibit 3.1 to Amendment No. 2 to the Company’s Registration Statement on Form S-1 (File No. 333-294941), filed with the SEC on April 30, 2026).
3.2

Bylaws (Incorporated by Reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 (File No. 333-294941), filed with the SEC on April 9, 2026).
3.3

Certificate of Designation of Preferences and Rights of Series C Convertible Preferred Stock (Incorporated by Reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on May 20, 2026).
3.4

Amended and Restated Certificate of Designation of Preferences and Rights of Series C Convertible Preferred Stock (Incorporated by Reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on August 21, 2026).
3.5

Second Amended and Restated Certificate of Designation of Preferences and Rights of Series C Convertible Preferred Stock (Incorporated by Reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on October 23, 2026).
3.6

Amendment No. 1 to the Bylaws of AMASS Brands Inc. (Incorporated by Reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on October 29, 2026).
4.1

Amendment No. 3 to the Warrant to Purchase Shares of Common Stock, dated July 10, 2026 (Incorporated by Reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with the SEC on July 10, 2026).
10.1

Side Letter Agreement, dated July 29, 2026, by and among Full Glass Wine Co., LLC, Full Glass – Licensing, LLC and AMASS Brands Inc. (Incorporated by Reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on August 5, 2026).
10.2

Warrant Termination Agreement, dated October 22, 2026, between AMASS Brands Inc. and Streeterville Capital, LLC (Incorporated by Reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on October 23, 2026).
31.1

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
32.1

Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
101.INS
 
Inline XBRL Instance Document.
101.SCH
 
Inline XBRL Taxonomy Extension Schema Document.
101.CAL
 
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF
 
Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB
 
Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE
 
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104
 
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 
40
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Date:
November 20,
2026


AMASS Brands Inc.
 
 
 
 
By:
/s/ Mark T. Lynn
 
 
Mark T. Lynn
 
 
Chief Executive Officer
 
 
(Principal Executive Officer)
 
 
 
 
By:
/s/ Mark T. Lynn
 
 
Mark T. Lynn
 
 
Acting Chief Financial Officer
 
 
(Principal Financial and Accounting Officer)

 
41

Keep reading